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Abstracts From the 24th Annual Health Care Systems
Research Network Conference, April 11–13, 2018,
Minneapolis, Minnesota
Improving Health and Well-Being: Connecting Research and Practice
Founded in 1994, the Health Care Systems Research Network (HCSRN, formerly named the
HMO Research Network) is a consortium of 18 research centers that are housed in communitybased health systems. Members of the HCSRN share a commitment to public domain research
designed to improve health and health care delivery for individuals and populations.
The HCSRN’s annual conference serves as a venue for research teams to disseminate scientific
findings, stimulate new collaborations, and share insights about conducting research in real-world
care-delivery settings. Abstracts accepted for presentation at HCSRN 2018 are published in this
supplement of Journal of Patient-Centered Research and Reviews, the official journal of the
conference. J Patient Cent Res Rev. 2018;5:56-131.

CARE SYSTEM, COMMUNITY ENGAGEMENT
OA1.01
Lessons Learned From a Program to Engage
Frontline Staff in Improvement and Innovation
Paula Lozano,1 Lorella Palazzo,1 Caitlin Morrison,1
Allen Cheadle1
Kaiser Permanente Washington Health Research Institute,
Seattle, WA
1

Background: Engaging frontline staff in problem-solving
is a core feature of a learning health system. Clinicians
and managers are close to patient care processes and well
positioned to identify opportunities for improvement and
devise potential solutions for piloting. These pilots may be
innovative interventions or adaptations of evidence-based
practices. Such efforts often face implementation challenges,
and most local pilots are not successfully scaled or spread.
Few models exist for systematically 1) engaging health care
staff in creative problem-solving, 2) ensuring successful
implementation of pilot interventions, 3) evaluating the
pilots, and 4) using findings to inform decisions about scale
and spread.
Methods: The Partnership for Innovation (PFI) program
at Kaiser Permanente Washington (formerly Group Health
Cooperative) was designed to support staff efforts to improve
and innovate by funding promising pilots. This study
examines the PFI experience, assesses program outcomes,
and extracts learnings to inform the creation and sustainment
56
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of pilot incubators within integrated health systems.
Results: Health system staff submitted proposals that
were reviewed by leaders. The PFI gave rise to and funded
50 intervention pilots between 2008 and 2016. Average
grant size was $94,500 (SD: $93,300). All pilots had an
evaluation component. Assessment of the first 7 years’
experience with PFI (n=38 projects) identified problems and
led to program redesign in 2015. In an effort to better align
pilots with the health system’s strategic goals, the redesign
included designating executive sponsorship and promoting
accountability for results. Examining the projects and
subsequent implementation success using the Consolidated
Framework for Implementation Research elucidates
constructs in four domains that are particularly relevant
for others considering similar efforts. Those constructs are
1) intervention complexity and strength of the evidence,
2) knowledge and beliefs of the individuals involved, 3)
funding, partnership, alignment and sponsorship within the
organizational setting, and 4) the opportunity to evaluate
and reflect as part of an established process. Evaluation and
reflection both supported learning in real time (formative
evaluation) and informed decisions about spreading
effective interventions and discontinuing ineffective or
infeasible ones.
Conclusion: Health systems that wish to leverage frontline
creativity in solving care delivery problems should consider
these factors.
Keywords: program evaluation, research, engagement
of stakeholders, health care organization, dissemination,
implementation, innovation, quality improvement

Supplement

OA1.02
Challenges, Lessons Learned, and Progress in
Expanding Health Plan Engagement With PCORnet
Kevin Fahey1
unaffiliated, Washington, DC

1

Background: In 2013, the Patient-Centered Outcomes
Research Institute (PCORI) established PCORnet
(National Patient-Centered Clinical Research Network), 11
clinical data research networks (CDRNs) and 18 patientpowered research networks, to create a national resource
for conducting patient-centered clinical comparative
effectiveness research. PCORnet has been challenged in
engaging health plans with the CDRNs as collaborators
sharing data and conducting research. With a common data
model, PCORnet resembles other networks, including U.S.
Food and Drug Administration’s Sentinel system and Health
Care Systems Research Network’s virtual data warehouse.
Lessons learned, particularly from Sentinel, have guided
PCORnet’s development. PCORnet is part of a national
evidence-generation network that includes government and
private entities such as manufacturers, health systems, and
insurers generating evidence to support a learning health care
system. Health plans are important partners for PCORnet
–– as sources of research questions and essential data for
answering them as well as end users of research findings.
Except for a few CDRN-specific links with individual plans,
PCORnet began with few established links to health plans.
In 2016, PCORI funded two large national health plans to
join PCORnet as partners with the CDRNs.
Methods: This highlights key lessons from a PCORIfunded Engagement Award project focused on building
collaboration by (PCORnet) and health plans. Updates on
progress since the completion of the award project will be
included.
Results: Among challenges for health plans engaging
with PCORnet: establishing trust and governance for
collaboration and use of data; efficiently merging claims and
clinical data; determining the minimum data necessary for
any purpose; and defining the business case for collaboration
by each stakeholder.
Conclusion: Among the lessons learned: organizations will
clearly be more motivated to share data when it is worth
their while to participate; health plans may be interested in
using PCORnet and sharing data to address a wide range
of research questions in which they have a stake; public
interest is a key motivating factor for sharing data through
PCORnet; completeness of data is an objective that supports
collaboration; and establishing bidirectional relationships
between the plans and CDRNs is necessary to sustain
collaboration.
Keywords: ownership, governance, health care organization,
virtual data warehouse, evaluation research, engagement
of stakeholders, research administration, contracting,
operations, HCSRN structure
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OA1.03
Real-Time Text Message Alerts to Emergency
Physicians Identifying Potential Study Candidates
Increases Clinical Trial Enrollment
Laura Simon,1 Adina Rauchwerger,1 Uli Chettipally,1
David Vinson,1 Margaret Warton,1 Anupam Kharbanda,2
Elyse O. Kharbanda,3 Dustin Ballard1
Kaiser Permanente, Oakland, CA; 2Children’s Hospitals and
Clinics of Minnesota, Minneapolis, MN; 3HealthPartners,
Minneapolis, MN
1

Background: Challenges in conducting prospective clinical
research in the emergency department (ED) include 1) the
unpredictable nature of the clinical environment, 2) the
often short duration of patient stay, and 3) the difficulty in
recognizing potentially eligible patients. To help mitigate
these challenges and increase enrollment rates in ED
research, we developed a software application that notifies
physicians if their patients are eligible for enrollment in a
prospective investigation. The Prospective Intelligence
System for Clinical Emergency Services (PISCES) system
scans electronic health records (EHR) for preselected
clinical characteristics and reports to the treating physician
via a real-time text message alert.
Methods: This investigation was conducted as part of a
larger prospective study that implemented an EHR-based
risk stratification tool for pediatric abdominal pain in the
ED. PISCES alerts began 3 months into the data collection
phase at 11 EDs across Northern California. When a patient,
age 5–20 years, with a chief complaint of abdominal pain
was admitted to the ED, the assigned provider received an
automatic text alert on their mobile phone within 3 minutes.
No protected health information was revealed in these text
alerts. Other study recruitment techniques (site investigator
education, iterative feedback, and gift card incentives) did
not change across pre- and postintervention periods. Study
enrollment rates were tracked before and after PISCES
implementation on a monthly basis. We present aggregate
enrollment over study periods by percentage of potentially
eligible patients (patients who met basic eligibility criteria)
before and after alert availability, and compare differences
in their means via chi-squared and Fisher’s exact tests.
Results: The study period ran from October 2016 through
June 2017, with PISCES implementation in January 2017.
Enrollment in the preintervention period was 10.2% (273
of 2687 eligible patients), with monthly rates ranging from
9.5% to 11.1%. Enrollment in the postintervention period
was 21.0% (1347 of 6424 eligible patients), with monthly
rates ranging from 20.8% to 24.1% (P<0.001).
Conclusion: Mobile phone text alerts of potential study
candidates to emergency physicians significantly increased
enrollment and can serve as a valuable tool to assist
prospective research in the ED setting. Additional strategies
are needed to further increase study enrollment.

www.aurora.org/jpcrr

57

Keywords: information technology adoption and
assessment, research administration, contracting, operations,
dissemination, implementation, innovation
OA1.04
Connecting Communities With Data: A Practical
Guide for Using Electronic Health Record Data to
Support Community Health
Bree Allen,1 Karen Soderberg1
Minnesota Department of Health, Saint Paul, MN

1

Background: Minnesota’s local health departments and
hospitals have a common need to develop actionable,
outcomes-oriented, and collaborative population health
assessments. Many Minnesota hospitals, being newer to this
reporting requirement, have reached out to their local public
health (LPH) departments for support in developing these
assessments and integrating social determinants of health.
Data housed within hospitals’ and health systems’ electronic
health record (EHR) systems have the potential to provide
timely data for subpopulations, geographic areas, and health
conditions that are typically underrepresented in traditional
assessment methods.
Methods: We identified a number of collaborations including
LPH departments, health plans, and providers that have
developed in Minnesota for the purpose of sharing EHR data
to support population health assessments. For example, the
Private/Public Health Informatics Collaborative (PPHIC)
is a partnership between multiple LPH departments within
Hennepin County and 5 health systems serving residents in
Hennepin County. The project’s aim is to share EHR data
from these providers, specifically around nonreportable
diseases and conditions (eg, diabetes), to produce timely
estimates of health status indicators to support program
and policy evaluation. A team based at the Minnesota
Department of Health interviewed these data-sharing
collaborations to gather best practices and lessons learned,
including definitions for EHR-extracted data, data-sharing
agreement templates, integration of social determinants of
health, data evaluation, and strategies for understanding data
limitations.
Results: Practices and lessons from Minnesota collaborations
have been combined into an informatics framework and
toolkit for guidance to support any community to develop
similar collaborations. The toolkit, freely available online,
can be used by any community to support collaboration
between LPH and health providers to explore the use of
EHR-based data for community health assessments and
public health prevention programs.
Conclusion: Communities face many challenges in acquiring
and using actionable data to measure health outcomes. By
working together to leverage EHR data and understand how
these data can describe population health, LPH can develop
strategies that can “move the needle” toward real outcomes
58
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and hospitals can understand how to apply meaningful
strategies to support community health.
Keywords: rural health, information technology adoption
and diffusion, primary care, state health policies, engagement
of stakeholders, social determinants of health, health care
organization, dissemination, implementation, innovation

CHILD, MATERNAL, AND MENTAL HEALTH
OA2.01
Risk of Febrile Seizures Following MeaslesContaining Vaccination in Children Born Preterm
or Full-Term
David McClure,1 Huong McLean,1 Nicola Klein,2 Allison
Naleway3
Marshfield Clinic Research Institute, Marshfield, WI;
Kaiser Permanente Northern California, Oakland, CA;
3
Kaiser Permanente Northwest, Portland, OR
1
2

Background: We examined whether the risk of seizures
in children born preterm would alter the known risk
relationship of age and exposure to measles-containing
vaccines (ie, measles, mumps, rubella [MMR] or measles,
mumps, rubella, varicella [MMRV]).
Methods: This was a Vaccine Safety Datalink cohort study of
children who received MCV at age 12–23 months and were
born from 2001 to 2014. Febrile seizures were identified
by electronic diagnostic codes in the inpatient or emergency
department setting. Using conditional Poisson regression, we
estimated the incidence rate ratio (IRR) for seizures associated
with measles-containing vaccine combinations (7–10 days postvaccination exposure compared to 15–42 days unexposed).
Results: There were 532,375 children that received their
first dose of MMR or MMRV at age 12 to 23 months; 45,343
were born preterm (8.5%) and 487,032 were born full-term
(91.5%). Preterm children had similar IRRs compared
with full-term children for any measles-containing vaccine
administered (IRR [95% CI]: 3.9 [2.5–6.1] vs 3.2 [2.7–3.7],
respectively; interaction P=0.394). The preterm birth status
by vaccine exposure interactions stratified by age at vaccination
were statistically indistinguishable (P=0.341 and P=0.811
for age 12–15 months and age 16–23 months, respectively).
MMRV administered to preterm children 12–15 months old
had a markedly larger IRR than for full-term children of the
same age (12 vs 4.9), although the interaction P-value was
modestly small (0.125).
Conclusion: Overall our results reinforce the recommendation
to vaccinate preterm children at their chronologic age. The
maximum benefit to risk of avoiding MMR and varicella
disease for preterm children is to vaccinate according to the
recommended childhood vaccine schedule.
Keywords: child and adolescent health, patient safety,
epidemiology
Supplement

OA2.02
Evaluating the Risk of Spontaneous Abortion
Following Inadvertent Human Papillomavirus
Vaccination in Pregnancy
Elyse O. Kharbanda,1 Gabriela Vazquez-Benitez,1
Heather Lipkind,2 Sangini Sheth,2 Jingyi Zhu,1 Allison
Naleway,3 Nicola Klein,3 Rulin Hecther,3 Matthew
Daley,3 James Donahue,4 Michael Jackson,3 Alison
Kawai,5 James D. Nordin1
HealthPartners Institute, Minneapolis, MN; 2Yale School of
Medicine, New Haven, CT; 3Kaiser Permanente Northwest,
Portland, OR; 4Marshfield Clinic Research Foundation,
Marshfield, WI; 5Harvard Pilgrim Health Care Institute,
Boston, MA
1

Background: The quadrivalent human papillomavirus
vaccine (4vHPV) has been recommended for girls 9–26
years of age in the United States since June 2006. Although
not intended for use in pregnancy, inadvertent exposures do
occur. We evaluated the risk of spontaneous abortion (SAB)
following 4vHPV vaccination during or peripregnancy
within the Vaccine Safety Datalink.
Methods: Using data from 7 Vaccine Safety Datalink
sites, we compared risks for SAB following 4vHPV in
three exposure windows: distal (16–22 weeks prior to last
menstrual period), peripregnancy (the 42 days prior to last
menstrual period), and during pregnancy (up to 19 weeks
gestation). Women 12–27 years of age with a pregnancy
between 2008 and 2014 were required to have continuous
insurance enrollment 8 months prior to pregnancy through
the end of pregnancy. We excluded therapeutic abortions,
ectopic pregnancies, gestational trophoblastic disease,
multiple gestations, SABs before 6 weeks gestation,
and women using medications increasing risk for SAB.
Pregnancy outcomes were assessed using automated
health care data for live births and via chart review for
stillbirths and SABs. Two obstetricians performed case
adjudication of SABs to confirm outcomes and gestational
age at outcome. Risks for SAB following 4vHPV during
pregnancy were compared to distal vaccination using timedependent covariate Cox models. Risks for SAB following
peripregnancy versus distal vaccination were evaluated with
standard Cox models.
Results: We identified 2800 pregnancies with 4vHPV
exposure in a specified risk window: 33% distal, 35%
peripregnancy, and 32% during pregnancy. Mean age was
22.4 years in distal and peripregnancy groups versus 21.4
years among women vaccinated during pregnancy. As
compared to distal vaccination, women receiving 4vHPV
during pregnancy had later entry into prenatal care (14 vs
12 weeks) and were more likely to receive other vaccines
during pregnancy (43% vs 24%). Among 919 women
with distal 4vHPV exposure, 10.4% experienced SAB.
Receipt of 4vHPV during pregnancy or peripregnancy
was not associated with increased risks for SAB (hazard
Supplement

ratios [95% CI]: 1.10 [0.81–1.51] and 1.07 [0.81–1.41],
respectively).
Conclusion: Inadvertent 4vHPV exposure during pregnancy
or peripregnancy is not associated with increased risk
for SAB. Next steps are to evaluate risks for the 9-valent
vaccine (9vHPV).
Keywords: child and adolescent health
OA2.03
Longitudinal Trajectories of Antidepressant Use
During Pregnancy and the Postnatal Period
Gretchen Bandoli,1 Grace Kuo,1 Renu Sugathan,1
Christina D. Chambers,1 Matthieu Rolland,2 Kristin
Palmsten3
University of California, San Diego, San Diego, CA;
University of Bordeaux, Bordeaux, France; 3HealthPartners
Institute, Minneapolis, MN
1
2

Background: Studies of antidepressant safety in pregnancy
typically reduce complex patterns of use into dichotomous
variables. Herein, we use longitudinal trajectory modeling to
describe patterns of antidepressant use in the first 32 weeks
of pregnancy, and test whether these distinct trajectories are
associated with a reduction in birth weight or gestational age
at delivery.
Methods: Our study included 166 pregnant women with
deliveries within the University of California San Diego
Health system from 2011 to 2015 who were prescribed an
antidepressant between 3 months prior to last menstrual
period and 32 weeks of gestation. Using electronic medical
records, we estimated average daily dose and cumulative
dose per week for the first 32 weeks of gestation and for the
first 13 weeks postnatal. We clustered women with similar
utilization patterns using k-means longitudinal modeling
and assessed the association between trajectory group and
birth weight and gestational age at delivery.
Results: We identified four cumulative-dose trajectory
groups and three average-daily-dose trajectory groups
in each period. Relative to the lowest cumulative-dose
trajectory group, the highest trajectory group during
pregnancy was associated with reduced birth weight on
multivariable analysis (average daily highest trajectory
vs lowest trajectory β: -314.1 g [95% CI: -613.7, -15.5])
adjusted for depression severity score, maternal age, race,
and smoking in pregnancy. Trajectory groups were not
associated with gestational age at delivery.
Conclusion: Trajectory groups of antidepressant use in
pregnancy were associated with birth weight but not with
gestational age at delivery. Longitudinal trajectories allow
for a dynamic visualization and quantification of medication
exposure during pregnancy.
Keywords: observational study, behavioral and mental
health, epidemiology, pharmaceutical prescribing/costs
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OA2.04
Implementation of Screening, Brief Intervention,
and Referral to Treatment for Behavioral Health
Problems in Pediatrics: A Qualitative Study
Stacy Sterling,1 Ashley Jones,1 Esti Iturralde,1 Asheley
Skinner,2 Agatha Hinman,1 Constance Weisner1
Kaiser Permanente Northern California Division of
Research, Oakland, CA; 2Duke University School of
Medicine, Durham, NC
1

Background: Pediatric primary care is an opportune setting
for screening, brief intervention, and referral to treatment
(SBIRT), but it has not been widely implemented, and there
is little research on factors contributing to its implementation.
What literature there is has focused on implementation of
SBIRT for adults.
Methods: This study used data from qualitative interviews
(N=20) with Kaiser Permanente Northern California
(KPNC) and community-based pediatric primary care
clinicians, specialty mental health and substance abuse
treatment clinicians, policymakers, and staff to examine
factors that may inhibit or facilitate implementation of
SBIRT in pediatric primary care. We used the Consolidated
Framework for Implementation Research (CFIR) to inform
our analysis, which used an inductive approach to build
an understanding of the complexities involved in SBIRT
implementation in pediatric primary care. Interviews were
audiotaped, transcribed, and double-coded, independently,
by coders blind to each other’s coding, using NVivo
software (QSR International Pty Ltd, Doncaster, Australia).
Themes were created based on the broad constructs of the
CFIR model: outer setting, inner setting, characteristics of
the intervention, characteristics of the individuals involved,
and process of implementation. Within those overarching
constructs, SBIRT-specific subthemes were developed
based on participant responses and informed by the extant
literature. Percentage coder agreement and a Kappa
coefficient were calculated to measure interrater reliability,
by interview, node, and across the sample.
Results: Outer-setting factors such as confidentiality
laws and societal attitudes about substance use also were
frequently cited as influencing implementation, as were
patient characteristics such as co-occurring mental health
concerns. Many respondents discussed the role of clinician
training and SBIRT skills. The single most frequently
discussed implementation facilitator was adopting an
integrated, embedded-behavioral health clinician model of
SBIRT. Interrater reliability was high: Kappa coefficients
ranged from 0.78 to 0.85, and agreement between coders
was > 98% across the constructs.
Conclusion: Participants identified many challenges to
SBIRT implementation, but responses suggested a number
of pragmatic policy and care delivery changes that could
be taken to encourage its greater adoption. We discuss such
facilitators in the context of real-world health systems.
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Keywords: child and adolescent health, behavioral and
mental health, substance abuse and addiction, dissemination,
implementation, innovation

HEALTH EQUITY
OA3.01
Using Online Portals to Reach Underrepresented
Primary Care Patients Due for Colorectal Cancer
Screening: Opportunities and Challenges
Jennifer Elston Lafata,1 Amir Alishahitabriz,1 Patrice
Jordan Fleming,1 Susan Flocke,2 Sarah Hawley,3 Resa
Jones,4 Kenneth Resnicow,3 Deirdre Shires,5 Yongyun
Shin,6 Shin-Ping Tu6
University of North Carolina at Chapel Hill, Chapel Hill,
NC; 2Case Western Reserve University, Cleveland, OH;
3
University of Michigan, Ann Arbor, MI; 4Temple University,
Philadelphia, PA; 5Michigan State University, East Lansing,
MI; 6Virginia Commonwealth University, Richmond, VA
1

Background: Patient portals represent an economical
means to offer decision support, deliver behavior change
interventions, and prevent loss to follow-up. We assess
the ability to use an electronic health record’s (EHR)
patient portal to reach primary care patients and encourage
colorectal cancer (CRC) screening following a physician
order for screening.
Methods: Cohort of adults age 50–75 years due for CRC
screening and receiving care from an integrated delivery
system in southeast Michigan was identified (N=127,333).
The EHR activity for those patients was electronically
monitored for a physician order for a stool test or
colonoscopy. Physician placement of the order triggered
patients receiving a portal inbox message inviting them
to explore an online CRC screening program. Using EHR
data, we tracked when patients were sent an email, read the
message, opened the attached communication, and agreed to
study participation. Using multivariable logistic regression,
we assessed race, gender, and age differences in account
activation, message reading, program opening, and study
participation agreement. Data are reported for the first 4
months of the trial (June 14, 2017–October 6, 2017).
Results: Overall, 59% (n=75,107) of patients did not have a
portal account. Those with an account were significantly less
likely to be male (odds ratio [OR]: 0.81, 95% CI: 0.79–0.83),
black (OR: 0.48, 95% CI: 0.47–0.49) or other minority race
(OR: 0.54, 95% CI: 0.50–0.58). During the initial trial period,
a total of 1093 messages were sent. Recipients were 63.1%
female, 62.5% white, 30.4% black, and 7.1% other race, and
mean age was 59.4 (SD: 7.3); 71.5% (n=781) of recipients
read the message, 34.5% (n=377) opened the program, and
31.0% (n=339) agreed to study participation. Black patients
were significantly less likely to read the message (OR: 0.48,
Supplement

95% CI: 0.36–0.63). Likelihood of opening the program and
agreeing to study participation increased with patient age
(OR: 1.03, 95% CI: 1.01–1.05 and OR: 1.03, 95% CI: 1.01–
1.04, respectively). No other significant differences in reach
were found.
Conclusion: Findings illustrate opportunities and challenges
afforded by online patient portals. Using the portal, we have
been able to reach and enroll a relatively large number of
primary care patients quickly and economically. Yet, black,
male and younger patients are underrepresented among those
we have reached and enrolled.
Keywords: cancer, survey research and methods, primary
care, ambulatory/outpatient care, pragmatic trials, access to
services
OA3.02
Measuring Health Equity in a Health Care System:
Development of a Health Equity Index

than expected given the population characteristics. This was
primarily driven by African American (AA) patients and, in
particular, AA women age 60+ years (HEI: 2.3) and AA men
age 45–64 years (HEI: 2.2). At this facility, utilization for
asthma by Hispanics and non-Hispanic whites was less than
expected across all ages, regardless of sex. After identifying our
target population, we partnered with a local Federally Qualified
Health Center to develop a pilot program for the population
subgroup of AA asthma patients.
Conclusion: The HEI provides information to allow the
health system to identify population subgroups that might
benefit from patient-centered asthma intervention to reduce
health inequities. The HEI and preliminary results from the
asthma pilot will be presented.
Keywords: program evaluation, ambulatory/outpatient
care, evaluation research, racial/ethnic differences, health
care, social determinants of health, chronic disease, access
to services, social work

Alice Pressman,1 Kristen Azar,1 Alice Jacobson,1
Ridhima Nerlekar,1 Sarah Robinson,1 Sylvia Sudat,1
Elizabeth Dingbaum,1 Brendan Darsie,1 Janice
Rashed,1 Erika Hall,1 Maria Moreno,1 Stephen
Lockhart1

OA3.03
Improving Thiazide Diuretic Dosing Among Blacks/
African Americans Using a Technology-Enabled
Monitoring Tool: A Mixed-Methods Evaluation of a
Health System Intervention

Sutter Health Research, Development & Dissemination,
Walnut Creek, CA

Cassondra Marshall,1 Alyce Adams,1 Lin Ma,1 Andrea
Altschuler,1 Eileen Kim,1 Mark Kim,1 Nailah Thompson,1
Joseph Young1

1

Background: Understanding health outcomes in socially
or economically disadvantaged subgroups is crucial to
improving community health, and it requires innovative
analytics and dynamic application of clinical and population
data. We designed and implemented a health equity index
(HEI), a novel empirical approach to identify and prioritize
health inequalities in health care systems.
Methods: The proposed HEI, an overall summary statistic,
is also available by race category. It represents the average
ratio of observed-to-expected hospital encounters for a
given disease in a set timeframe at a given hospital within
Sutter Health, a large health system in Northern California.
Expected encounters for a condition are adjusted by age/
sex/race for underlying population distribution of hospital
catchment area, condition prevalence, propensity to utilize
the given hospital, and average frequency of that utilization.
Underlying U.S. Census tract population estimates are
derived from the American Community Survey. Prevalence
estimates are derived from California’s Behavioral Risk
Factor Surveillance System and the California Health
Interview Survey and compiled by the California Department
of Public Health. Hospital utilization is calculated from
Sutter Health’s electronic health records. This presentation
focuses on asthma at one hospital in Alameda County,
California –– Alta Bates Summit Medical Center (ABSMC).
Results: In 2016, 649 patients utilized ABSMC 877 times for
asthma. ABSMC’s HEI of 1.5 indicates that among minority
demographic subgroups, there were 50% more encounters
Supplement

Kaiser Permanente Northern California, Oakland, CA

1

Background: Despite national guidelines calling for
use of thiazide diuretics as first-line therapy for blacks/
African Americans with hypertension, use of these
clinically effective therapies is suboptimal. In 2015, Kaiser
Permanente Northern California implemented a technologyenabled database monitoring tool to enable health care
providers to identify black patients with poor blood pressure
control who may benefit from thiazide diuretic initiation or
intensification. We conducted a mixed-methods evaluation
of this natural experiment.
Methods: We employed an interrupted time series design to
determine if implementation of the tool led to an increase in
the proportion of patients using any thiazide diuretics from
2012 to 2016. We modeled the month-to-month difference
in thiazide use between blacks and whites, overall, and by
gender. We also conducted key informant interviews with
quality and operations leaders at 5 medical centers in the
delivery system to identify modifiable facilitators and
barriers to optimal thiazide dosing and implementation of
the tool.
Results: We identified 425,379 eligible black (n=49,305)
and white (n=269,415) patients. At baseline, 36.3% of all
patients were using thiazide diuretics. A greater proportion
of blacks used thiazides at baseline compared to whites,
with highest use among black women (45.6%) and lowest
www.aurora.org/jpcrr
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use among white women (39.3%). The difference in thiazide
use between black and white men increased immediately
after implementation of the tool (0.47 percentage points,
P<0.001), reflecting an increase in the proportion of black
men using thiazides postimplementation that was not present
among whites. No difference was found for women. Factors
affecting the tool’s implementation included physician and
pharmacist resistance to maximizing thiazide doses and
differences in how and by whom the tool was managed,
partially due to the proportion of blacks served by the
medical center.
Conclusion: Implementation of the thiazide database
monitoring tool led to an increase in the overall proportion of
black men using thiazides, although the magnitude was small.
Medical center-level variation in terms of how the tool was
implemented and managed was substantial and contributed
to the tool’s effectiveness. Additional research is needed to
examine the impact of the tool on thiazide dose intensification
and to explore reasons for gender differences in thiazide use.
Keywords: evaluation research, racial/ethnic differences,
health, health care, qualitative research, quasi-experiments,
chronic disease
OA3.04
Accessible Health Services Predict Community
Health Center Patients’ Mobile Health Technology
Engagement: A Quantitative Cross-Sectional
Analysis
Sharon S. Laing,1 Ryan Sterling,2 Carlota Ocampo,3
Stacey Baugh3
University of Washington Tacoma, Tacoma, WA; 2University
of Washington School of Public Health, Seattle, WA; 3Trinity
Washington University, Washington, DC
1

Background: Mobile health technology (mHealth)
can reduce health disparities by promoting health care
involvement among low-income populations; studies are
needed to ascertain factors likely to support an engaged
patient, thus leading to positive health outcomes. Objectives:
1) assess mHealth knowledge and practices of community
health center patients; and 2) evaluate health service factors
predicting mHealth knowledge and practices.
Methods: Community health center patients in Washington
state and Washington, DC, (N=159) completed a 47item, self-administered questionnaire. Primary outcomes:
knowledge of smartphone use for wellness; frequency
of smartphone use for wellness; and use of health apps.
Predictors: 1) health services access (eg, health information
access); 2) health services satisfaction; 3) healthy eating
counseling; and 4) physical activity (PA) counseling.
Multiple regression analyses assessed impact of predictors.
Results: Mean age was 34.98 years; study population
comprised mostly women (68%), white race (36%), and
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income at/below $20,000/year (63%); 71% reported
knowledge of smartphone use for wellness, 73% used
smartphones for wellness, and 48% used health apps.
Outcome 1: PA counseling contributed uniquely to
smartphone use for wellness knowledge. Patients receiving
PA counseling were 2.61 times more likely to know about
using smartphones for wellness (odds ratio [OR]: 2.61,
95% CI: 1.01–6.73; P=0.047). Outcome 2: Two predictor
variables made unique contributions to use of health-based
mobile apps: PA counseling (OR: 2.89, 95% CI: 1.17–7.17;
P=0.022), and access to health information (OR: 0.29,
95% CI: 0.09–0.96; P=0.043). Respondents receiving
PA counseling were 2.89 times more likely to report use
of health-based mobile apps for wellness compared to
individuals not receiving PA counseling. Respondents
who reported having easy access to broad-based health
information were 0.29 times less likely to report use of
health-based mobile apps for wellness compared to those
not having easy access to health information.
Conclusion: Results suggest that health service access at
community health centers predicts patients’ engagement
with mobile health technologies outside of clinic settings.
Keywords: human subjects research, access to services,
information technology, patient-provider communication,
communication of research findings

PAIN MANAGEMENT
OA4.01
Impact of a Multidisciplinary Chronic Pain
Management Program on Patient Care Utilization
and Cost of Care
Daniel Maeng,1 Kelly Baylor,1 John Han,1 John Bulger1
Geisinger Health, Danville, PA

1

Background: In 2013, over 17,000 patients with chronic
pain-related diagnoses were seen in Geisinger Clinic.
Chronic pain patients also used over $5.1 million in opioid
prescriptions. In 2014, Geisinger’s Department of Pain
Medicine piloted the Multidisciplinary Pain Program (MPP)
to address the needs of this population. MPP consisted
of a 3-day seminar for each referred patient, followed by
12 months of comprehensive care with pain specialists.
This study sought to examine the impact of MPP on care
utilization and cost between 2014 and 2016.
Methods: This study was a retrospective health insurance
claims data analysis covering a 3-year period from January
2013 through December 2016. Among all the patients who
had been referred to MPP during the period, a subset of those
who were also Geisinger Health Plan (GHP) members was
identified. Those patients who were referred to MPP after
December 2016 served as the contemporaneous comparison
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group. GHP’s claims data for the corresponding period were
analyzed on a per-member-per-month basis. A multivariate
linear regression model with patient fixed effects was
estimated for each of the following dependent variables:
total cost (medical + prescription drug), frequencies of acute
hospital admission, outpatient emergency department visits,
and physician office visits, as well as frequency of high-end
diagnostic imaging (CT, MRI, PET, etc).
Results: 113 patients were included in the MPP intervention
group, and 69 were included in the comparison group. The MPP
intervention group was followed, on average, for approximately
1 year after the initial MPP appointment. MPP was associated
with 42% reduction in acute hospitalization (P=0.029), 18%
reduction in primary care office visits (P=0.008), and 38%
reduction in high-end imaging utilization (P=0.013). MPP also
was associated with 23% increase in specialist visits (P=0.038)
but was not associated with outpatient emergency department
visits. Lastly, MPP was associated with 20% total cost of care
reduction (P=0.038).
Conclusion: MPP has been designed to improve function
and quality of life for individuals living with chronic
pain. Results of this study support this expectation by
demonstrating that MPP was associated with significantly
lower care utilization and cost.
Keywords: financial analysis, ambulatory/outpatient care,
evaluation research, complex disease management, multiple
chronic conditions, chronic disease, health care costs,
resource use

monitoring initiatives (n=653) and control settings with
similar COT patients that did not (n=935).
Results: Among COT patients, 86.1% in the control
clinics trusted their doctor’s judgment compared to 77.9%
in the intervention clinics (P=0.002). The percentage who
worried that their doctor would stop prescribing opioid pain
medicine was 29.3% in intervention clinics and 21.8% in
control clinics (P=0.007). Among COT patients, 5.8% from
intervention clinics compared to 3.2% from control clinics
did not believe that their physician trusted in how they
managed their opiate pain medicines (P=0.002).
Conclusion: While COT patients typically reported
favorable perceptions of clinician-patient trust in managing
opiate pain medicines, implementation of dose-reduction and
risk-stratification/monitoring initiatives may have reduced
levels of trust for a small percentage of COT patients. This is
consistent with prior research suggesting that efforts to reduce
COT dose and to more closely monitor opiate use can cause
stress in doctor-patient relationship.
Keywords: program evaluation, quality of care, patientprovider communication, clinical decision-making,
chronic disease, quality improvement, patient experience/
satisfaction

OA4.02
Doctor-Patient Trust Among Chronic Pain Patients
on Chronic Opioid Therapy: A Survey

Harold Tu,1 Robert Nadeau,2 Chad Wagner2

Karen Sherman,1 Rod Walker,1 Kathleen Saunders,1
Susan Shortreed,1 Michael Parchman,1 Ryan Hansen,2
Manu Thakral,1 Evette Ludman,1 Sascha Dublin,1
Michael Von Korff1
Kaiser Permanente Washington, Seattle, WA; 2University of
Washington, Seattle, WA
1

Background: Risk reduction initiatives for patients on
chronic opioid therapy (COT) are desirable to prevent known
harms. However, more active and structured monitoring,
key components in many plans, may have adverse effects
on already challenging doctor-patient relationships. This
analysis examined the level of trust in the doctor-patient
relationship among COT patients exposed to an opioid
dose-reduction and risk-stratification/monitoring initiative
compared to patients who were not.
Methods: We surveyed 1588 adults with chronic pain
receiving COT about their views of trust in their doctor,
their doctor’s trust in them, and their concerns about
opioid prescribing and safety of opioids. The population
included adults receiving care in intervention settings that
implemented opioid dose-reduction and risk-stratification/
Supplement

OA4.03
Impact of an Opioid Prescribing Protocol on the
Prescribing Behavior at the University of Minnesota
School of Dentistry

University of Minnesota School of Dentistry, Minneapolis,
MN; 2University of Minnesota, Minneapolis, MN
1

Background: This study evaluates the use of opioid
analgesics at the University of Minnesota School of
Dentistry prior to and following implementation of an opioid
prescribing protocol for acute postsurgical pain. The misuse
of prescription pain relievers is the second most common
form of drug abuse behind marijuana. Dentists are among
the leading opioid prescribers and are responsible for the
majority of prescriptions to minors. To improve postoperative
pain management and limit the misuse of opioid medication,
the university’s Division of Oral and Maxillofacial Surgery
introduced an opioid prescription protocol in February 2016.
The protocol was based on evidence that acute postoperative
pain can be effectively managed utilizing nonsteroidal antiinflammatory drugs as the first pain management drug of
choice.
Methods: Retrospective analysis compares the number
of total opioid prescriptions and the number of tablets per
prescription in the previous 10 quarters prescribed by the
University of Minnesota School of Dentistry. Prescription
data were collected from institutional electronic health
record software.
Results: The results show an overall 47.1% decrease in the
www.aurora.org/jpcrr
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total number of opioid prescriptions in the 5 quarters after
the initial opioid prescribing protocol was approved by the
Clinical Affairs Committee in February 2016.
Conclusion: These results support the hypothesis that
an opioid prescribing protocol would be successful in
decreasing the total number of prescriptions written and
number of tablets dispensed per prescription.
Keywords: substance abuse and addiction, clinical decisionmaking, dental care, quality improvement, pharmaceutical
prescribing/costs
OA4.04
Transformative Self-Management for Chronic Pain
Utilizing Online Training and Telehealth Coaching
James Fricton,1 Robin Whitebird,2 Gabriela VazquezBenitez,1 Jeanette Y. Ziegenfuss,1 Elizabeth Grossman1
HealthPartners Institute, Minneapolis, MN; 2University of
St. Thomas, Minneapolis, MN
1

Background: The U.S. Institute of Medicine has made
research on pain conditions among its highest priorities
due to their high prevalence, functional limitations, missed
work, opioid dependency, and high cost. They recommend
that health professionals’ primary role for chronic pain
should be guiding, coaching, and assisting patients with
day-to-day self-management. However, health professionals
often lack the time and training to perform this role, and
there has been limited research on approaches for selfmanagement. A transformative care model integrates robust
self-management training with evidence-based treatment to
improve outcomes of care. The purpose of this research was
to evaluate a telehealth coach-based online training program
for self-management of chronic pain as part of routine care.
Methods: The Personalized Activated Care and Training
(PACT) program was developed to enhance understanding,
compliance, and success in self-management of pain
conditions. The program provides patients with a telehealth
coach and self-directed online self-management modules
using cognitive behavioral strategies to train patients to
reduce risk factors that contribute to delayed recovery and
implement protective actions that can reduce chronic pain.
We conducted a pilot randomized clinical trial to refine the
program and evaluate the feasibility to conduct a full trial. We
compared the PACT program to traditional self-care (TSC) for
temporomandibular disorder pain. All participants continued
usual treatment with their dental providers. We evaluated
preliminary efficacy on mean change of pain severity, jaw
function, and pain interference with daily living at 8 weeks,
presented as Cohen’s d statistics.
Results: A total of 81 subjects were randomized to PACT
or TSC; one subject withdrew from the study. Mean age
was 47 years (SD: 16), 86% of subjects were female, and
82% had pain onset of 1 year or more. Participants showed
improvement in measures of pre-post change at 8 weeks for
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pain severity (PACT: -0.94 vs TSC: -0.5) but not for pain
interference or jaw functioning.
Conclusion: This research demonstrated that a
transformative care model including telehealth coaching and
online training was feasible and ready for a broader clinical
trial. It provides an accessible, scalable, and transferable
method for self-management that can be integrated into
routine care without increasing the burden of time demands
on providers.
Keywords: information technology, patient-provider
communication, patient experience/satisfaction

INFORMED DECISION-MAKING
OA5.01
What Happens if Things Go Wrong? Searching for
Evidence of Preoperative Advance Care Planning
Discussion and Documentation Among Older
Adults Undergoing High-Risk Surgery
Ellis Dillon,1 Yan Yang,1 Victoria Tang,2 Rebecca
Sudore,2 Ming Tai-Seale3
Palo Alto Medical Foundation Research Institute,
Mountain View, CA; 2University of California, San
Francisco, San Francisco, CA; 3University of California,
San Diego, San Diego, CA
1

Background: Older adults with multiple comorbid
conditions undergoing high-risk surgery are likely to suffer
life-altering complications, which often lead to functional
and/or cognitive decline and loss of independence. Experts
strongly recommend advance care planning (ACP) in the
preoperative setting. It is unknown whether ACP discussions
happen prior to high-risk surgeries or if they are documented
in the electronic health record (EHR).
Methods: Data were from a multispecialty group practice
extracted from January 2013 to December 2014. Patients
included were ≥ 65 years old, had ≥ 1 office visit and a
Charlson index score ≥ 2, and underwent high-risk surgery
(defined by CPT codes associated with ≥ 1% postoperative
30-day or in-hospitalization mortality rate). Preoperative
documentation of ACP was defined as a Physician Order for
Life-Sustaining Treatment (POLST) or advance directive in
the EHR’s problem list. Logistic regression was performed
to test associations between ACP documentation and patient
characteristics. Detailed chart review of a random sample
of 25 decedents assessed the presence and extent of ACP
discussion and documentation.
Results: 393 patients were identified with high-risk
surgeries. Their mean age was 79 years, 45% were female,
26% were nonwhite, and 26% (n=101) had ACP documented
prior to surgery. Older age (ie, 85+ years, P<0.05), being
white (P<0.05), having ≥ 4 office visits in the year prior to
surgery (P<0.001), and having dementia/mild cognitive
Supplement

impairment (P<0.01) were associated with higher odds of
preoperative ACP documentation. Chart review revealed
that most documentation of ACP in progress notes was either
absent or cursory and did not include goals of care or values,
eg, “Patient does not want CPR,” “Brought me a copy of
advance directive, discussed,” “Feels strongly that does not
want to have CPR or ventilator.”
Conclusion: Only a quarter of older high-risk surgical
patients with multimorbidity had ACP documentation in the
EHR. Nonwhite patients were less likely and older patients
and those with cognitive impairment were more likely to
have ACP documentation. Chart review demonstrated that
documentation of these wishes may be sparse. ACP should
be incorporated into the preoperative workflow and should
include documented goals of care and values in addition to
legal forms.
Keywords: aging, elderly, geriatrics, end-of-life care/
decisions, patient-provider communication, ambulatory/
outpatient care, complex disease management, multiple
chronic conditions

given in the ED (antibiotics, dental block, narcotics),
insurance status, voucher assignment and redemption, and
ED returns. Provider prediction of voucher redemption had
poor positive and fair negative predictive values (0.531 and
0.753, respectively). We found no significant difference in
total ED charges or net margins between the two groups. Of
note, 49% of dental vouchers were redeemed, covering an
average of 79% of clinic costs.
Conclusion: Our study found that vouchers for prompt
dental care can provide access to definitive care for NTDC
and reduce ED return visits without changing ED margins.
Providers are poor predictors of patient follow-up with
dentistry. Though vouchers covered the majority of dental
clinic costs, the average cost of a clinic visit for definitive
care was less than the average cost of an ED visit for
temporizing care. To improve patient access to appropriate
care, health system coordination and cost sharing between
EDs and dental clinics should be explored further.
Keywords: health care costs, resource use, access to
services, dental care

OA5.02
A Randomized Controlled Trial of Emergency
Department Dental Care Vouchers to Improve Care
and Reduce Return Visits

OA5.03
Precision
Pharmacy:
Positioning
Clinical
Pharmacists to Improve Patient Care Through
Genetically Guided Medication Selection

Bjorn Westgard,1 Kory Kaye,1 Abigail Zagar,1 Jeffrey
Anderson,1 Sandi Wewerka,1 Kevin Nakagaki1

Rebecca Pulk,1 Mike Evans,1 Jenna Carmichael,1
Gerald Greskovic,1 Melissa Kern,1 Dean Parry,1 Eric
Wright,1 Marc Williams1

HealthPartners, Minneapolis, MN

1

Background: Emergency department (ED) visits are
increasing everywhere, with 1.4% of visits related to
nontraumatic dental conditions (NTDC). These visits
are associated with high return rates due to the limited
interventions available in the ED, widespread lack of dental
insurance, and difficulties accessing definitive dental care.
Current standards of care lead to treatment dissatisfaction and
provider stress and are frequently ineffective, insufficient,
and systemically costly.
Methods: We conducted a randomized controlled trial to
determine if distributing a voucher for prompt dental care
decreases return rates to the ED for patients with NTDC who
have Medicaid or no dental insurance. We asked providers
to predict which of these patients would follow up with a
dentist and utilize their vouchers. We also compared actual
treatment costs for participants’ visits to the ED and at our
collaborating dental clinic.
Results: From 2015 to 2016, we randomized 316 participants
to voucher (n=129) or no-voucher (n=187). In intention-totreat analysis, voucher recipients had a significantly lower
likelihood of returning to the ED at 30 days (odds ratio:
0.48, 95% CI: 0.22–1.02) and 90 days (0.49, 0.25–0.96)
as well as a longer time to first return to the ED (0.50,
0.24–1.02; 0.51, 0.27–0.97). We found no confounding
associations with demographics (age, sex, race), treatments
Supplement

Geisinger Health, Danville, PA

1

Background: Precision medicine promises to improve
patient care through the consideration of the whole person,
including genetics. We introduce the concept of “precision
pharmacy,” in which pharmacists are empowered to
implement precision medicine through the integration of
genetic information into medication selection, dosing, and
monitoring. This triad conceptual model consists of applied
clinical pharmacogenomics, medication management for
patients with genetically identified disease, and targeted
cancer pharmacotherapy.
Methods: We describe the conceptual model of precision
pharmacy with select examples from the implementation
throughout Geisinger Health.
Results: Applied clinical pharmacogenomics matches
genomic test results to just-in-time medication use and is
built on testing, data storage, clinical decision support, and
consultation. Through the genomic pharmacy consultation
service, the integration of pharmacogenomic-guided therapy
selection is occurring across Geisinger. This service is
facilitating the return of preemptive pharmacogenomic panel
results for a cohort of 2500 patients, with integrated clinical
decision support within the medical record. This service has
partnered with Geisinger’s MyCode return of results team to
guide medication therapy in patients with pathogenic/likely
www.aurora.org/jpcrr
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pathogenic variants associated with inherited disease. To
date, pharmacists have cared for over 100 patients receiving
genetic results, performing comprehensive medication
reviews, providing recommendations on potential
chemoprevention and medication avoidance directly to
patients and providers, documenting findings in the medical
record, and referring patients to Geisinger’s Medication
Therapy Disease Management Program pharmacists for “inperson” clinic visits for conditions for which collaborative
practice agreements are in place. Finally, targeted cancer
pharmacotherapy matches chemotherapy to tumor-specific
genetic markers. Oral chemotherapy pharmacists play an
active role in the management of targeted chemotherapeutic
regimens tailored to the unique genetic fingerprints within
each patient’s malignancy. This team currently manages a
panel of 800 patients receiving targeted agents.
Conclusion: As precision medicine evolves and genetic
testing becomes more common, pharmacists are key members
of the multidisciplinary team needed to improve the care and
outcomes of patients. Precision pharmacy as implemented
within Geisinger can serve as a comprehensive strategy that
guides health systems, practitioners, payers, and patients in
the most effective use of genomic information to optimize
medication therapy. As medication experts, pharmacists are
positioned to lead this effort.
Keywords: cardiovascular disease, cancer, pharmacy,
ambulatory/outpatient care, dissemination, implementation,
innovation, patient safety, pharmaceutical prescribing/costs
OA5.04
We Want to Know: Patient Comfort Speaking Up
About Breakdowns in Care and Patient Experience
Kimberly A. Fisher,1 Kelly Smith,2 Thomas H. Gallagher,3
Jim Huang,2 Jim Borton,4 Kathleen M. Mazor1
University of Massachusetts Medical School / Meyers
Primary Care Institute, Worcester, MA; 2MedStar Health
Research Institute, Hyattsville, MD; 3University of
Washington, Seattle, WA; 4MedStar Health, Columbia, MD

and April 2017. Respondents were grouped as follows:
1) no problems during hospitalization; 2) always felt
comfortable speaking up; and 3) usually/sometimes/never
felt comfortable speaking up. We compared these groups
for demographics and selected patient experience items
using chi-squared and Student’s t-test. A binomial logistic
regression model was constructed to identify independent
predictors associated with not experiencing problems and
always feeling comfortable speaking up.
Results: Responses from 10,212 patients were analyzed:
5254 indicated no problems; 3444 always felt comfortable
speaking up; 1514 usually/sometimes/never felt comfortable
speaking up. Patients who did not have any problems were
older, more likely to be African American or Hispanic,
less likely to be college educated, and reported better
overall and mental health than patients who experienced
a problem. Among patients who experienced a problem,
patients who were always comfortable speaking up were
younger, more likely to speak English, and reported
better overall and mental health compared to patients who
were not always comfortable speaking up. Patients who
always felt comfortable speaking up reported better nurse
communication (80.4 vs 47.8; P<0.01) and better physician
communication (82.6 vs 57.2; P<0.01), provided higher
hospital ratings (8.7 vs 7.1; P<0.01), and were more likely
to definitely recommend the hospital (71.7% vs 36.7%;
P<0.001) than patients who were not always comfortable
speaking up.
Conclusion: Patients who are always comfortable speaking
up about problems reported better experiences of care
across multiple HCAHPS dimensions. This illustrates
the importance of encouraging patients to speak up about
problems in care, as these may be opportunities to address
breakdowns and improve patients’ experience of care.
Keywords: patient-provider communication, hospital,
patient safety, patient experience/satisfaction

1

Background: Patients have important insights into care
experiences, particularly about breakdowns in care.
However, many patients are reluctant to speak up about
breakdowns, resulting in missed opportunities to improve
care. We sought to identify patient characteristics associated
with speaking up and to examine whether speaking up is
associated with better patient experiences.
Methods: We created a new item: “How often did you feel
comfortable speaking up if you had any problems in your
care?” with the following response options: always, usually,
sometimes, never, and Did not have any problems. This
item was administered as part of the Hospital Consumer
Assessment of Healthcare Providers and Systems (HCAHPS)
patient satisfaction survey at 8 hospitals between May 2016
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HEALTH SYSTEM IMPROVEMENT
OA6.01
Sustained Impact of Lean Redesigns on Primary
Care Workflow Efficiency
Dorothy Hung,1 Quan Truong,1 Qianyun Zhang,1 SuYing Liang,1 Harold S. Luft1
Palo Alto Medical Foundation Research Institute,
Mountain View, CA
1

Background: Workflow interventions are increasingly
being implemented to enhance practice efficiency. We
examined the sustained impact of Lean redesigns on
physician workflows 3.5 to 5 years after being introduced
in primary care clinics. We monitored performance metrics
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before and after redesigns were implemented in 46 internal
medicine, family medicine, and pediatrics departments at a
large ambulatory care delivery system.
Methods: Using a stepped-wedge study design with
interrupted time series analysis, we examined four workflow
metrics reflecting physicians’ timely completion of tasks:
1) closure of patient charts < 2 hours of the office visit; 2)
electronic reply to patient messages; 3) renewal of prescription
medications; and 4) resolution of telephone calls, each
completed in < 4 business hours. Using generalized linear
mixed models, we first estimated the immediate impact of
Lean on physician workflows. We then estimated these
effects over time by comparing postintervention metrics
with projected values had Lean not been implemented. These
counterfactual values were projected by extending baseline
trends in workflow forward until the end of the study period.
95% bias-corrected bootstrap confidence intervals were
used to compare differences between post-Lean intervention
and projected values absent Lean.
Results: After Lean intervention, there were significant
increases in timely office visit chart closures (+27.7%),
telephone resolutions (+14.1%), and prescription refills
(+34.9%). When comparing differences post-Lean vs
projected values over time, we found that physicians did
better at meeting targets for responding to patient messages
(84.3% completion) and refilling prescriptions (59.1%) with
Lean redesigns as compared with projected metrics absent
Lean (80.0% and 53.5%, respectively). However, timely
chart closure (55.3%) and telephone response (55.0%) after
the redesigns were slightly lower over time compared with
projected values at the end of the study period (56.6% and
57.8% timely completion rates, respectively).
Conclusion: These findings align with previous research
showing Lean redesigns can positively impact workflow
efficiency. However, despite large improvements
immediately following implementation, after several years
we found attenuated effects in some metrics. This finding
raises questions about intervention sustainability and
longer-term impacts of Lean redesigns on physician tasks
and workflows.
Keywords: health care workforce, primary care, quality
improvement
OA6.02
Referrals and Diagnostic Orders as a Tool to
Conclude Primary Care Visits Running Over Time
or Behind the Schedule
Sukyung Chung,1 Harold S. Luft1

who have complex conditions or who present new problems
may take extra time, primary care providers (PCPs) need to
conclude a visit within a reasonable time frame in order to
be on time for following appointments. With time pressure,
providers may consider tradeoffs between time and other
resources including referrals or diagnostic procedures. We
sought to understand situations when PCPs spend additional
time with patients. We then assessed whether PCPs resort
to more diagnostic orders or referrals when facing time
constraints.
Methods: Routine nonpreventive primary care visits
of established adult patients in a large group practice
organization were studied. Data from electronic health
records (EHR) were used to create indicators of patient,
provider, and practice characteristics at each visit. Access
logs of EHR were used to estimate visit length, defined as
time between a PCP first logged in and last logged out of the
patient chart from the examination room computer. Visits
with valid access log data, in addition to other characteristics,
in 2014 (N=339,947) were analyzed using generalized linear
models with provider random effects.
Results: Visits were longer for patients who were older,
had multiple chronic conditions, and were the PCP’s own
patients. Visits were also longer when new problems were
noted or procedures were done. Given patient and visit
characteristics, PCPs spent less time when they were under
time pressure such that visits were significantly shorter
when providers were running behind schedule and were
longer when the visit was followed by a break. Part-time
physicians spent more time with each patient. The longer
predicted visit length based on these factors was the more
likely the visit was to be involved with a referral, lab, or
imaging order. After controlling for the predicted visit
length, PCPs were much more likely to make diagnostic
orders or referrals when actual visit length was longer than
predicted visit length.
Conclusion: Primary care physicians adjust visit length
under time pressure. Making diagnostic orders or referrals
may be a way to conclude a visit when it stretches beyond
expected time.
Keywords: observational study, primary care, ambulatory/
outpatient care, health care costs, resource use, access to
services, incentives
OA6.03
Factors Associated With Physician Well-Being ––
Time for a Change

Palo Alto Medical Foundation Research Institute, Palo
Alto, CA
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Background: Time is the most scarce commodity in primary
care practices. While it is expected that visits with patients

University of California, San Diego, San Diego, CA; 2Palo
Alto Medical Foundation, Sutter Health, Palo Alto, CA
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Background: About half of America’s physicians report
burnout symptoms. In response to an organizational priority
to enhance physician well-being, we assessed physician
well-being and empirically examined its relationship with
factors encompassing multiple dimensions of their work
and life.
Methods: The study took place in a large multispecialty
group practice serving about 1 million patients. A survey
was delivered to 1292 employed physicians regarding life
satisfaction, burnout symptoms (using a nonproprietary
single-item measure), self-care practices, and perceptions
of work environment. Survey responses, electronic health
record, and administrative data on physician workload, eg,
number of InBasket messages received per week, clinical
FTE, and leadership role, were used in descriptive and
multivariate regression analyses.
Results: Survey response rate was 72%. Average life
satisfaction was 78 (SD: 16) on a scale of 0–100; 36%
reported burnout symptoms, 36% slept ≥ 7 hours/
night, 70% exercised ≥ 2 days/week, 31% practiced
mindfulness ≥ 1 day/week; 83% perceived having control
over work schedule; 12% felt that physicians are highly
valued; 60% reported calm atmosphere in work area. In
terms of workload, 43% received more than the average
(ie, 183) number of InBasket messages per week. Life
satisfaction was positively and significantly associated
with self-care practices such as sleeping ≥ 7 hours/night
(P<0.001), exercising ≥ 2 days/week (P<0.001), practicing
mindfulness ≥ 1 day/week (P<0.01), perceived control over
work schedule (P<0.001), feeling highly valued (P<0.01),
and a positive atmosphere in work area (P<0.01). Female
physicians reported lower life satisfaction (P<0.05) and
higher odds of burnout (P<0.05). Higher odds of burnout
also were associated significantly with higher volume of
InBasket messages (≥183) received per week (P<0.01)
and with having a leadership role (P<0.05). Physicians
sleeping ≥ 7 hours/night (P<0.001), exercising ≥ 2 days/
week (P<0.01), perceiving control over work schedule
(P<0.001), feeling highly valued (P<0.001), and reporting
calm atmosphere in work area (P<0.001) had lower odds
of burnout.
Conclusion: Life satisfaction and burnout symptoms
varied by self-care practices, InBasket message volume,
gender, leadership role, and perceived work experience,
suggesting important protective and harmful associations
with physician well-being. Changes in health care have
resulted in increasing numbers of female physicians,
physicians with leadership roles, and proliferating InBasket
messages. Organizational changes are necessary to address
these risk factors, eg, reducing/restructuring InBasket
work and better supporting leaders and female physicians.
Keywords: health care workforce, observational study,
survey research and methods
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Using Boot Camp Translation to Inform a SystemBased Intervention to Improve Rates of Colon
Cancer Screening Among Latino Patients in
Community Health Centers
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Jennifer Rivelli,1 Marta Castro,3 Brittany Younger,3
Melissa Castillo,3 Sacha Reich,1 Gloria Coronado1
Kaiser Permanente Center for Health Research, Portland,
OR; 2Oregon Health & Science University, Portland, OR;
3
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Background: Colon cancer is the second-leading cause of
cancer death in the United States, and screening rates are
disproportionately low among Latinos. One factor thought to
contribute to the low screening rate is the difficulty Latinos
encounter in understanding health information and therefore
in taking appropriate health action. As part of our study, we
used boot camp translation, a community-based participatory
approach, to elicit input from diverse stakeholders (ie,
patients, clinic staff) and refine the messages and format
of colon cancer screening reminders for a direct mail fecal
immunochemical testing (FIT) program.
Methods: Patient participants were Latino, age 50–75 years,
able to speak English or Spanish, and willing to participate
in an in-person meeting and follow-up conference calls.
Separate sessions were held for English- and Spanishspeaking participants. As part of the in-person meetings, a
bilingual colon cancer expert delivered a presentation on
colon health and screening messages. Boot camp translation
facilitators led interactive sessions where participants
reviewed materials and reminder messages using various
modalities (eg, text, automated call recordings). We asked
participants to consider what information about colon cancer
screening is important, what the best methods are to share
these messages, and the timing and frequency with which
these messages should be delivered to patients to encourage
FIT completion. Results were used to define the intervention
for the pilot and main trial.
Results: A total of 25 adults participated in the in-person
sessions (English, n=12; Spanish, n=13). Patient participants
were primarily enrolled in Medicaid/uninsured (64%) and
had annual household incomes less than $20,000 (56%).
Key themes from the process included increasing awareness
about colon cancer screening, stressing the urgency of
screening, enhancing discussions between provider and
patient, and using personalized messages in reminders. Both
groups noted the importance of receiving an alert before the
FIT is mailed and a reminder within 2 weeks of FIT mailing.
Conclusion: Using boot camp translation, we successfully
incorporated patient feedback to design culturally relevant
health messages to promote FIT testing among Latino
patients served by community clinics.
Keywords: cancer, patient-provider communication, racial/
ethnic differences, health, health care
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CARDIOVASCULAR DISEASE
OA7.01
Bleeding and Thromboembolism Associated With
CYP3A4 Inhibitors in Patients on Rivaroxaban
Joseph Goble,1 Kiumars Zolfaghari,2 Stephanie Yu,1
Paul Godley,1 Laurel Copeland,2 Gregory Dehmer,3
Jeffrey Michel3
Department of Pharmacy, Baylor Scott & White Health,
Temple, TX; 2Center for Applied Health Research, Baylor
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also had less thromboembolism, suggesting pharmacologic
interaction rather than chance association. While bleeding
risk increases with age, increased age cannot explain lower
rates of thromboembolism. Our data suggest that bleeding
rates for rivaroxaban may be modulated by coadministration
of agents that undergo CYP3A4 metabolism.
Keywords: cardiovascular disease, pharmacy, observational
study, quality of care, ambulatory/outpatient care,
pharmaceutical prescribing/use/costs
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Background: The factor Xa inhibitor rivaroxaban is the most
frequently prescribed novel oral anticoagulant (NOAC) in
our health care system. It is both metabolized via cytochrome
P450 3A4 (CYP3A4) and undergoes renal excretion, with
potential for CYP3A4 inhibitors (CYP3A4-i) to alter serum
levels and clinical activity. Increased bleeding is known
to occur with coadministration of platelet aggregation
inhibitors (PAI). We hypothesized that coadministration
of CYP3A4-i might increase bleeding risk while reducing
thromboembolism.
Methods: Claims from a 250,000-member system
generated a patient cohort ≥ 18 years of age with ≥ 1 claim
for rivaroxaban during 2012–2015. Inclusion required
documented prescriptions filled for rivaroxaban and
CYP3A4-i based on pharmacy claims data. Exclusions were
> 3-month gap in health plan enrollment, and no medical
claims pre/post-rivaroxaban administration. Coadministrated
CYP3A4-i included clarithromycin, diltiazem, dronedarone,
erythromycin, and verapamil. PAI included anagrelide,
aspirin, cilostazol, clopidogrel, and ticagrelor. Patients were
designated as receiving CYP3A4-i or receiving PAI, leaving
the comparison group on rivaroxaban alone (rivaroxabanonly).
Results: A total of 751 patients with average age of 70.8 years
(50% male) were included. Compared to rivaroxaban-only,
patients given CYP3A4-i (18.4%) were older (74.7 vs 69.9,
P<0.0001) and more likely to have atrial fibrillation (87% vs
47%, P<0.0001). Bleeding occurred in 8.1% of all patients
on rivaroxaban, but more commonly with coadministration
of CYP3A4-i (13.8% vs 6.9%, P=0.007) or PAI (17.5% vs
7.3%, P=0.005). Thromboembolism was reported in 10.8%
of all patients: 2.9% CYP3A4-i vs 12.6% rivaroxaban-only,
P=0.0009; 6.4% PAI vs 11.2% rivaroxaban-only, P=0.2. In
modified Poisson models adjusted for age, sex, and Charlson
score, CYP3A4-i signaled higher relative risk (RR) of bleed
(RR: 1.8, 95% CI: 1.1–3.0). A 10-year increase in age also
was associated positively with bleeding (RR: 1.6, 95% CI:
1.2–2.1) but inversely with thromboembolism (RR: 0.8,
95% CI: 0.7–0.9).
Conclusion: In our health care system, patients on
rivaroxaban plus CYP3A4-i were twice as likely to experience
bleeding as patients on rivaroxaban alone. CYP3A4-i users
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Impact of the Latest USPSTF Recommendations for
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Background: The U.S. Preventive Services Task
Force (USPSTF) recently issued a primary prevention
recommendation for statin use for individuals age 40–75
years with a cardiovascular (CV) risk factor and a 10-year
atherosclerotic CV disease (ASCVD) risk score > 10%
(grade B rating). Because the Affordable Care Act requires
insurers to cover preventive services with USPSTF ratings
of A or B without cost sharing, the impact of this USPSTF
recommendation is of interest to payers and care systems.
Methods: Electronic health record data were extracted at all
adult primary care office encounters in a large Midwestern
care system from June 1, 2016, to May 31, 2017, and
processed through a clinical decision support system called
CV Wizard that algorithmically identified CV risk factors,
calculated a 10-year ASCVD risk score, and assessed current
statin use.
Results: 207,163 unique individuals age 40–75 were
identified; 5809 (7.63%) were excluded for known CV
disease; 119,786 (57.8%) had at least one USPSTF CV risk
factor criteria (12.2% diabetes, 31.2% hypertension, 10.6%
smokers, and 33.6% dyslipidemia); and 46,173 of 207,163
(22.3%) met additional CV risk criteria of 10-year ASCVD
risk score > 10%. Only 13,594 of 46,173 (22.9%) of these
individuals were on a statin. A total of 49,815 (24%) were
determined to be eligible for statin therapy when including
an additional 3642 (1.7%) currently on a statin who would
likely meet USPSTF criteria if their statin was stopped (10year ASCVD risk score 7.5%–9.9%). Using the average
cost of $60 annually per person (atorvastatin $5/month,
simvastatin $2/month, and rosuvastatin $11/month), the
annual cost of statin medication for primary CV prevention
for patients in this care system is approximately $3 million
(not including cost related to additional office visits, labs,
and drug side effects and toxicity).
www.aurora.org/jpcrr
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Conclusion: One-fourth of all individuals age 40–75 in a
large Midwestern care system met USPSTF criteria for
statin use for primary CV prevention, and only about onefourth of them were on a statin. While statin use for primary
prevention using the USPSTF criteria is considered by most
to be cost-effective and of substantial net clinical benefit,
many operational and cost challenges exist to providing this
service to patients.
Keywords: cardiovascular disease, pharmaceutical
prescribing/costs

Conclusion: Our study provides the best longitudinal
profile of CVD risk in the Somali community. Rising rates
of diabetes, hypertension, and dyslipidemia are of concern,
while obesity and smoking are of particular concern in
women and men, respectively. This research identifies the
most modifiable targets of CVD risks to which treating
clinicians, health systems, and public health efforts should
devote their resources.
Keywords: cardiovascular disease, racial/ethnic differences,
health, health care
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Background: Since the early 1990s, Somali people from
East Africa have been migrating to and assimilating in
more developed countries where new environments have
affected dietary intake and energy expenditures. The effects
of these new health risks among Somalis warrant assessment
to prioritize public health measures to prevent metabolic
syndrome and cardiovascular disease (CVD). However,
assessments to date have largely employed self-reported and
clinic data. Our current study provides the best estimate of
changing CVD risks in the Somali community.
Methods: The prevalence of CVD risk was determined in
Somali adults in the Twin Cities metro area at two points in
time by trained ethnicity- and gender-concordant community
health workers. In 2001, a cluster-randomized sample of
Somali household members (N=253) was surveyed. In 2015–
2016, a larger respondent-driven sample of the growing
Somali community (N=1180) was surveyed to approximate
a random sample. In both efforts we measured body mass
index, waist circumference, blood pressure, hemoglobin
A1c, total cholesterol, and high-density lipoprotein as well
as historical variables of smoking, health insurance, and time
in the United States, among other demographic variables.
Results: In the 2001 survey, 58% were female, with 50%
age 18–34 years, 21% age 35–49, 17% age 50–64, and 11%
older than 65. In the 2015–2016 survey, 61% were female,
with 35% age 18–34, 20.5% age 35–49, 20% age 50–64,
and 24.6% older 65. Prevalence of diabetes, hypertension,
and dyslipidemia has increased significantly, from 5.9% to
24%, 7% to 34.6%, and 5% to 19%, respectively. Obesity
has increased from 61% to 72%. Overall smoking has
not changed, at 11%, but has increased among young and
middle-aged men. In the recent survey, 97.7% of participants
have lived in the United States for over 10 years compared
to 4% in 2001, and the health insurance rate has decreased
from 83% to 78%.
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Background: Population health management depends,
largely, on segmenting patients based on common clinical
needs into groups to facilitate customized services. Previous
segmentation work has relied primarily on experiential and
ad hoc methods (eg, disease management), not on machine
learning methods (clustering) that account for how various
features (ie, comorbidities and overall disease burden) are
distributed in a population. However, clustering methods
applied directly to electronic health record (EHR) data
may not yield reproducible and distinct segments. Herein
we present a segmentation using consensus clustering
approach with features derived from the EHR and discuss
its implications to customized care models.
Methods: We extracted a random sample of 10,000 primary
care patients who were age 35 years or older from an
integrated health system in Northern California and derived
features from EHR data that represent disease burden ––
cardiometabolic biomarkers A1c, low-density lipoprotein,
high-density lipoprotein, triglyceride, estimated glomerular
filtration rate, etc –– along with patient characteristics. We
applied consensus clustering method to those features, which
resulted in assignment of patients to 3 to 5 clusters, along
with reliability and reproducibility metrics of the clusters.
Results: The three-segment model was the most reliable
solution, with consensus probability above 80% for each
cluster (ie, the probability of assigning each pair of subjects
to the same cluster is 80% or above). Three clusters had
distinct disease profiles; 58% were assigned to segment 1,
for which mean age was 52 years, with low prevalence of
diabetes (7%), cardiovascular, and coronary heart diseases.
Segment 2 accounted for 22% of the population, which had
higher prevalence of cardiometabolic conditions (diabetes
17%, hypertension 60%, and dyslipidemia 60%), atrial
fibrillation (8.3%), and severe chronic kidney disease (15.4%
in stage 3 or above). Segment 3 accounted for the rest, 20%,
with very high prevalence of cardiometabolic conditions
Supplement

(diabetes 31%, hypertension 65%, and dyslipidemia 79%)
and high cardiovascular disease risks as well.
Conclusion: Quantification of the underlying structure
of co-occurrence, disease severity, disease control, and
other relevant factors (eg, body mass index) informs how
distinct pathophysiologic subtypes emerge and persist in
populations. We identified three distinct patient segments;
each reflects a unique set of underlying pathophysiology
features, which paves the path toward segment-specific or
customized care models for population health management.
Keywords: cardiovascular disease, primary care, health
care organization, chronic disease, epidemiology
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Background: Nearly half of Americans with hypertension
have uncontrolled blood pressure (BP). Control rates are
consistently higher in white patients than black patients. The
purpose of this study is to identify covariates that contribute
to racial disparities in BP control using the Oaxaca-Blinder
decomposition method (OBDM).
Methods: We included white and black patients ≥ 21 years
of age with ≥ 2 outpatient diagnoses of hypertension and
≥ 2 BP measures. Uncontrolled BP was defined as ≥ 2 BP
measures ≥ 140/90 mmHg. Covariates of interest included
demographics, baseline BP measures, clinical factors,
utilization, provider characteristics, and engagement with
health care. Distributions of covariates were calculated
by race; multivariable logistic regression models were
constructed overall and by race; and OBDM was used
to determine the proportion of the racial disparity in
uncontrolled BP that could be reduced by equalizing select
characteristics as well as the proportion of the disparity due
to differential impact of covariates.
Results: We identified 34,900 adult Kaiser Permanente
Mid-Atlantic States patients, of whom 15,907 (46%) had
uncontrolled BP and 22,363 (64%) were black. Uncontrolled
BP occurred in 48% of blacks compared to 41% of whites.
Blacks were significantly younger and more likely to have
household income < $25,000, diabetes, female gender, and
higher average systolic BP. Blacks were less likely to engage
with the kp.org website and have race-concordant providers.
In a multivariable logistic regression model, blacks had 20%
increased odds of having uncontrolled BP. The contribution
of the differences in the average values of the study
covariates between blacks and whites (OBDM covariate
effect) accounted for 40% of the overall racial disparity.
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Age and kp.org use contributed to worsening the whiteblack disparity by 22% and 8%, respectively, while gender,
baseline systolic BP, and diabetes contributed to diminishing
the disparity by 5%. The contribution of the difference in
how covariates impact BP control (OBDM coefficient effect)
accounted for 60% of the overall racial disparity.
Conclusion: It may not be possible to reduce the racial
disparity in uncontrolled BP by equalizing the currently
reported covariate values in blacks and whites (since many
of these covariates are nonmodifiable). Supplementing health
system data with patient-reported outcomes may be needed
to effectively use OBDM and parse contributors of disparity.
Keywords: cardiovascular disease, observational study,
racial/ethnic differences, health care, chronic disease,
epidemiology
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Background: Visceral adipose tissue (VAT) and a high
proportion of central vs peripheral adipose tissue have been
shown to be important predictors of incident atherosclerotic
cardiovascular disease (ASCVD) events in middle-aged
individuals, but this has not been established in older men.
Dual-energy X-ray absorptiometry (DXA) can accurately
measure VAT and other regional adipose tissue depots
compared to computed tomography and magnetic resonance
imaging. Our study aim was to estimate the associations
of DXA-VAT and the proportion of central vs peripheral
adipose tissue (android-to-gynoid fat mass ratio) with
incident ASCVD (myocardial infarction, coronary heart
disease death, or fatal or nonfatal stroke) among older men.
Methods: 2,899 older men (mean age: 76.3 [SD: 5.5] years)
were enrolled in the Outcomes of Sleep Disorders in Older
Men study; they had valid baseline measures of VAT on DXA
body composition studies (Hologic QDR4500A), complete
covariate data, and rigorous adjudication of incident ASCVD
events. Participants were surveyed by postcard every 4
www.aurora.org/jpcrr
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months for any potential ASCVD events, and 2 physician
experts reviewed all relevant medical records to determine if
an event had occurred. We used proportional hazards models
to estimate the hazard ratios (HR) for incident ASCVD
events per SD increase of VAT or android-to-gynoid fat
mass ratio, adjusted for age, race, education, systolic blood
pressure, smoking status, oxidized low-density lipoprotein
level, treatment for hypertension, statin use, aspirin use, and
presence of diabetes mellitus.
Results: Over a mean follow-up time period of 7.9 (SD:
3.4) years, 424 men (14.6%) had an incident ASCVD event.
Neither VAT nor android-to-gynoid fat mass ratio were
associated with incident ASCVD events in either unadjusted
or multivariable-adjusted analyses (multivariable-adjusted
HR per SD increase of 1.03 [95% CI: 0.93–1.14] and 1.06
[95% CI: 0.96–1.17], respectively).
Conclusion: Neither VAT nor android-to-gynoid fat mass ratio
are associated with ASCVD events in older men. These results
are not generalizable to women or middle-aged individuals,
and further research of DXA measures of VAT with ASCVD
in these populations is warranted. Further research is also
warranted to explain how and why the association of central
obesity with incident ASCVD may change with age.
Keywords: cardiovascular disease, epidemiology
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Background: The U.S. Preventive Services Task Force
recommends screening adults for high blood pressure (BP). If
BP is high, out-of-office BPs are recommended before making
a new diagnosis of hypertension, preferably using 24-hour
ambulatory BP monitoring (ABPM), because over 30% have
normal BPs outside of clinic or “white coat hypertension”
with risk of cardiovascular events and death similar to those
without hypertension. Currently, few physicians use and few
patients have heard of ABPM, which may be less convenient
than clinic, home, or kiosk-based monitoring. Objective:
The BP-CHECK randomized controlled diagnostic study
will compare the accuracy and acceptability of clinic, home,
and kiosk-based BP monitoring compared to ABPM for
diagnosing hypertension. The study aims, design, protocols,
materials, and evaluation described herein are informed by
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patient, health care, policy, and expert stakeholders.
Methods: Adults age 18–85 years will be recruited and
randomized to routine screening via clinic screening, home
BP monitoring over 5 days, or kiosk-based monitoring
on 3 separate days. After completion, all participants will
complete ABPM. Mean BP assessed via each screening
method (clinic, home, kiosk) will be compared with 24-hour
APBM to assess the accuracy of each method. We also will
assess the acceptability of each method from the patient’s
perspective and the impact of the tests longer-term. Finally,
a mixed-method analysis is planned to explore physician
knowledge and beliefs about BP measurement, diagnosing
hypertension, and the perceived feasibility of using each of
the tested BP strategies in routine clinical practice.
Results: Stakeholder committees that included patients,
health care providers, hypertension, and BP measurement
experts, advocacy group, and policy leaders informed the
study design and protocols. Enrollment began in May 2017
with a target of randomizing 510 participants.
Conclusion: BP-CHECK will inform which hypertension
diagnostic methods are most accurate, acceptable to patients,
and feasible to implement in primary care. This evidence
base is critical to compare alternate methods of diagnosing
hypertension to ABPM
Keywords: cardiovascular disease, technology adoption
and diffusion, primary care, clinical decision-making,
patient experience/satisfaction
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Background: When it comes to prevention, primary
care providers face a wide range of competing demands
with respect to following national care guidelines and
recommendations, achieving quality measures, and meeting
the needs of patients often presenting with more acute needs.
To help shed light on this issue, the National Commission on
Prevention Priorities developed a consistent methodology
of population measures for comparing clinical preventive
services on the basis of their relative value. Using the case
of preventive services for cardiovascular disease (CVD),
this study seeks to advance the relevance of these prioritysetting tools to the point of care by incorporating patient
demographics and preferences.
Methods: A microsimulation model was developed to
estimate patient- and population-level impacts of three
services recommended by the U.S. Preventive Services Task
Force: aspirin counseling for the primary prevention of CVD
Supplement

and colorectal cancer; cholesterol screening and treatment; and
screening and treatment for hypertension. Analyses compare
lifetime outcomes for U.S.-representative birth cohorts,
stratified by sex and race/ethnicity, with and without access
to each clinical preventive service. Each synthetic patient
in the model serves as its own control. Primary outcomes
were overall health impact (measured by the net difference
in lifetime quality-adjusted life-years [QALYs]) and lifetime
prevented myocardial infarctions and strokes.
Results: Across all adults, overall health impact was highest
for hypertension screening and treatment (16,000 QALYs per
100,000). However, this result was driven by the large benefits
for women (18,000 QALYs); whereas for men, cholesterol
screening and treatment ranked highest for reducing
CVD burden (19,000 QALYs). For both men and women
specifically motivated to reduce their risk of a myocardial
infarction, cholesterol screening was favored (1500 fewer
myocardial infarctions per 100,000); whereas for stroke,
hypertension screening was favored (1000 fewer strokes
per 100,000). Although qualitatively similar, quantitative
differences by race/ethnicity were notable. For example,
screening and treating for hypertension was found to prevent
almost 3 times the number of strokes for non-Hispanic black
women in comparison to non-Hispanic white women.
Conclusion: These results show the value of tailoring prevention
priorities to individual patient characteristics and preferences
and also highlight opportunities to reduce health disparities.
Keywords: primary care, health promotion, prevention,
screening, racial/ethnic differences, health care, gender/sex
differences, economic studies
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Background: Team science, defined as collaborative
research efforts that leverage the expertise of diverse
disciplines, is recognized as a critical means to address
complex health care challenges, but the practical
implementation of team science can be difficult. Our
objective is to describe the lessons learned from our team
science experience as applied to the complex and growing
challenge of multiple chronic conditions (MCC). MCC is the
Supplement

presence of “two or more chronic conditions that collectively
have an adverse effect on health status, function, or quality
of life and that require complex healthcare management,
decision-making, or coordination.” Due to the increasing
impact on U.S. society, MCC research has been identified
as a high-priority research area by multiple federal agencies.
Methods: To address this need, two national research
entities, the Health Care Systems Research Network
(HCSRN) and the Claude D. Pepper Older Americans
Independence Centers (OAIC), formed the Advancing
Geriatrics Infrastructure and Network Growth (AGING)
Initiative to build nationwide capacity for MCC team
science. Initiative structure and barriers/solutions are
described (eg, addressing cultural differences, including
diverse perspectives and expertise).
Results: In its first 3 years, the AGING Initiative
demonstrated success in advancing team science for MCC.
Eighteen manuscripts have been published or are in press,
and an additional 11 manuscripts are in development. In
addition to manuscripts, several new grant applications have
been produced by AGING Initiative research teams. From
the AGING Pilot Projects Program, 7 grant applications
have been submitted as a result of the 6 pilot projects in the
first two cycles of funding.
Conclusion: Team science has emerged as an important
method to bring together diverse skill sets and data to
solve complex clinical problems. The AGING Initiative
experience demonstrates that, in less than 3 years, building
a team science platform can expand capacity and catalyze
collaboration around a complex health problem. Building
nationwide infrastructure to foster team science requires
understanding different workplace cultures, efficiency in
data sharing, thoughtfully designing organizational structure,
disseminating to expand a diverse community, engaging the
next generation of team scientists, and applying a flexible,
iterative approach to create solutions to unanticipated
barriers during implementation.
Keywords: aging, elderly, geriatrics, complex disease
management, multiple chronic conditions, dissemination,
implementation, innovation, communication of research
findings
OA8.02
Distributed Health Data Networks: Implementing
a Scalable Query Interface Within PopMedNet for
Use in Large-Scale Diverse Networks
Hozefa Divan,1 Kyle Erickson,1 Kimberly Barrett,1
Zachary Winer,1 Jessica Malenfant,1 Chayim HerzigMarx,1 Jeffrey Brown1
Harvard Pilgrim Health Care Institute, Boston, MA

1

Background: There is significant need to utilize electronic
health data across distinct health care institutions for public
health surveillance and research purposes. Distributed data
www.aurora.org/jpcrr
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networks (DDNs) typically use a common data model
to standardize data across institutions (data partners) to
facilitate rapid distributed analyses while keeping data
behind local firewalls. However, data partners often have
varying governance and data infrastructures that can lead
to substantial ecosystem heterogeneity across partners,
including use of various relational database management
system (RDBMS) platforms (ie, Oracle, SQL Server,
PostgreSQL). To enable rapid distributed querying across
heterogeneous technical ecosystems we developed a novel,
open-source tool within the PopMedNet (PMN) platform
that bridges these platforms and software challenges. This
tool enables investigators to compose and distribute custom
queries via a user interface in PMN, referred to as the MenuDriven Query (MDQ).
Methods: The MDQ tool includes a point-and-click,
scalable query interface that supports complex logic for
users to define cohorts of interest (eg, medical codes, date
ranges) for use in distributed queries that can be executed in
various technical ecosystems. Underpinning the MDQ is a
series of file conversions, e-workflow, and software-enabled
governance. The tool is modularized, enabling functionality
to be database-agnostic and can be run against multiple
RDBMS platforms without custom programming, as it
utilizes widely adopted data exchange formats.
Results: MDQ testing and validation process has been
implemented and has shown consistent, valid results
across database platforms; this process has informed tool
development and continuous enhancements. As further realworld evidence for the tool, over 4300 unique MDQ-to-site
requests have been submitted within PCORnet, a DDN,
since early 2016.
Conclusion: This new tool is helping to close gaps by
creating more opportunities for investigators to ask research
questions more easily, flexibly, and rapidly within their DDNs
while adhering to their local governance and technology
policies. There is continued work to improve the MDQ tool
in ways that will enable even more scalability in designing
reusable query interfaces and electronic workflows.
Keywords: information technology, dissemination,
implementation, innovation
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(NLP) to identify uterine perforations and intrauterine device
(IUD) expulsions following IUD insertions.
Methods: All women with an IUD insertion in a 7-year
period were identified using the Kaiser Permanente
Northern California virtual data warehouse (VDW).
Separate algorithms were developed to identify potential
uterine perforations and expulsions using data from the
VDW, the surgical procedure database (OpTime), and the
Clarity and radiology notes tables. Uterine perforations
were identified electronically with an algorithm using a
combination of codes and NLP. There were structured codes
for identification of suspected or confirmed perforations
but not for delineating them as complete or partial. There
were no structured codes specific for IUD expulsion, so
algorithms using NLP terms only were developed to identify
this outcome. For both outcomes, 100 potential cases were
randomly chosen for manual medical record review and
validation. Positive predicted values (PPV) comparing
the algorithm results to the manual medical record review
results (gold standard) with 95% confidence intervals were
calculated and used to assess the accuracy of the algorithms.
Results: There were 444 potential perforations identified
among 168,744 IUD insertions. The PPV among 100
randomly selected potential perforation cases was 77% (95%
CI: 68%–85%), with 16 that were classified as not a case
and 7 that could not be classified with any certainty. Based
on medical record review, 28 of 77 were classified as partial,
48 were classified as complete, and 1 did not have enough
information for classification as partial or complete. There
were 4185 potential expulsions identified among 168,744
IUD insertions. The PPV among 100 randomly chosen
potential expulsions was 77% (95% CI: 68%–85%), with 2 of
100 potential cases classified as undetermined.
Conclusion: The PPV was 77% for both uterine perforation
and expulsions, indicating excellent performance of both
algorithms for the capture of these complex health outcomes.
Keywords: virtual data warehouse, natural language
processing
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Institute, Boston, MA; 2Avacoda LLC, Amherst, MA
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Background: Electronic medical records (EMRs) have been
used successfully in health research to identify outcomes and
risk factors in a cohort of interest. The purpose of this study
was to use EMR data to develop and validate algorithms using
ICD-9-CM codes, CPT codes and natural language processing

Background: With the proliferation of health data
networks, increasingly diverse data are becoming available
for secondary purposes like research. Enabling access to
the wealth of data resources and potential collaborators
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could help pave the way for a learning health system. We
describe our implementation approaches in creating CrossNetwork Directory Service (CNDS) software. This pilot
created a secure, sustainable sociotechnical platform that
enables people to form new partnerships to discover and
share characteristics about data sources and expertise not
previously accessible to them. We demonstrate CNDS using
the U.S. Food and Drug Administration’s Sentinel system and
Patient-Centered Outcomes Research Institute’s PCORnet
distributed networks.
Methods: CNDS enables users to discover data and
collaborators in accordance with local governance policies.
Features include 1) a flexible data model that enables quick
changes to what can be collected as metadata standards and
inventories change, 2) software that dynamically generates
the user interface in real time, and 3) cross-network search and
query capability. CNDS is a web service with a database and
application programming interface server for communicating
between web applications built on PopMedNet™ version 6.0.
Sentinel and PCORnet user, organization, and data source
information were populated by the CNDS test networks.
Results: The data model has been successfully integrated
with the CNDS infrastructure. The metadata management
module, search functionality, and cross-network query
capability have been implemented in the CNDS test
environments. We have demonstrated the ability to send
a query from a CNDS Sentinel network to the PCORnet
network without disrupting existing workflows while
adhering to the various governance policies.
Conclusion: Challenges to be discussed include defining
metadata vs data; striking a balance between developing a
flexible data model and the impacts of fully implementing
it as a dynamic application interface; and keeping current
on emerging health IT standards and best practices. CNDS
is valuable beyond its ability to search metadata and send
queries across PopMedNet networks. Future work includes
expanding to more people, organizations, and data sources
and incorporating this proof-of-concept scaffolding into the
current PopMedNet codebase.
Keywords: ownership, governance, health care organization,
information technology, research administration, contracting,
operations, dissemination, implementation, innovation

VARIOUS/MISCELLANEOUS
OA9.01
Streamlining Hepatitis C Screening to Treatment in
the Mid-Atlantic Region
Carla Rodriguez,1 Kevin Rubenstein,1 Cabell Jonas,1,2
Yan Sun,2 Michael Horberg,1 Bernadette Loftus2
Mid-Atlantic Permanente Research Institute, Rockville, MD;
Mid-Atlantic Permanente Medical Group, Rockville, MD

Background: Kaiser Permanente Mid-Atlantic States
implemented a hepatitis C virus (HCV) care pathway
(Pathway) to improve the identification and care of patients
with HCV, particularly those born from 1945 to 1965 (birth
cohort) who bear the greatest burden of disease. A screening
alert for patients without a prior HCV antibody (Ab) screen
prompts clinicians to order a specific HCV Ab that triggers
reflex testing for HCV RNA, hepatitis B virus (HBV) and
human immunodeficiency virus (HIV) on stored samples of
those patients testing HCV Ab+. The order code also engages
coordinators to assist patients and support clinical workflow.
Our objective was to evaluate whether the Pathway improved
the carriage of patients through each step along the HCV care
continuum and increased HIV and HBV screening.
Methods: We used electronic health record data to
retrospectively compare patients’ successful passage from
screening to HCV treatment during two 16-month periods
before and after the Pathway began. Proportional hazards
models compared the time to HCV, HIV and HBV screening,
follow-up HCV communication, fibrosis staging, and
treatment, adjusting for potential confounders. Chi-squared
tests compared the difference in proportions receiving HCV
RNA and genotyping. We evaluated fibrosis staging and
treatment since initiation of the Pathway among patients
with a Pathway order code versus usual care.
Results: Over 72,000 of 506,000 participants were HCVscreened. Comparing the Pathway to the prior era, the
adjusted hazard ratio (aHR) was 2.89 (95% CI: 2.83–2.95)
for HCV screening, with greater improvement within the
birth cohort (6.80 [6.60–7.00]). Among Ab+ patients, aHR
was 2.09 (1.77–2.48) for HIV screening and 0.94 (0.82–1.08)
for HBV screening, and HCV confirmatory testing increased
from 85% to 93% (P<0.001). Among RNA+ patients,
aHR was 1.77 (1.50–2.08) for HCV communication, and
genotyping increased from 82% to 87% (P<0.05). RNA+
patients with a Pathway order had a higher rate of fibrosis
staging and treatment compared to those in usual care (aHR:
2.65 [95% CI: 2.1–3.32] and aHR: 1.45 [95% CI: 1.07–
1.98], respectively).
Conclusion: The Pathway was associated with improved
HCV screening and care, as well as improved HIV screening.
Research to understand effective translation to other health
systems is needed.
Keywords: observational study, chronic disease, quality
improvement, epidemiology
OA9.02
Metabolic Outcomes for Type 2 Diabetes Patients
on New Antidiabetic Drug Classes Compared With
Those on Traditional Classes in Central Texas
Stephanie Yu,1 I-Chia Liao,1 Linda Chen,1 Paul Godley,1
Delaney Ivy,1 Anthony Cryar1
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Background: According to the 2017 American
Association of Clinical Endocrinologists/American
College of Endocrinology Comprehensive Type 2 Diabetes
Management Algorithm, new antidiabetic classes (NAC) of
drugs –– SGLT2i, GLP1-RA, DPP4i –– are preferred over
more traditional antidiabetic classes (TAC) –– SU, TZD,
meglitinide –– for dual therapy after initiation of metformin.
Clinical trials suggest that NAC offer favorable effects on
cardiovascular risk factors with noninferior reductions in
glycated hemoglobin (HbA1c) compared with TAC. This
study evaluated the validity of this recommendation.
Methods: This retrospective analysis of medical and
pharmacy claims from the period 2013–2015 evaluated
patients > 18 years old with ICD-9 diagnosis of type 2
diabetes mellitus (T2DM) and use of TAC at least 1 year prior
to first claim for a NAC (index date) or matched claim for a
TAC for the index date ± 14 days. Differences in HbA1c and
weight reduction were evaluated between the NAC and TAC
cohorts. Pre-index HbA1c, Diabetes Comorbidity Severity
Index, pre-index lag times, and post-index lag times were
controlled in this analysis.
Results: Data from 126 NAC and 373 TAC patients were
analyzed (52% female; mean age: 58.71 years, SD: 11.77,
min–max: 24.00–85.00). Patients in the NAC and TAC
cohorts had equivalent pre-index mean baseline HbA1c
(9.1% vs 8.9%, P=0.194). Adjusting for covariates, patients
who took an agent in the NAC had significantly greater
average -1.6 kg weight reductions compared to those in TAC
(P=0.02). In addition, mean HbA1c reductions were not
significant between NAC and TAC cohorts (P=0.49) while
also adjusting for covariates.
Conclusion: This real-world study demonstrated that
addition of agents in the new antidiabetic drug classes
resulted in significant weight reductions compared with
traditional antidiabetic drug classes while maintaining
equivalent HbA1c reduction.
Keywords: pharmacy, diabetes, clinical practice patterns/
guidelines, pharmaceutical prescribing/use
OA9.03
Transmitting Unique Device Identifiers From Point
of Use to Insurance Claims
Jove Graham,1 Kevin Capatch,1 Bret Yarczower,2 Dan
Krupka,3 Yasmin Zerhouni,4 Amanda Reich,4 Angela
Li,5 Joel Weissman4
Geisinger Health, Danville, PA; 2Geisinger Health Plan,
Danville, PA; 3Twin Peaks Group, Lexington, MA; 4Partners
HealthCare, Boston, MA; 5Blue Cross Blue Shield of
Massachusetts, Boston, MA
1

Background: Patients, providers, insurance payers, and
manufacturers need reliable information on the performance
and safety of implanted medical devices such as coronary
stents, but availability of those data has been lacking.
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Billing records and claims employ standard codes for
procedures but lack information on implanted devices.
In 2013, the U.S. Food and Drug Administration began
requiring manufacturers to label devices with unique device
identification (UDI) numbers, but hospitals and payers
must decide how to leverage that information in their own
information systems. The purpose of this project was to
demonstrate, with two different provider/payer sites, the
feasibility of transmitting UDIs to insurance claims.
Methods: Implementation teams at two provider institutions
(Geisinger Health and Partners HealthCare), working with
two insurance providers (Geisinger Health Plan and Blue
Cross Blue Shield of Massachusetts, respectively) designed
different strategies for capturing point-of-use information on
devices implanted in the cardiac catheterization laboratory
and transmitting that information to the insurance claim.
After the design phase, strategies were implemented at each
system through collaboration with internal information
technology and external vendor teams.
Results: The first insurance claims containing UDIs for
implanted cardiac devices were processed at both sites in
October 2017. At both institutions, barcode labels were
scanned at point-of-use to establish links between patient
and device. At Geisinger, new records containing UDIs
were created by inventory management software and sent to
billing, then mapped to the note field of the electronic claims
transaction. At Partners, the UDI was transmitted to billing
via the electronic health record and an extension rule within
the record was created to write this information to the claim
if specific criteria were met.
Conclusion: Integrating device-specific information into
claims will be an important step in allowing researchers who
use health plan data to evaluate devices in the same way that
we study surgical procedures or prescription drug use. This
implementation project and the lessons learned along the
way demonstrate that there are multiple feasible pathways
to include UDI numbers in claims in order to provide better
real-world data to evaluate long-term outcomes associated
with specific products.
Keywords: information technology, health care, financing,
insurance, premiums, costs, resource use, patient safety
OA9.04
A Novel Mixed-Methods Approach to Identifying
Contextual Patterns in Treatment Decision-Making:
The Ethnoarray
Katharine Rendle,1 Sarah Garrett,2 Corey Abramson,3
Daniel Dohan2
University of Pennsylvania, Philadelphia, PA; 2University of
California, San Francisco, San Francisco, CA; 3University
of Arizona, Tucson, AZ
1

Background: In patient-centered outcomes and health
services research, qualitative methodologies have been
Supplement

embraced with enthusiasm for their ability to capture
individual and contextual factors that shape care experiences
and medical decision-making. From interviews to
ethnographic observation, these approaches provide insight
into the complex ways factors interact to shape outcomes
that are difficult to capture using quantitative approaches
alone. However, communicating and identifying patterns
in qualitative data remains challenging, particularly in large
data sets that feature complex multilevel data. Drawing from
two longitudinal qualitative studies examining treatment
decision-making in breast cancer patients (N=36) and
late-stage melanoma patients (N=13), we present a novel
approach modeled after the genetic microarray to analyze
and display complex qualitative data.
Methods: We used an iterative mixed-methods approach
that combines thematic qualitative analysis with hierarchical
clustering to produce a patterned heatmap (“ethnoarray”). For
each dataset, we completed the following four-stage analysis:
First, using the constant comparative method, we inductively
and deductively coded interview and ethnographic data.
Second, based on thematic coding and literature review, we
identified influential factors relevant to treatment decisionmaking. Third, using Atlas.ti, we created a code co-occurrence
table to identify presence or absence of each decision-making
factor. Fourth, using R, we applied complete-link clustering
to sort patients (columns) and decision-making factors
(rows) by statistical proximity, resulting in a visual heatmap
that identifies patterns across patients and factors. Last, we
created narrative summaries for each clustered group based
on qualitative and clinical data.
Results: We will present the two resulting ethnoarrays,
highlighting how the tool can be used to identify similarities
and differences across and within patients. We will discuss
how this tool can be applied to other types of qualitative
data, and how it can help to advance rigor and transparency
in qualitative and mixed-methods research.
Conclusion: Although treatment decision-making is a wellstudied topic, identifying patterns across patients without
losing the context captured by qualitative methods remains
challenging. We present a novel analytic tool that can
represent and retain these contextual complexities and can
support rigorous and transparent qualitative health research
in embedded research environments.
Keywords: cancer, sociology, ethnography, qualitative
research, clinical decision-making

AGING AND MULTIMORBIDITY
P1.01
Care Transition Intervention and Hospital
Readmission: Experience From Baylor Scott &
White Health
Rashmita Basu,1 Alan Stevens1
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Background: In response to the Centers for Medicare and
Medicaid Services (CMS) hospital readmission penalty policy,
many hospitals across the country have implemented models
to keep their readmission rates low. The Care Transitions
Intervention® (CTI), a patient-centered 30-day intervention
model (1 home visit and 3 phone calls) that aims to empower
patients, was implemented at Baylor Scott & White Health
hospital during early 2011 to March 2013. The goal of this
study was to examine the impact of the CTI on 30-day hospital
readmission and factors that predict patient’s decision not to
accept the CTI after being enrolled in the program.
Methods: This retrospective analysis covered the 6 months
leading to the “index” hospital admission to the 6-month
period after discharge during the CTI period.
Results: Primary outcome measure: 30-day hospital
readmission from index hospital admission. We calculated 30day hospital readmission by constructing four groups: 1) those
who enrolled and completed the full CTI intervention; 2) those
who enrolled and completed only home visits, not phone calls; 3)
those who enrolled but decided not to receive treatment (neither
home visits nor phone calls); and 4) those who were eligible but
declined to participate in the program. All-cause readmission
rates were calculated based on CMS’s definition by dividing
the number of at least one subsequent hospital admission
within 30 days from the index hospitalization (numerator) by
total number of hospital admissions after discharge from the
index hospitalization during the CTI period (denominator).
Those who enrolled and completed the full CTI intervention
had the lowest 30-day readmission rate of 22%. We also found
that those who enrolled but did not receive any treatment had
higher readmission rates (28%) compared to those who did not
enroll to the program (25%).
Conclusion: We did not find statistically significant
differences in readmission rates among groups. Results from
predicting decision not to receive CTI indicated that patients
with the higher number of CMS hierarchical condition
categories were less likely (P=0.02) to receive the CTI
even after they were enrolled into the program during their
hospital stay. This indicates that patient comorbidity burden
is an important factor to consider while offering this type of
health intervention.
Keywords: aging, elderly, geriatrics
P1.02
Multimorbidity Burden and Outcomes in Adults
With Heart Failure
Mayra Tisminetzky,1,2 Jerry Gurwitz,1,2 Robert
Goldberg,2 Grace Tabada,3 Sue Hee Sung,3 Alan Go3
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Background: We aimed to assess multimorbidity burden
and its association with clinical outcomes in a communitybased cohort of patients with heart failure (HF) according to
sex, age, and HF type.
Methods: A total of 114,553 HF patients were characterized
with respect to the presence of 24 chronic conditions and
the overall burden of multimorbidity. Clinical outcomes
included all-cause mortality and any-cause and HF-specific
hospitalization. Cox proportional hazards regression models
were used to account for potential confounders.
Results: Adjusted hazard ratios for all-cause mortality
among those with 5–6, 7–8, or 9 or more morbidities (vs
0–4) were 1.27 (95% CI: 1.24–1.31), 1.52 (95% CI: 1.48–
1.57), and 1.92 (95% CI: 1.86–1.99), respectively. Adjusted
hazard ratios for any-cause hospitalization among those with
5–6, 7–8, or 9 or more morbidities (vs 0–4) were 1.28 (95%
CI: 1.25–1.30), 1.47 (95% CI: 1.44–1.50), and 1.77 (95%
CI: 1.73–1.82), respectively. Adjusted hazard ratios for HFspecific hospitalization among those with 5–6, 7–8, or 9 or
more morbidities (vs 0–4) were 1.22 (95% CI: 1.19–1.26),
1.39 (95% CI: 1.34–1.44), and 1.68 (95% CI: 1.61–1.74),
respectively. For each outcome of interest, similar trends
were found among men and women, across age groups, and
by HF type. Associations between multimorbidity burden
and all of the examined outcomes were especially prominent
among those < 65 years old.
Conclusion: The impact of multimorbidity on outcomes
among adults with HF is substantial and may be an important
consideration in clinical management and decision-making
in these high-risk patients.
Keywords: cardiovascular disease, aging, elderly, geriatrics,
chronic disease, epidemiology
P1.03
The Association of Food Insecurity With SelfReported Falls Among the Medicare Population
David Mosen,1 Matthew Banegas,1 Nicole Friedman,2
Elizabeth Shuster2
Kaiser Permanente Center for Health Research, Portland,
OR; 2Kaiser Permanente Northwest, Portland, OR
1

Background: Falls among the Medicare population are
associated with higher morbidity and mortality. Food
insecurity may contribute to increased risk of falls, although
this is not well studied. The objective of this analysis was to
examine the independent association of food insecurity with
falls among the Medicare population.
Methods: We employed a cross-sectional survey design
to analyze 25,196 Medicare Total Health Assessment
(MTHA) surveys collected between November 1, 2012, and
October 31, 2016. The MTHA is an operations-based survey
that measures quality of care among Medicare members
receiving care at Kaiser Permanente Northwest (KPNW), an
integrated health care system in the Pacific Northwest. The
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primary outcome measure in the analysis is self-reported
falls, assessed by asking whether the patient fell in the
previous 12 months (yes vs no). The primary independent
variable is food insecurity, assessed by asking respondents
to respond to the statement, “I don’t always have the
money I need to buy food” (yes vs no). We used the KPNW
electronic health record to procure information in three
categories: demographic, which included age (continuous),
sex (female vs male), and low socioeconomic status (yes
vs no); clinical, comprising the Charlson comorbidity
index (CCI) score (0, 1, 2+); and utilization, which covered
primary care visits (0, 1, 2+), emergency department visits
(0, 1+), and hospital admissions (0, 1+). Clinical and
utilization measures were based on the 12 months prior to
the MTHA survey date. Multivariable logistic regression
was used to assess the association of food insecurity with
self-reported falls, adjusting for demographics, clinical, and
utilization measures.
Results: Approximately 2.41% (n=607) of survey
respondents reported food insecurity, while 2.40% (n=604)
reported having a fall. We found that food insecurity was
associated with a higher likelihood of falls (odds ratio: 1.66,
95% CI: 1.40–1.96), adjusting for age, sex, socioeconomic
status, CCI score, and utilization measures.
Conclusion: Our analysis underscores the importance of
assessing food insecurity among the Medicare population,
finding a significant increase in the likelihood of self-reported
falls among those who do not always have the money they
need to purchase food. Further research is warranted to
determine whether programs to reduce food insecurity lead
to reduced falls among Medicare patients.
Keywords: aging, elderly, geriatrics, social determinants of
health, Medicare
P1.04
Racial/Ethnic Comparisons in Multiple Chronic
Conditions and Health Care Utilizations Among
Male Oldest-Old Patients With Cardiovascular
Disease and/or Diabetes Mellitus
Jinmyoung Cho1 Alan Stevens1
Baylor Scott & White Health, Temple, TX
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Background: With a growing aging population, racial and
ethnic minority populations have increased. Nevertheless,
a great deal of uncertainty still exists regarding variability
in health care services utilization, comorbidity, mortality,
and longevity in minority populations. This study aims to
compare multiple chronic conditions (MCC) and frequency
of hospital visits between white/Caucasian and nonwhite/
non-Caucasian oldest-old male patients with diabetes
mellitus or cardiovascular disease, the most common
prevalent conditions among older adults.
Methods: Data from Baylor Scott & White Health identified
5847 male patients, age 85 years or more, with cardiovascular
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disease and/or diabetes during 2010–2013. Clinical comorbidity
for MCC is defined by the Charlson comorbidity index or
Elixhauser comorbidity score after eliminating overlapping
diagnoses. Cardiovascular disease is defined by diagnoses
including hypertension, hyperlipidemia, coronary heart disease,
atrial fibrillation, heart failure, peripheral arterial disease, and
other atherosclerotic diseases. Bivariate correlation analyses
were conducted to compare chronic conditions and number
of hospital visits between whites and nonwhites. Multivariate
analysis (eg, generalized linear models) examined the role
that race/ethnicity has on the relationship between health care
utilization and the outcome of survival.
Results: Significant differences were observed in several
variables. Compared to nonwhites, whites showed a higher
prevalence in all types of cardiovascular disease diagnoses
(white: 10%–84% vs nonwhite: 6%–74%); whereas whites
were less frequently diagnosed with diabetes (whites: 29.5%
vs nonwhites: 31.6%). Regarding the number of hospital
visits, more white male patients had emergency room
visits and hospital admissions than nonwhite male patients.
Furthermore, male oldest-old whites reported a higher
average number of clinic visits compared to nonwhites
(t=8.16, P<0.001).
Conclusion: Bivariate correlation analyses indicate that
there is a significant difference in MCC and health care
utilization between white and nonwhite oldest-old male
patients. A closer investigation with advanced statistical
analysis is needed to assess the association between health
status and health care services utilization among diverse
groups (ie, white/Caucasian, black/African American,
Hispanic, other) in advanced age.
Keywords: cardiovascular disease, aging, elderly, geriatrics,
demographics, diabetes
P1.05
Using Self-Reported Data to Segment Populations
With Complex Care Needs
Elizabeth Bayliss,1 Jennifer Ellis,1 Chan Zeng1
Institute for Health Research, Kaiser Permanente Colorado,
Denver, CO
1

Background: Populations with complex care needs are
not well served by a one-size-fits-all approach. Delivering
tailored care management requires effective methods to
segment heterogeneous populations; standard clinical
data are not sufficiently informative or nuanced to serve
this purpose. The Medicare health risk assessment (HRA)
provides an opportunity to use patient-reported information
to segment complex-needs populations for more optimal
care management.
Methods: The cohort included Kaiser Permanente Colorado
members age ≥ 65 years who were previously identified as at
risk for high utilization due to advanced illness and geriatric
issues and who had completed an HRA between April
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2014 and May 2017. HRA variables reflected self-reported
quality of life, mood, activities of daily living (ADL), urinary
incontinence, falls, living situation, isolation, financial
constraints, nutrition, and advance directives as potentially
likely to reflect different clinical and/or psychosocial profiles.
We iteratively applied clustering methods to refine variable
selection for cluster inputs and identify groups of individuals
with distinct, actionable clinical or psychosocial profiles
amenable to tailored care management. Groups were described
in terms of HRA items and 1-year hospital utilization.
Results: From 9617 individuals, we identified 15 clusters
that could be described based on care needs. For example,
two groups (n=273 and n=269) consisted primarily of frail
individuals with some memory impairment less likely
to live independently: One group had poor physical and
mental well-being and ADL limitations, and one had ADL
limitations but good mental and physical well-being.
Another group (n=287) was characterized by poor physical
and mental well-being, pain, ADL limitations, and financial
constraints. Three groups (n=1872, n=1098, and n=491) had
few health or other limitations and relatively low utilization
and were differentiated by age, presence or absence of a
documented advance directive, and tobacco use.
Conclusion: Segmenting populations with chronic illness
and psychosocial needs into meaningful subgroups can
optimize limited care management resources and minimize
patient burdens from redundant care management. Using
self-reported data, we identified over 3000 individuals
initially categorized as having chronic care needs requiring
limited intervention and multiple smaller groups that could
potentially benefit from intensive care management. Novel
methods coupled with new sources of data can make care
more efficient and patient-centered.
Keywords: aging, elderly, geriatrics, complex disease
management, multiple chronic conditions, patient-reported
outcomes and functional status
P1.06
Association Between Cancer Treatment and
Mortality in Older Adults With Superficial Bladder
Cancer and Multiple Chronic Conditions
Tullika Garg,1 Amanda Young,1 Maureen O’KeeffeRosetti,2 Carmit McMullen,2 Matthew Nielsen,3 H.
Lester Kirchner,1 Terrence Murphy4
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Background: Bladder cancer has the highest median age
at diagnosis (73 years), and 75% of tumors are superficial
at diagnosis. Rates of progression and death are low for
superficial bladder cancer (SBC). As smoking is the most
common risk factor, SBC patients have high chronic
www.aurora.org/jpcrr
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condition burdens, which may influence cancer treatment
decisions. The objective was to evaluate the association
between cancer treatment and mortality in older adults with
SBC and multiple chronic conditions (MCC).
Methods: Using data from 1800 older (60+ years) SBC
patients (stage ≤ 1) from Geisinger Health and Kaiser
Permanente Northwest, we examined the association
between treatment within 6 months of diagnosis (eg, bladder
instillation or transurethral resection of bladder tumor) and
10-year mortality. Univariate comparisons and KaplanMeier curves were generated. Multivariable Cox models
were adjusted for age, sex, race, center, SBC stage/grade, and
MCC. MCC was defined as 2 baseline chronic conditions.
A propensity-score analysis to estimate the causal effect of
cancer treatment was performed with standardized inverse
probability of treatment weights to balance the sample.
Results: Over a median follow-up of 6.6 years, 725 subjects
died (40%). Subjects who died were older at diagnosis
(77 years vs 71 years) and more likely to be male (81.7%
vs 76.8%), have normal body mass index (73% vs 63%),
be current/former smoker (76.6% vs 71.4%), and have
baseline MCC (73.2% vs 62.6%), and were less likely to
have cancer treatment (76.3% vs 86.7%); P<0.01 for all
comparisons. Median survival was not significantly longer
for treated subjects (8.2 years vs 6.8 years, log rank P=0.12).
In multivariable analyses, cancer treatment was associated
with a 30% reduction in hazard of death (adjusted hazard
ratio [HR]: 0.70, 95% CI: 0.58–0.85, P<0.0002) and MCC
was associated with a 72% increase in hazard of death
(adjusted HR: 1.72, 95% CI: 1.44–2.05, P<0.0001). In the
weighted analysis, cancer treatment was associated with
hazard of death (HR: 0.77, 95% CI: 0.61–0.98, P=0.0338).
Conclusion: In this cohort study of older adults with SBC
from two health systems, although cancer treatment was
associated with a reduced hazard of death, the increased
hazard due to MCC was much greater. This information may
guide patient-centered decision-making in older, medically
complex patients with SBC.
Keywords: aging, elderly, geriatrics, cancer, complex
disease management, multiple chronic conditions
P1.07
Development of a Patient-Reported Outcome
Measure for the Elderly Orthopaedic Hip Fracture
Patient
Naomi Johnson,1 Jennifer Renner,2 Jennah Durham,1
Lisa Schroder,1 Jeanette Y. Ziegenfuss,2 Julie Switzer1
Department of Orthopaedics, Regions Hospital, Saint Paul,
MN; 2Survey Research Center, HealthPartners Institute,
Bloomington, MN
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Background: The population of fracture patients is aging.
While there are validated functional outcome measures
for orthopaedic fracture patients in general, few measures
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address the unique concerns and needs of the oldest fracture
patients. In light of this, we have developed a patientreported outcome (PRO) measure for elderly hip fracture
patients. We aimed to develop a PRO measure tailored to
hip fracture patients age 65 years and older for immediate
practical use and as a foundation for development of future
elderly outcome measures.
Methods: Preliminary open-ended telephone interviews
were conducted with a group of hip fracture patients > 65
years old or their proxies to identify aspects and outcomes
of post-hip fracture care that are important to them. Based
on preliminary qualitative interview responses and expert
opinion, a telephone survey was created to determine the
relative importance of the identified post-hip fracture
care components and outcomes. These interviews were
conducted with a second group of elderly hip fracture
patients. Respondents were asked to rate and rank items
based on importance. Survey responses will be used to
create a PRO measurement tool that can be pilot tested as a
basis for further studies.
Results: Of 96 subjects, 46 responded to the interview
request for a final response rate of 48%. Respondents first
rated and then ranked items based on importance. Overall,
items relating to “Providers and Care Team” were ranked as
most important to 52% of respondents, followed by items
related to “Communication” (24%). “Having confidence that
I/my loved one received the best care possible” and “Having
access to the surgeon” were perceived as very important for
most respondents (98% and 76%, respectively). Physical
outcomes were only ranked as most important by 4
respondents (9%).
Conclusion: There is a need to understand factors that are
of greatest importance to elderly hip fracture patients. Our
survey results provide rudimentary insight into the relative
importance of various outcome measures to elderly hip
fracture patients. These findings will allow us to create
a geriatric-specific PRO measure. Further research will
include more rigorous cognitive interview and validity
testing to create a PRO measure acceptable for use at a
national scale.
Keywords: aging, elderly, geriatrics, quality of life, survey
research and methods, quality of care, acute inpatient care,
patient-provider communication, patient-reported outcomes
and functional status, patient experience/satisfaction
P1.08
National Trends in Obesity in Nursing Homes,
2005–2015
Ning Zhang,1 Terry Field,1 Yanhua Zhou,1 Kathleen M.
Mazor,1 Jerry Gurwitz1
Meyers Primary Care Institute, Worcester MA
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Background: The prevalence of obesity among nursing
home residents increased rapidly, from 15% in 1992 to 26%
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in 2009. However, reports of the most contemporary trend
of obesity prevalence in nursing homes are lacking. In this
study, we will examine obesity prevalence among the longstay residents in nursing homes.
Methods: We obtained national Minimum Data Set 2005–
2015 for all long-term residents admitted to Medicare- and
Medicaid-certified facilities for at least 100 days. Residents
were underweight (body mass index [BMI]<18.5), healthy
to overweight (18.5≤BMI<30), or obese (BMI≥30).
Obese residents were further categorized as having class I
(30≤BMI<35), class II (35≤BMI<40), or class III (BMI≥40)
obesity. In our study, the annual prevalence of obesity was
the ratio of the total number of obese long-stay residents
divided by the total number of long-stay residents in a year.
The prevalence of other weight categories had the similar
definition. Logistic regression models were used to assess
the associations of age group, race/Hispanic origin, and
gender.
Results: Between 2005 and 2015, there were about 1.7
million nursing home residents in our study. The prevalence
of obesity increased from 22% in 2005 to 29% in 2015
(absolute change: 7%; relative change: 32%). Class III
obesity increased from 4% in 2005 to almost 7% in 2005
(absolute change: 3%; relative change: 75%). In 2015,
the most recent available year, women had higher obesity
prevalence than men (31% vs 25%, P<0.001). Obese
residents tended to be younger, had higher percentage
of diabetes, heart failure, chronic obstructive pulmonary
disease, arthritis, depression, and renal failure, and had
lower percentage of stroke, Alzheimer’s, dementia, vision
impairment, and incontinence than residents who were
healthy weight or overweight. Logistic regression (adjusted
for age groups, race/ethnicity, and gender for obesity)
showed that age was an important predictor.
Conclusion: In this national study of nursing home residents,
the age-adjusted prevalence of obesity in 2005 was 28%
among men and 35% among women. The corresponding
values for class III obesity were 8% for men and 9% for
women. Studies are needed to determine the reasons for
these differences and trends.
Keywords: aging, elderly, geriatrics, long-term care
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Factors Affecting Time Between Symptom Onset
and Emergency Department Arrival in Stroke
Patients
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Benge,1 Leigh Allen,1 Jinmyoung Cho,1 I-Chia Liao,1
Jennifer Rasmussen1
Baylor Scott & White Health, Temple, TX
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activator (tPA), consistent with American Stroke
Association guidelines. Furthermore, there is strong
evidence that patients who are treated more quickly will
have greater benefit. The purpose of this study is to assess
factors associated with time between symptom onset and
emergency department (ED) arrival in stroke patients.
Methods: This study included patients presenting to the
Baylor Scott & White ED in Temple, Texas, within 7
days of symptom onset between January 2015 and July
2017 and who were diagnosed with transient ischemic
attack (TIA), ischemic stroke, cerebral hemorrhage, or
subarachnoid hemorrhage. Data were extracted from
Get With the Guidelines, a national dataset summarizing
stroke cases. The dependent variable was time between
discovery of stroke symptoms and presentation at ED.
Covariates included patient and system measures. Factors
with a bivariate association to time to ED were entered into
multivariable regression models predicting time to ED:
0–4 hours vs longer (dichotomy), or vs >4 to 8 hours, >8 to
24 hours, >24 to 48 hours, 2–7 days (5 groups).
Results: The cohort of 1874 patients averaged 67.5 years
(SD: 14.8), was 50% male, 82% white and 16% black.
Average time from symptom discovery to presentation was
15.0 hours (SD: 23.2); 44% presented within 4 hours, 13%
within >4–8, 25% within >8–24, 10% within 1–2 days, and
8% within 2–7 days. Adjusted models suggested that female
gender, diabetes, race, Medicaid, smoking, and substance
use disorders were significantly associated with >4-hour
presentation, while symptom onset during waking hours
(7 am–9 pm; odds ratio: 8.8), higher National Institutes of
Health Stroke Scale score (odds ratio: 1.04), and advance
notification of ED team by emergency medical services
were protective (odds ratio: 2.0). Additional factors were
identified in the ordered logit analysis of time categories,
including obesity.
Conclusion: A combination of timing of symptom discovery
and demographic and health care factors predicts delays to
presenting for stroke treatment. Such information can be
incorporated into clinical policies and treatment decisions
to enable personalized care and improved outcomes for
patients presenting with stroke symptoms. Further research
should validate predictive models and integrate research
results into system processes and clinical practice to reduce
time from stroke onset to presentation.
Keywords: rural health, cardiovascular disease, aging,
elderly, geriatrics, quality of care, demographics,
acute inpatient care, ambulatory/outpatient care, social
determinants of health, gender/sex differences, diabetes,
Medicaid/SCHIP, substance abuse and addiction, Medicare,
complex disease management, multiple chronic conditions,
health care costs, resource use, hospital, biostatistics,
access to services, quality improvement, epidemiology

Background: Despite effective treatment options, delays
in presentation for acute stroke are common. Delays of
more than 4 hours preclude use of tissue plasminogen
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Use of Clinical Data in Assessing Long Risk of
Keratinocyte Carcinoma Among Patients With
Parkinson’s Disease
Sharon Lerman,1 Boaz Amichai,2 Gabriel Weinstein,3
Varda Shalev,3 Gabriel Chodick3
Hadassah Medical School, Hebrew University, Jerusalem,
Israel; 2Tel Aviv University, Tel Aviv, Israel; 3Maccabi
Healthcare Services, Tel Aviv, Israel
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Background: The association between Parkinson’s
disease (PD) and melanoma is well recognized, but its
relationship with nonmelanoma skin cancers (NMSCs) has
not been studied in depth. Study objective was to assess
the relationship between PD and risk of melanoma or
keratinocyte carcinoma (squamous cell carcinoma [SCC],
basal cell carcinoma [BCC]).
Methods: This historical cohort study used the data of 1.2
million adult members of a large health organization between
2000 and 2015. Individuals who were diagnosed with PD any
time between 2000 and 2010 were retrospectively followed
until August 2016 for incidence of SCC, BCC, or melanoma
identified from physician diagnoses and pathology reports.
Results: The PD cohort included 7727 patients (mean age:
69.9 years, SD: 14.8 years) among the 1,251,695 study
population. During follow-up, a total of 4553, 32,069, and
4015 cases of BCC, SCC, and melanoma were identified
in the study population, respectively. Multivariable models
revealed that older age, male sex, never smoking, residence
in southern Israel, and actinic keratosis were associated with
an increased risk of both BCC and SCC. PD patients age
45–64 years and 65–84 years at baseline had odds ratios of
2.11 (95% CI: 1.40–3.18) and 1.52 (95% CI: 1.21–1.91) for
BCC, respectively. Weak or no associations were calculated
for melanoma or SCC.
Conclusion: We report a positive relationship between PD
and risk of BCC. These results should stimulate greater
awareness on the part of health care providers to the
increased risk of BCC in PD patients.
Keywords: cancer
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Defining Priorities to Improve Patient Experience
in Superficial Bladder Cancer
Tullika Garg,1 Jill Connors,2 Ilene Ladd,1 Tyler
Bogaczyk,3 Sharon Larson1
Geisinger Health System, Danville, PA; 2Indiana University
School of Medicine, Indianapolis, IN; 3Drexel College of
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Background: Approximately 75% of bladder cancers are
superficial at diagnosis. Though muscle-invasive disease
affects far fewer, much research focuses on experiences related
to radical cystectomy and urinary diversion. Significant gaps
remain in our understanding of the experiences and needs
of superficial bladder cancer patients across the cancer
continuum. The objective of this study was to understand
patient experience, define care priorities, and identify targets
for care improvement in superficial bladder cancer.
Methods: Patients treated for superficial bladder cancer
(stage < T2) were invited to share their care experiences
throughout the cancer continuum, including diagnosis,
treatment, and survivorship, in focus groups. Transcripts
were analyzed using conventional content analysis to
identify themes and subthemes.
Results: A total of 20 patients participated in three focus
groups. Mean age was 71 years, 16 participants were male,
and all were white. Five primary themes emerged: access to
care, provider characteristics and communication, quality of
life, goals of care/influences on decision-making, and role
of social support. Patients with superficial bladder cancer
desired timely access to care and honest and caring provider
communication. They described urinary function and
emotional quality of life changes resulting from diagnosis and
treatment. Avoiding cystectomy and being alive for family
were the major decision influencers. In the poster, we will
present themes, subthemes, and representative quotations.
Conclusion: In this qualitative study, we identified access
to care, provider characteristics and communication, quality
of life, values/influences on decision-making, and social
support as priority areas to improve patient experience in
superficial bladder cancer. Care redesign efforts should focus
on improving access, enhancing provider communication,
reducing side effects, and supporting caregiver roles.
Keywords: cancer, qualitative research, patient experience/
satisfaction
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Background: Multiple myeloma is preceded by the largely
asymptomatic and incidentally diagnosed monoclonal
gammopathy of undetermined significance (MGUS).
Supplement

Retrospective studies estimate that 3% of U.S. adults age ≥50
years have this premalignant condition, yet MGUS patients
progress to multiple myeloma at a rate of only 1% per year. The
resulting uncertainty leads to heightened patient anxiety and
repeated clinical surveillance. To facilitate population-based
MGUS research, we are developing an algorithm to efficiently
identify MGUS patients in automated health care data.
Methods: Eligible men and women were age ≥ 50 years,
sought care at a large, community-based health care provider
group in central Massachusetts at least once between 2007 and
2015, and were enrolled for ≥ 12 months. Patients diagnosed
with multiple myeloma prior to or within 3 months of MGUS
diagnosis were excluded. The first step of the algorithm
identified eligible patients with two or more MGUS diagnosis
codes in their electronic medical record (EMR) entered on
different dates within a 12-month period. Next, we selected
those patients who, within 90 days of MGUS diagnosis, had:
A) one or more serum protein electrophoresis tests; B) a serum
or urine immunofixation test; and C) an office visit with an
oncologist. A targeted manual EMR review conducted by 3
nurse abstractors and adjudicated by 2 clinicians constituted
the gold standard for positive predictive value calculations.
Results: The algorithm identified 833 subjects who met the
first algorithm step; 429 (52%) patients met all 4 algorithm
criteria. EMRs for 250 patients in the latter group (58%) were
reviewed. Potential MGUS cases meeting all four algorithm
criteria were 85% white and 51% female, had a median of 10
MGUS diagnosis codes in their EMR, and had a mean age
of 74 years at diagnosis. Review of the first 20% of charts
suggests a preliminary positive predictive value of 78% or
greater for the 4-step algorithm; chart review is ongoing.
Conclusion: Early results from this single-site study suggest
that MGUS cases can be identified with reasonable accuracy
in electronic health data through a 4-step algorithm. Following
completion of chart review, the algorithm will be applied to
a second Cancer Research Network health care system to
evaluate performance in an independent population.
Keywords: cancer, epidemiology
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Adherence to Surveillance Guidelines for
Colorectal Cancer Survivors Based on Follow-Up
Care Provider Specialty
Devon Check,1 Neetu Chawla,2 Valerie Lee,1 Leslie
Manace Brenman,1 Aileen De Mucha Flores,1 Raymond
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Background: Guidelines recommend that patients with
early-stage (I–III) colorectal cancer (CRC) receive regular
posttreatment surveillance with colonoscopy, computed
tomography (CT) scans, and carcinoembryonic (CEA) blood
Supplement

testing. Depending on patient’s stage, completed treatment,
preferences, and access, surveillance may be managed
by a primary care provider (PCP) and/or a specialist. We
investigated whether different providers’ involvement in
follow-up care may impact patients’ receipt of guidelinerecommended surveillance.
Methods: We conducted a retrospective cohort study using
data from Kaiser Permanente Northern California’s cancer
registry and electronic medical records. Patients in our sample
(N=2,615) were diagnosed with stage I–III CRC from 2011
to 2014, received surgery, and had at least 1 follow-up visit
in the 6–18 months postdiagnosis. We created indicators of
patients’ visits with oncologists, surgeons, gastroenterologists,
and PCPs. Using modified Poisson regression, we examined
the association of each indicator with patients’ receipt of ≥ 1
colonoscopy (stages I–III), ≥ 1 CEA test (stages II–III), and ≥
1 chest, abdomen, or pelvis CT (stages II–III) during the same
period. All models were adjusted for patient age, race, gender,
comorbidity, tumor stage, site, and treatment received.
Results: In total, 67% of all patients saw an oncologist, 18% a
surgeon, 16% a gastroenterologist, and 72% a PCP. In adjusted
analyses, stage I–III patients who saw an oncologist were
38% more likely to receive a colonoscopy (adjusted risk ratio
[aRR]: 1.38, 95% CI: 1.21–1.55). Stage II–III patients seeing
an oncologist were 129% more likely to receive CT (aRR:
2.29, 95% CI: 1.93–2.72) and 219% more likely to receive
CEA testing (aRR: 3.19, 95% CI: 2.72–3.78) compared
to those who saw a different type of provider. Seeing a
gastroenterologist versus a different type of provider was
positively associated with colonoscopy receipt (aRR: 1.14,
95% CI: 1.01–1.28). Contact with a PCP was not statistically
significantly associated with receipt of any of these tests.
Conclusion: Patients seen by medical oncologists were
more likely than those seen by other providers to receive
each recommended surveillance test in the 6–18 months
postdiagnosis. Our results highlight the need for further
research on multilevel factors (eg, patient-provider
relationships, provider familiarity with guidelines) that may
explain our findings. They also highlight a potential need
for interventions to improve surveillance for CRC survivors.
Keywords: observational study, primary care, quality of
care, clinical practice patterns/guidelines
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Background: The influence of sustained virologic
response induced by oral direct-acting antivirals on the
risk of hepatocellular carcinoma (HCC) among patients
with chronic hepatitis C is conflicting. Our objective was
to determine the incidence and recurrence of HCC among
adults with chronic hepatitis C who received oral directacting antivirals.
Methods: A retrospective cohort study among users of oral
direct-acting antivirals from January 1, 2015, to December
31, 2016, in the NIH Collaboratory Distributed Research
Network (DRN). The cohort included members ≥ 18 years
of age during the 2-year query period who had continuous
drug and medical coverage for a minimum of 183 days.
Incidence use was defined as no exposure to any of the directacting antivirals in the 90 days before the index dispensing.
National Drug Codes were used to identify exposures and
create the treatment episodes. The ICD-9-CM and ICD-10CM were used to identify the outcome of HCC. The users
were required to have no preexisting HCC during the 180
days prior to the index date for the analysis of incident users.
The analysis for recurrent HCC included incident users
with preexisting HCC in the 366 days prior to incident use.
Each data partner conducted its analysis in the local data
environment and returned aggregate information to the NIH
Collaboratory DRN Coordinating Center (Harvard Pilgrim
Health Care Institute), which combined the data across sites.
Results: There were 14,365,692 members eligible for the
incident analysis and 4092 members eligible for the recurrent
HCC analysis. Rates of new HCC for ombitasvir/paritaprevir/
ritonavir/dasabuvir (1.6%), sofosbuvir/lepidasvir (11.9%),
sofosbuvir/veltapasvir (0%) and sofosbuvir (1.6%) were
uniformly low. Rates of recurrent HCC for sofosbuvir/
lepidasvir were high. Limitations include the small number
of users for several drugs, absence of an unexposed arm,
and confounding by disease severity and use of only 3 of the
organizations that participate in the NIH Collaboratory DRN
to minimize cost. Use of the full dataset would increase the
number of users by approximately 8-fold.
Conclusion: Sofosbuvir/lepidasvir was associated with low
incidence of new-onset HCC. The persistence of recurrent
HCC after treatment with oral direct-acting antivirals
deserves further exploration.
Keywords: cancer, virtual data warehouse, clinical decisionmaking, epidemiology
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Background: As a minority group within the Veterans
Affairs (VA) system, women veterans may experience
unique challenges to accessing and coordinating health care
services, such as identifying providers to manage and treat
gender-specific health conditions or obtaining specialized
services (eg, mammograms). Coordination of care is even
more challenging for those with complex chronic conditions,
such as cancer, which may require receipt of care outside the
VA system. In this study, we examined how receipt of care
outside VA impacts overall ratings of care among women
veterans with and without a history of cancer.
Methods: We used patient-reported data from a crosssectional, weighted, telephone survey conducted between
January and March 2015 at 12 VA medical centers among
1395 women veterans who had 3+ VA primary care visits in
the prior year. We analyzed how women rated their overall
health care on a 0–10 scale and compared ratings between
veterans with and without a history of cancer. Using
linear regression, we modeled associations of care receipt
outside the VA system with overall ratings of care among
those with and without a history of cancer, controlling for
sociodemographic and insurance characteristics. We ran an
overall model in the full sample and stratified models among
the cancer and noncancer populations.
Results: A majority of the sample was over 45 years old
(65%) or white race (59%); nearly half reported having
only VA coverage (42%). Approximately 13% of the sample
reported a history of cancer. In the overall model, we found
that use of care from outside the VA system was associated
with poorer ratings of care (P=0.018). However, when we
stratified by cancer status, we saw that this association was
only significant for the cancer population (P=0.001).
Conclusion: Among women veterans with a history of cancer,
those receiving health care outside the VA system reported
poorer overall care ratings versus those receiving care
within the VA system alone. These findings may underscore
care coordination challenges that exist for women veterans
with cancer and point to the need for health care and policy
interventions to improve coordination of care between VA and
non-VA providers in the context of cancer care delivery.
Keywords: cancer, quality of care, VA health system, access
to services
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Associated With Early-Age Pancreatic Cancer
Diagnosis
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Background: Recent research has found increased incidence of
pancreatic cancer among younger populations (≤50 years old).
Little is known about risk factors associated with pancreatic
Supplement

cancer diagnosis at an early age. This study examined
demographic, clinical, and utilization factors associated with
diagnosis at a younger age (≤50) compared to older age (>60).
Methods: Using tumor registry data, we analyzed 17 years
of pancreatic cancers diagnosed from January 1, 2000, to
December 31, 2016, within Kaiser Permanente Northwest
(KPNW), an integrated health system in the Pacific Northwest.
This population was further divided into two age groups:
younger age (n=56) and older age (n=810). Demographic,
clinical, and utilization measures were identified via KPNW’s
electronic health record, including sex (female vs male),
race/ethnicity (nonwhite vs white), smoking status (yes vs
no), diabetes mellitus status (yes vs no), body mass index
(BMI ≥ 30 vs BMI < 30), and Charlson comorbidity index
(CCI) score (1+ vs 2+ vs 0), along with primary care visits,
emergency department utilization, and hospital admissions in
the 12 months prior to index diagnosis (1+ visits vs none).
Multivariable logistic regression was used to measure the
associations between these variables and the likelihood of
pancreatic cancer diagnosis at an early age.
Results: We found a higher likelihood of being diagnosed
with early-age pancreatic cancer: current smoker (odds ratio
[OR]: 2.75, 95% CI: 1.34–5.62), nonwhite ethnicity (OR:
3.61, 95% CI: 1.79–7.28), BMI ≥ 30 (OR: 1.89, 95% CI:
1.02–3.53), and 1+ hospital admissions in the year prior
to cancer diagnosis (OR: 2.07, 95% CI: 1.05–4.11). A CCI
score of 2+ (OR: 0.40, 95% CI: 0.19–0.84) and 1+ primary
care visits in the year prior to diagnosis (OR: 0.36, 95% CI:
0.13–0.96) were associated with a lower likelihood of earlyage pancreatic cancer diagnosis.
Conclusion: We found several demographic, clinical, and
utilization factors associated with early-age diagnosis of
pancreatic cancer. Specifically, the finding that nonwhites
were more likely to be diagnosed at an early age deserves
further exploration, with respect to key drivers explaining
the finding. Moreover, future work is needed to understand
how potentially modifiable factors like smoking status and
obesity are linked to early-age pancreatic cancer diagnosis.
Keywords: observational study, demographics
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Background: Psychosocial distress is common among
women diagnosed with cancer. The Institute of Medicine
and Commission on Cancer have each emphasized the
significance of addressing psychosocial health needs among
Supplement

cancer survivors and the importance of care coordination
between providers to better manage patients’ needs. The
purpose of this study was to evaluate care coordination
experiences among women veterans and examine whether a
history of cancer and a co-occurring mental health condition
was associated with poorer care receipt.
Methods: Data are from a cross-sectional, weighted,
telephone survey of 1395 women veterans with 3+ visits in
the prior year. The survey was conducted between January
and March 2015 at 12 VA medical centers with a response rate
of 46%. We examined associations of a history of cancer and
a co-occurring mental health condition with the following
self-reported outcomes: 1) primary care team managed care
between providers poorly; 2) care coordination was difficult
between VA and non-VA providers; and 3) care coordination
was difficult between primary and specialty care within the
VA. In multivariable regression analyses, we controlled for
sociodemographic and insurance characteristics and ran
separate models for women with a history of cancer and
depression and women with a history of cancer and anxiety.
Results: A majority of the sample was over 45 years old
(65%) or white race (59%); nearly half reported having
only VA coverage (42%). In evaluating care management
experiences, we found that women with depression (odds
ratio [OR]: 2.11, 95% CI: 1.56–2.83) and women with
anxiety (OR: 2.08, 95% CI: 1.47–2.94) reported significantly
poorer care. Women with anxiety also reported significantly
poorer coordination experiences between VA and nonVA providers (OR: 2.11, 95% CI: 1.31–3.40). Women
with cancer reported poorer care for both outcomes but
findings were not significant. Experiences of coordination
between VA primary and specialty care providers were not
significantly different for any of these groups.
Conclusion: Our results indicate that women with cancer
and a co-occurring mental health condition have poorer care
coordination experiences, primarily driven by their mental
health status. Screening and treating psychosocial distress
among women veterans may help to improve patient care
experiences, while further investigation is needed to examine
the needs of cancer patients within the VA system.
Keywords: cancer, quality of care, VA health system, patient
experience/satisfaction
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Background: HealthPartners (HP) and Park Nicollet (PN)
merged in 2014 to form one multispecialty care group with
a cohesive electronic health record (EHR). This unique,
integrated, open-access structure provides HealthPartners
www.aurora.org/jpcrr
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Institute (HPI) access to large populations of members,
patients, and patient-members to enhance the virtual data
warehouse (VDW). HPI has undertaken efforts to augment
its VDW, including incorporating additional cancer cases by
gaining access to additional owned sites, refining staging
information, and adding new analytic data variables.
Methods: Tumor data from two PN hospitals, Methodist
and St. Francis, were incorporated into the VDW. Through
collaborations with the Hospital Tumor Registry, mapping
of ERS variables to North American Association of Central
Registries variables was reviewed to ensure comprehensive
identification of staging information. We subsequently
developed a new method for obtaining American Joint
Committee on Cancer (AJCC) stage information. This
method was validated via chart review on a sample of 27
colorectal cancer (CRC) cases. Clinical record linkages
to identify PN patients have been completed across the
integrated EHR. Additional VDW enhancements include
the inclusion of chemotherapy infusion data and laboratory
values including prostate-specific antigen (PSA), alphafetoprotein (AFP), cancer antigens 19-9 (CA 19-9) and 125
(CA 125), and carcinoembryonic antigen (CEA).
Results: With the inclusion of the additional hospital data,
our VDW tumor table now includes 51,207 total cancer
cases (increased from 25,924 available in 2016), including
11,453 breast, 3129 colorectal, 5849 lung, and 4867 prostate
cancer cases. Results of the staging validation indicated
concordance between the EHR and the new AJCC stage
method for 81% (22 of 27) of the CRC cases. Following
the addition of PN, HPI data now includes over 6 million
patients whose utilization will be added to the VDW. In
addition, data on more than 900,000 administered infusions
and 15,000 PSA, 49,467 AFP, 13,288 CA 19-9, 23,094 CA
125, and 302 CEA values are available in the VDW.
Conclusion: With the expansion of our VDW, we have
doubled our cancer cases, increased the accuracy of staging
data, included data regarding infusions administered and
laboratory values, and will be incorporating additional EHR
utilization. These additions greatly expand our capabilities
for performing cancer research.
Keywords: virtual data warehouse
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Cisplatin-Associated Ototoxicity May Affect Patient
Adherence to Cancer Treatment
Steven Chang1

to assess the relationship of cisplatin-associated ototoxicity
on patient completion of a cisplatin-based chemotherapy
regimen at a single academic institution.
Methods: A retrospective database of patients with
head and neck cancer was queried for those treated with
chemotherapy during 2013–2016. Patients who received
cisplatin during their treatment were included in this study.
Statistical analysis was used to study the association of
cisplatin-associated ototoxicity on patient completion of the
prescribed chemotherapy regimen.
Results: A total of 193 patients were included in the database.
Average age was 61.39 years (SD: 12.30), and 79.8% of
patients were male. A total of 103 patients (53.4%) were
prescribed cisplatin as a treatment modality. Pre-, mid- and
post-chemotherapy treatment audiograms were recommended
for 68.9% of patients receiving cisplatin therapy; however,
3.9% (n=4) completed pretreatment audiograms, 8.7% (n=9)
completed midtreatment audiograms, and 19.4% (n=20)
completed posttreatment audiograms. Among patients on
cisplatin treatment, 14.6% (n=15) reported otologic concerns
at 3-month follow-up compared to 2.2% (n=2) on noncisplatin
chemotherapy. In analyzing adherence to therapy, 4.9% (n=5)
of patients on cisplatin treatment switched their chemotherapy
regimen due to ototoxicity, while 12.6% (n=13) switched
their chemotherapy regimen due to nonototoxic reasons.
Comparatively, of those undergoing noncisplatin therapy,
none switched their chemotherapy due to ototoxicity while
11.1% (10) switched due to nonototoxic reasons.
Conclusion: Cisplatin-associated ototoxicity is associated
with noncompletion of a prescribed chemotherapy regimen
in some patients. Further research is needed into this area,
as the ototoxic effects are likely to have impact on patient
quality of life in survivorship.
Keywords: aging, elderly, geriatrics, cancer, quality of life,
quality of care, clinical practice patterns/guidelines, quality
improvement
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Background: Cisplatin is a common and effective drug used
in the management of numerous malignancies. A number of
studies have reported on the ototoxic profile of cisplatin;
however, no study has analyzed the impact of cisplatinassociated ototoxicity on patient completion of a prescribed
cisplatin-based chemotherapy regimen. This study aimed
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Background: A cancer diagnosis can carry enormous
personal financial hardship. Patients frequently struggle
with finances and make tough decisions. To understand the
Supplement

personal financial toll from cancer, our National Cancer
Institute (NCI) Community Oncology Research Program is
participating in the NCI-funded cancer care delivery research
study “Implementation of a Prospective Financial Impact
Assessment Tool in Patients with Metastatic Colorectal
Cancer” (S1417CD). The ultimate goal of this research is
to measure the association between cancer treatment and
financial hardship, using a comprehensive financial impact
assessment tool that can be adopted in routine clinical care
and alongside cooperative group clinical trials. Challenges
anticipated include a lack of knowledge of financial
terminology, reluctance to discuss financial details, and health
professionals being unprepared to discuss financial matters.
Methods: S1417CD will assess the incidence of treatmentrelated major financial hardship over 12 months following
a diagnosis of metastatic colorectal cancer. Patients will
complete questionnaires at baseline and every 3 months
regarding the impact of cancer on their financial situation.
Data regarding credit attributes will be collected by a
third party. Our local study implementation plan included
engaging community programs and advocacy networks
to understand how best to discuss this sensitive topic and
incorporating a variety of communication vehicles targeting
the general public, research community, and providers. We
leveraged local newspaper and television news, a regional
webinar with the American Cancer Society, and a local
physician magazine.
Results: Our institutional review board approved the study in
March 2017. Staff training and site implementation occurred
in April 2017, and the study was activated locally in May
2017 at 5 component sites. As of October 2017, 10 local
component sites are enrolling. To date, 13 participants have
been enrolled locally and 117 nationally. There are 470 study
locations nationally and the total targeted enrollment is 374.
Conclusion: The successful local implementation of this
study is the result of our strong local infrastructure and
the salience of financial toxicity research. In addition, the
concerted effort to communicate the importance of this
research and the availability of the study through a variety
of communication vehicles targeted to multidisciplinary
audiences enhanced our recruitment and enrollment efforts.
Keywords: cancer, quality of life, health care costs, resource
use
P4.02
Exploring Patient and Health Care Professional
Experience With the Medication Prior Authorization
Process Within a Rural Health Care Setting
Laney Jones, Ilene Ladd, Jove Graham, Michael
Evans,1 Michael Gionfriddo1
1

1

1

decade due to increased use of high-cost medications (eg,
biologics) for previously untreated or targeted conditions.
PA has been shown to be burdensome for health care
professionals; little is known, however, about the impact of
the PA process on patient experience.
Methods: Semi-structured interviews were conducted
with patients, and a focus group was conducted with health
care professionals. Patients who had received a medication
requiring PA and who had been seen at Geisinger Health’s
Wilkes-Barre Rheumatology Clinic, as well as health care
professionals who work at that clinic, were recruited by
study team. Participants were asked about their experience
with the current PA process. Recordings were transcribed
verbatim and reviewed for accuracy and completeness. Two
reviewers independently reviewed the transcripts and coded
the data. Consensus coding was then completed and relevant
themes were extracted.
Results: Seven patients shared their experience with
receiving a medication that required PA. Most patients felt
that insurance companies imposing restrictions on access to
medications caused a delay in their care and that the process
was confusing and unfriendly. Overall, patients had positive
experiences with their doctors and pharmacies when being
prescribed a medication that required PA but did express
concerns when learning about high costs of their medications.
Ten medical staff within the rheumatology department were
asked to give feedback on the appropriateness and usefulness
of survey questions regarding the PA process. Individuals
had varying perspectives based on their level of engagement
with the PA process, but all felt that a team approach was
necessary to provide high-quality care for their patients.
Many expressed uncertainty in knowing which medications
require PA and perceived that this process delays care for
their patients. Physicians felt that individuals making PA
decisions at some health insurance companies did not have
the medical expertise required.
Conclusion: This study provides insights into the patient’s
experience when obtaining medications that require PA and
expands the current literature on health care professional
experience. In addition, learnings will be used to impact
implementation of new PA processes.
Keywords: qualitative research
P4.03
Advancements in Care Coordination: Findings
From an Evaluation of Minnesota’s State Innovation
Model Initiative
Christina Worrall,1 Donna Spencer,2 Caroline AuYeung,1 Emily Zylla,1 Kelli Johnson,1 Lacey Hartman1

Geisinger Health, Danville, PA
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Background: The number of medications requiring prior
authorization (PA) is projected to increase over the next

Background: Between 2013 and 2017, under a federal
State Innovation Models (SIM) cooperative agreement,

1
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Minnesota implemented a model for transforming the
state’s health care payment and service delivery systems
in order to lower costs, increase quality, and improve
population health. One aim of Minnesota’s SIM model
was that the majority of individuals would receive care
that is patient-centered and coordinated across settings.
This aim underpinned four of the state’s SIM strategies:
1) advance providers’ health information exchange (HIE)
ability; 2) increase provider access to data analytics; 3)
implement practice transformation to expand the number
of patients receiving team-based integrated/coordinated
care; and 4) increase partnership among organizations
and individuals to create Accountable Communities for
Health (ACHs). Under a contract with the state, external
researchers examined whether and how these strategies
increased the capacity of participating organizations to
deliver coordinated care.
Methods: This analysis was part of a broader evaluation
of Minnesota’s SIM model conducted from 2015 through
2017 using both quantitative and qualitative methods. Key
data sources included semi-structured interviews with
organizations participating in SIM and with the state, a
SIM organization survey, an ACH provider survey, and a
survey of HIE users under SIM.
Results: Interview and survey data indicated, broadly,
an increased capacity to deliver coordinated care across
medical and nonmedical settings, which interviewees
attributed largely to strengthened relationships with, and
knowledge of, other providers, organizations, and resources.
Data also showed, to a varying extent, improvement
in select care coordination processes/capabilities (eg,
assessments of social determinants). Where growth was
not seen, data indicated that SIM participants came into
the initiative with capabilities. SIM participants reported
an increase in access to or collection of data to improve
care/service coordination. Providers participating in ACH
care coordination models reported positive impacts on
workload and workflow.
Conclusion: This analysis found an increased capacity to
coordinate care among organizations participating in SIM
in Minnesota. Future efforts to enhance this capacity should
work to demonstrate the value of care coordination with a
population health focus while also targeting organizations
that are less developed, encouraging community
connections, and prioritizing investments in HIE and data
analytics to support care coordination.
Keywords: program evaluation, referrals, networks, quality
of care, state health policies, evaluation research, health
policy/regulation, social determinants of health, Medicaid/
SCHIP, qualitative research, quality improvement, patient
experience/satisfaction
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P4.04
The Underpads Study: Safe Delivery of Patient
Output Without the Risk of Catheter-Associated
Urinary Tract Infection
Kealy Ham1
HealthPartners Medical Group / Regions Hospital /
University of Minnesota, Saint Paul, MN
1

Background: Historically, the indwelling catheter has
been an automatic accessory in critically ill patients to
measure accurate input and output measurements. Catheterassociated urinary tract infections (CAUTI) can be decreased
or eliminated by using simple scales and weighing of
underpads for adult patients in the hospital. By not inserting
an indwelling catheter, the risk of infection is eliminated. We
developed an alternative quality improvement plan using
underpads instead of indwelling catheters to capture the
same data in a safer way for our patients. Department-based
standard-of-care procedures may be improved by measuring
fluid accumulation or volume loss in patients with this novel
method.
Methods: On the medical intensive care unit in our
urban Level I trauma hospital, we identified patients who
required input and output data who were admitted with a
diagnosis of alcohol use/abuse, polysubstance use/abuse,
ingestion, or toxic encephalopathy. Patients were eligible
if they were not on diuretic therapy, did not have wounds
at risk for contamination, and did not have a history of
urinary retention. If the patient had an existing indwelling
catheter, it was removed. If the patient did not have one,
none was placed. A simple metric-scale weight was
obtained and the clean pad was placed under the patient.
The pad was checked every 2 hours as is standard for our
patient-positioning strategy. Any wet pad was immediately
removed from the patient and the standard cleaning and
skin protection process was followed. The weight of the
pad was documented as milliliters of urine (or mixed)
output.
Results: There was a 68% reduction in duration of indwelling
catheter time in patients with underpad use versus routine
care. There was a decrease in CAUTI rates compared to
pretrial and the national rate. There was no incidence of
pressure ulcers in either group.
Conclusion: The evaluation of the use of underpads instead
of indwelling catheters challenges common practices and
questions why we continue to use practices that may lead to
harm. This may result in safer patient care, improved quality
of care, and elimination of potential financial consequences
from publicly reportable infection data.
Keywords: acute inpatient care, health care costs, resource
use, hospital, patient safety, quality improvement
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Variation in Patterns of Care Related to Control of
Cardiovascular Risk Factors Across Primary Care
Providers
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PACT — A Self-Management Program for Chronic
Pain Utilizing Online Education and Telehealth
Coaching: Findings of the Pilot Study
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Ekstrom,1 Patrick J. O’Connor1
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Background: We used output from a primary care clinical
decision support system to investigate the degree of variation
across primary care providers (PCPs) in firing frequency of
two treatment recommendations related to aspirin use for
cardiovascular prevention and screening for diabetes.
Methods: We identified 12,234 adults (with high 10-year
cardiovascular disease risk but without diabetes or heart
disease) under the care of 161 PCPs (range: 7–494 eligible
patients), in a subset of a larger randomized trial (HL102144).
We used descriptive statistics to summarize the distribution
of PCP-specific proportions of patients for whom these
selected treatment recommendations fired. Additionally,
we stratified these distributions by the proportion of each
PCP’s patients who were insured by Medicaid to evaluate
whether observed variation in treatment recommendations
could be explained by differences in socioeconomic status
across provider-specific patient populations. Statistical
comparisons were done using Wilcoxon rank-sum tests.
We also computed r2 values using linear regression, which
indicate the amount of variation in care recommendation fire
rates that could be explained by Medicaid distribution.
Results: The concurrent nonsteroidal anti-inflammatory
drug and aspirin use safety recommendation fired for 21.5%
of patients of the median PCP (10th percentile: 10.0%; 90th
percentile: 36.1%). The frequency of this recommendation
was significantly higher for PCPs with a greater proportion of
patients on Medicaid (median of ≥5% vs <5% on Medicaid:
25.0% vs 19.7%; P=0.026). However, variation in the
frequency of this recommendation was substantial regardless
of Medicaid status (≥5% vs <5% on Medicaid for 10th
percentile: 11.1% vs 10.2%; 90th percentile: 38.6% vs 30.8%;
r2=0.032). The diabetes screening recommendation fired for
28.0% of patients of the median PCP and varied across PCPs
(10th percentile: 15.8%; 90th percentile: 39.5%). The rate of
this recommendation firing did not differ by proportion of
PCP’s patients on Medicaid (P=0.631; r2=0.003).
Conclusion: These data demonstrate substantial variability
across primary care providers in key safety and care practice
patterns. The results suggest an opportunity to design PCP
interventions based on PCP-specific care improvement
opportunities that can be identified through clinical decision
support systems.
Keywords: cardiovascular disease, ambulatory/outpatient
care, observational study, quality of care, diabetes, Medicaid/
SCHIP, chronic disease, clinical practice patterns/guidelines

Background: Temporomandibular disorders (TMD) are
one the most common pain conditions, affecting more than
10% of the general population. The Personalized Activated
Care and Training (PACT) program provides patients with a
telehealth coach and online self-management modules using
cognitive-behavioral strategies to train patients to reduce
risk factors and implement protective actions that can reduce
chronic pain. Our focus of this analysis was to evaluate the
use of telehealth coaching among those participants in the
PACT online program.
Methods: Data were gathered from participants enrolled in
the TMD self-care pilot randomized clinical trial. The pilot
compared the PACT program to traditional self-care for TMD
pain. To understand the impact of the telehealth coach in the
online self-management program, we examined participant
compliance with the telehealth coach model. Within the
PACT arm, we identified participants who engaged in 3
or more sessions with coaches (high engagement). We
examined their baseline characteristics, usability of the
online program, and change in chronic pain self-efficacy at
8-week follow-up. Participant feedback was captured from
program evaluation, and telehealth coaching experience was
obtained from phone interviews.
Results: Among the 40 subjects who were randomized
to the PACT program, 27 (69%) demonstrated high
engagement in health coaching. Characteristics associated
with higher engagement were being female, age 30–65
years, experienced chronic pain for 3 or more years, having
a TMD screen score of 5 points, and self-efficacy. Highly
engaged participants had better adherence to the online
program and had lower change in self-efficacy (6.5% vs
36.26%). Based on interviews regarding their experiences
with health coaching, highly engaged participants reported
that “She helped me set goals; her support was great” and “It
was a way to make sure that I stayed on track” and “I used it
as part of my self-management.”
Conclusion: For participants with chronic pain, telehealth
coaching is a key component of the online self-management
PACT program. Those who have a high level of engagement
are more likely to adhere to the program and have a
positive perception of their health coach in supporting selfmanagement of pain.
Keywords: information technology, quality of care, health
promotion, prevention, screening, dental care, patient
experience/satisfaction
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P4.07
Prehospital Lactate: A Severity Indicator in Early
Sepsis Management

P4.08
Encouraging Patients
Breakdowns in Care
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Background: Serum lactate levels can rapidly dictate
clinical awareness of shock and prompt intervention in
sepsis. Collecting serum lactate levels is restricted to the
hospital setting. The objective of this study was to investigate
whether a prehospital lactate (PL) measurement improves
time to intervention upon emergency department (ED)
arrival. We hypothesized that emergency medical services
communication of a PL value to the ED physician would
result in improved time to antibiotics and an in-hospital
lactate order.
Methods: This prospective, observational study included
patients with a prehospital impression of infection based on
systemic inflammatory response syndrome criteria. A pointof-care testing PL was collected by paramedics prior to ED
arrival and reported during presentation. ED metrics were
collected and compared to a previously collected control
group of patients presenting without a PL but who met early
sepsis criteria. Cox regression models were used to estimate
hazard ratios with 95% confidence intervals for time to
physician order for an antibiotic or in-hospital lactate test.
Results: Study patients (60–96 years old) included 170
with PL measures and 269 controls. The PL group was
older on average (mean age: 69 vs 54 years, P<0.001)
and was more likely to have expired in the hospital (10%
vs 5%, P=0.027). An antibiotic was ordered for 104 PL
patients (61%) and 216 controls (80%). In a Cox model
adjusted for age and gender, the control group had a nearly
2-fold faster rate of time to antibiotic order (hazard ratio:
1.93, 95% CI: 1.50–2.48), relative to PL patients. Among
the PL patients, time to antibiotic order did not differ by PL
(>2 vs ≤2 mmol/L, P=0.545). Time to in-hospital lactate
order did not significantly differ between control group and
patients with PL > 2 mmol/L (P=0.811), but time to inhospital lactate order was twice as slow for patients with
PL ≤ 2 mmol/L (hazard ratio (vs control group): 0.47, 95%
CI: 0.33–0.68).
Conclusion: In this small study, the availability of PL
value did not improve time to antibiotics. Patients with a
normal PL had a prolonged time to antibiotics compared to
the control group, and a higher death rate. A larger study is
required to validate these results.
Keywords: acute inpatient care, clinical decision-making,
clinical practice patterns, guidelines
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Health Research Institute, Hyattsville, MD; 3University of
Washington Medical Center, Seattle, WA; 4University of
Massachusetts Medical School, Worcester, MA
Background: As many as 40% of hospitalized patients
perceive a breakdown in their care, but many are reluctant to
speak up, resulting in missed opportunities to improve care.
Strategies to encourage patients to speak up are needed.
Methods: We surveyed a national sample of adults age >
35 years using an online, vignette-based questionnaire.
Participants were asked to imagine experiencing 3 common
breakdowns during hospitalization: slow response to the call
bell; rudeness on the part of the aide; and having unanswered
questions. Participants were randomly presented with one
of 9 versions of a brief conversation that might prompt a
patient to speak up. Conversations described a doctor, nurse,
or patient specialist who provided a minimal, intermediate,
or extended prompt to speak up. Participants rated how
upset they would be about each breakdown, whether they
would speak up about each breakdown, and whether they
would recommend the hospital.
Results: The final sample size was 1188 (response rate:
64.4%). Overall, participants were most upset about having
unanswered questions (84.7% would be extremely/very
upset), least upset about slow response to the call bell (35.4%
extremely/very upset), with rudeness of the aide in between
(66.3% extremely/very upset). The inquirer’s role affected
whether participants would report the slow response to the
call bell (23.4% definitely would tell the physician, 27.7%
the nurse, 42.7% the patient specialist; P≤0.0001) and
rudeness (34.2% would definitely tell the physician, 40.3%
the nurse, 54.5% the patient specialist; P≤0.0001) but not
intent to speak up about unanswered questions (80.7% would
definitely speak up overall; P>0.10). We found no impact
of wording on intent to speak up (P>0.10), but wording did
affect willingness to recommend the hospital; 18.4% would
probably or definitely recommend when given an extended
prompt, compared to 14.6% and 8.8% for the intermediate
and minimal prompts, respectively (P=0.0067).
Conclusion: Knowing when patients and family members
perceive a breakdown in care is the first step in addressing
their concerns and may help to improve care for future
patients. The findings from this national survey suggest that
the type of breakdown experienced and the person inquiring
about care influence whether patients will speak up.
Keywords: survey research and methods, patient-provider
communication, patient experience/satisfaction
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Moving the Needle: Is Adjusting the Needle Between
Endobronchial Ultrasound Passes Necessary?
David Niccum1
Regions Hospital, Saint Paul, MN

1

Background: Endobronchial ultrasound (EBUS) with
transbronchial needle aspiration biopsy is effective for
diagnosing multiple thoracic pathologies and staging lung
cancer. In EBUS, a biopsy needle is inserted through the
working channel of an EBUS bronchoscope and directed
via linear ultrasound into a suspected lymph node or lesion.
Multiple passes increase the probability of adequate specimen
retrieval. A protective sheath surrounds the biopsy needle,
protecting the working channel of the EBUS bronchoscope
from damage during the procedure. Prior to the biopsy, the
sheath is adjusted to the length of the working channel.
Some manufacturers recommend readjustment after each
pass. Readjustment requires additional time, potentially
prolonging sedation time and patient discomfort. Previous
studies addressing needle repositioning were not identified.
This study sought to determine whether readjustment is
necessary.
Methods: A total of 29 sequential passes were performed
with an Olympus ViziShot NA201SX4021 needle and
Olympus UC160F-OL8 EBUS bronchoscope; 10 passes
were performed in a neutral position, followed by 10 passes
alternating between fully flexed and extended, and 9 with
the bronchoscope flexed or extended into simulated tissue.
The position of the catheter in relation to the bronchoscope
was measured and photographed after each pass.
Results: After the 29th pass, the spring guarding the needle
dislodged from the sheath, resulting in structural failure.
This form of sheath failure has been reported previously.
The maximal deviation of the sheath was 1.5 mm beyond the
end of the working channel and occurred twice. No inward
sheath deviation occurred beyond the initial position on any
pass. On the final pass, the sheath was 0.5 mm beyond the
initial position.
Conclusion: Minimal variation of the position of the
biopsy needle in relation to the bronchoscope between
passes was observed. As none of the passes demonstrated
inward deviation of the sheath into the working channel, it
is unlikely the slight deviation observed would damage the
bronchoscope. Since concluding this study, our group has
adopted the policy that needle readjustment is not required
between passes. While there is potential for widespread
adoption of this practice, additional study is needed on other
biopsy needles to determine whether these observations are
true for all biopsy needles.
Keywords: quasi-experiment, clinical practice patterns,
guidelines, quality improvement
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Elevated Blood Pressure and Risks for Progression
to Hypertension in Youth 10 to 17 Years of Age
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Background: Elevated blood pressure (BP) in children and
adolescents is defined as having 1 or more BP measurements
≥ 90th percentile or ≥ 120/80 mmHg. Prior studies have
reported annual risks for elevated BP to progress to
hypertension as high as 7%. The goal of the current study,
conducted in a large health system, was to evaluate risk for
progression to hypertension among youth with elevated BP
confirmed by 2 or more elevated BPs.
Methods: All BPs, heights, and weights measured in
10–17-year-olds receiving care in one of 21 primary care clinics
in a large Midwestern health system from April 15, 2014, to
April 14, 2017, were pulled from the electronic health record.
Using methods specified in the fourth report by the National
High Blood Pressure Education Program Working Group on
Children and Adolescents, BP percentiles were calculated.
Patients with at least 2 elevated BPs within the initial 2 years
and at least 2 subsequent BP measurements within 12 months
were retained in the cohort. Hypertension was defined as having
2 or more BPs ≥ 95th percentile at consecutive health care
visits. Covariates included race/ethnicity, age, gender, and body
mass index (BMI) at date of second elevated BP. Associations
were tested with Pearson’s chi-squared and Fisher’s exact
tests. Multivariable logistic regression predicted progression to
hypertension from sex and BMI (≥95% vs <95%).
Results: Of 31,579 patients with at least one BP recorded
over a 2-year period, 5306 (17%) had 2 or more elevated
BPs and 1821 (34% of those with persistent elevated BP)
had 2 or more BPs measured in the subsequent 12 months.
Among 1821 youth with persistent elevated BP and followup available, 46 (2.5%) progressed to meet criteria for
hypertension. Rates for progression were directionally
higher for females (3.3% vs 1.9% in males, P=0.06), higher
for youth with obesity (defined as BMI ≥ 95th percentile)
(4.6% vs 1.7% in nonobese youth, P≤0.001). In the
multivariable model, progression to hypertension differed by
sex (P=0.03) and BMI (P<0.001). No pairwise interactions
were significant in this model.
Conclusion: Persistent elevated BP in children and
adolescents had a mild-moderate annual risk for developing
hypertension of 2.5%. Interventions to promote exercise and
weight loss are indicated for youth with persistent elevated
BP and obesity, as they are at highest risk for progression.
Keywords: child and adolescent health
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Effectiveness of Maternal Tdap Administration on
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Background: Since late 2012, the tetanus, diphtheria, and
acellular pertussis (Tdap) vaccine has been recommended
for routine administration during pregnancy to protect
infants from pertussis disease. Few studies have evaluated
the effectiveness of this immunization practice on infant
pertussis. We aimed to determine the vaccine effectiveness
of maternal Tdap at preventing pertussis disease in infants.
Methods: We conducted a matched case-control study of
infants age < 365 days from January 1, 2012, to June 30, 2012,
with diagnostic code (ie, ICD-9 or ICD-10) or laboratory
result positive for pertussis. We matched controls based on
age (birthdate within 2 weeks of case), number of infant
diphtheria, tetanus, and pertussis (DTaP) vaccinations received,
and primary care clinic location for HealthPartners patients.
We attempted to contact caregivers to enroll participants and
then administer a survey to verify pertussis disease, determine
maternal Tdap vaccination status, identify potential covariates/
confounders, and obtain consent for medical chart review. We
used the Council of State and Territorial Epidemiologists case
definition for probable and confirmed pertussis. We calculated
matched odds ratios for the association between maternal
vaccination and infant pertussis disease. We calculated vaccine
effectiveness as 1.0 minus the odds ratio.
Results: We identified 172 cases, enrolled 76 (44%), and
performed chart reviews on 53 (31%). Polymerase chain
reaction testing was performed for 51 of 53 (96%) and
positive for 27 of 51 (53%); we classified 11 of 53 (21%)
as confirmed and 21 of 53 (40%) as probable pertussis. A
total of 31 cases were matched to at least 1 control (range:
1–3); only matched cases contributed to analysis. Mothers
of 10 (32%) case patients and 23 (40%) control patients
received pertussis vaccination during pregnancy (unadjusted
odds ratio: 0.76, 95% CI: 0.31–1.95), providing vaccine
effectiveness of 24%.
Conclusion: We did not find a significant decrease in odds
of pertussis disease in infants whose mothers received Tdap
during pregnancy compared to those with mothers who
did not receive Tdap. A small response rate, resulting in a
lower than anticipated sample size, likely contributed to our
results. Additionally, nonresponse bias may have biased our
results toward the null, as those we were unable to contact
may have more unstable lives and would be less likely to
adhere to health recommendations.
Keywords: child and adolescent health, human subjects
research, survey research and methods, primary care,
ambulatory/outpatient care, epidemiology

Background: We are studying the utilization and physician
experience of a navigation program within an adolescent
behavioral health (BH) quality improvement project in a
multispecialty practice setting. The navigation program
of this project was developed to support primary care
physicians (PCPs) and to improve the quality of BH care by
facilitating adolescent referrals from PCPs to BH specialists.
Methods: Navigation referral data were analyzed to assess
service utilization. Pediatric and family medicine PCPs were
surveyed about their experience with the navigation program.
Survey collection is ongoing and results will be updated.
Results: Within a 30-month period, 313 PCPs referred
3211 adolescent patients to the navigation program. The top
three reasons for referral were depression (37.2%), anxiety
(24.1%), and attention disorders (7.6%). Among the 114
survey respondents to date, 90.4% reported that they had
referred patients to navigation, most commonly for mood
(97.1%) and anxiety (86.4%) disorders. PCPs indicated that
they made referrals because they wanted help with finding BH
providers within their patients’ insurance networks (92.2%),
ensuring that patients received timely BH care (75.7%), and
determining the appropriate type of BH provider or level of
care (41.8%). Of the PCPs surveyed, 82.5% indicated that
they would like the navigation program to continue after the
grant-funded quality improvement project ends; 72.8% agreed
that navigation enhanced clinical care; 68.9% believed that
navigation improved patients’ care experience; and 60.2%
reported that navigation increased their own confidence about
addressing patients’ BH needs. However, only 58.3% of PCPs
positively rated their overall experience with the navigation
program; 36.9% reported they had not made referrals in the
past 3 months, in part because their past referrals had not been
processed in a timely manner (36.8%).
Conclusion: PCPs appear to value the services provided
by the navigation program and would like for it to continue
despite the challenges associated with high demand and limited
resources. This highlights the potential utility of BH navigation
as an approach to improving the health care of teens and for
enhancing the practices of those physicians who care for them.
Keywords: child and adolescent health, program evaluation,
research, primary care, quality improvement, behavioral and
mental health, dissemination, implementation, innovation
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Background: Approximately 20% of U.S. adolescents have
a behavioral health (BH) condition. Early detection and
effective treatment can ease their burden. The Adolescent
Behavioral Health Project is a multifaceted, integrated BH
quality improvement effort, implemented over a 4-year
period within a multispecialty medical practice. This study
examines the extent to which primary care physicians’
(PCPs) knowledge and views on teen BH changed during
this implementation period.
Methods: All pediatric and family medicine PCPs were
invited to complete a survey, which included questions from
American Academy of Pediatrics Periodic Survey and the
Physician Belief Scale, during 2013–2014 (baseline) and in
2017 (follow-up).
Results: Survey response rate was 49.3% at baseline and
51.6% at follow-up. Compared to 21.4% at baseline, 62.2%
of PCPs stated that they believe mental health conditions are
extremely/very common in their teen patients in the followup survey; 17.1% stated that substance abuse is extremely/
very common in the follow-up survey, compared to 2.6%
at baseline. PCPs reported higher levels of confidence in
the follow-up survey in their abilities to identify teen BH
problems (baseline: 76.9%; follow-up: 88.3%) and to make
effective referrals (baseline: 51.3%; follow-up: 67.6%).
Throughout the project period, a relatively small proportion
of PCPs reported feeling confident in their abilities to
provide brief counseling (baseline: 37.6%; follow-up:
37.8%) and psychopharmacotherapy (baseline: 27.4%;
follow-up: 28.8%). Nonetheless, the majority agreed that
teens want their PCPs to treat their BH problems (baseline:
76.1%; follow-up: 70.3%). Time constraints appeared to be
a persistent concern for PCPs, with the majority continuing
to report that time does not allow them to consider BH
problems during visits (baseline: 52.1%; follow-up:
60.4%), that evaluating or treating BH problems would
cause them to become overburdened (baseline: 58.1%;
follow-up: 64.0%) and that investigating BH problems will
decrease their work efficiency (baseline: 63.25%; followup: 68.5%).
Conclusion: Approximately 3 years after implementation
of an integrated BH project, PCPs reported improved
awareness of BH problems and greater confidence in
their abilities to identify BH needs and to make effective
referrals. However, substantial barriers remain that
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may deter PCPs from addressing teen BH problems and
highlight the need for additional educational and systemlevel interventions.
Keywords: child and adolescent health, survey research and
methods, primary care, behavioral and mental health
P5.05
Identifying Asthma Severity and Visits for Asthma
Exacerbations From Chart Audit Data
James D. Nordin,1 Gabriela Vazquez-Benitez,1 Elyse
O. Kharbanda,1 Avalow Olsen,1 Leslie Kuckler1
HealthPartners Institute, Minneapolis, MN

1

Background: Asthma is the most common chronic medical
condition in children. Prior observational studies of influenza
vaccine safety in asthmatic children have been limited due
to confounding by indication. Improved methods are needed
to classify asthma severity and to identify visits for asthma
exacerbations from automated data. These data represent the
first step in that process.
Methods: We reviewed charts of a random sample of 100
subjects, age 2 to 18 years, with clinic visits between 2011
and 2016. All visits with an asthma or wheezing diagnosis in
42 days following influenza immunization were classified as
management or exacerbation using a chart algorithm based
on positive physical findings or in-clinic treatments for
asthma. Visit assessment and plan were available. Children
were classified as having asthma controlled and whether
asthma was persistent or intermittent using visits occurring
from 12 months prior to the day of influenza immunization.
Asthma control was classified based on asthma control test
(ACT) scores of ≥ 20 (controlled) or < 20 (uncontrolled).
Persistent or intermittent was determined based on
classification in asthma management plans (AMPs) and
prescription of controller medications.
Results: A total of 77 office visits with a diagnosis of asthma
or wheezing were available. The chart audit algorithm was
compared to the chart assessment and plan (kappa=0.67). Of
the 93 subjects with complete chart audits, based on ACT, 45
subjects were classified as controlled, 18 were classified as
not controlled, and 30 had no ACTs. In AMPs, 21 (38%) were
classified as persistent, 34 were intermittent, and 38 had no
AMP classification. Based on medication prescriptions only,
75 (80%) were persistent and 18 were intermittent.
Conclusion: An algorithm based on chart audit findings
was moderately accurate in determining which visits were
for management and which were for exacerbation. AMPs
classified far fewer patients as persistent compared to
controller medications. All of these determinations will be
compared to electronic data algorithms to see which match
best. The final electronic data algorithms will be used to
analyze the entire cohort.
Keywords: child and adolescent health, chronic disease
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P5.06
Costs of Clinical Decision Support on the
Recognition and Management of Hypertension in
Youth

P5.07
Development of a Clinical Decision Support System
for Pediatric Abdominal Pain in Emergency Room
Settings

Steven P. Dehmer,1 Nicole K. Trower,1 Stephen E.
Asche,1 Heidi L. Ekstrom,1 James D. Nordin,1 Patrick
J. O’Connor,1 Alan R. Sinaiko,2 Elyse O. Kharbanda1

Heidi L. Ekstrom,1 Elyse O. Kharbanda,1 Gabriela
Vazquez-Benitez,1 Steven P. Dehmer,1 Patrick J.
O’Connor,1 Gopi Kunisetty,1 Rashmi Sharma,1 Anupam
Kharbanda2

HealthPartners Institute, Minneapolis, MN; 2University of
Minnesota, Minneapolis, MN
1

Background: Blood pressure (BP) is routinely measured
in youth, but hypertension (HTN) is often not clinically
recognized. This study evaluates the economic outcomes
of a randomized clinical trial (TeenBP) of an electronic
health record-embedded clinical decision support (CDS)
tool designed to assist in the recognition and management of
hypertension in youth.
Methods: Twenty primary care clinics within an integrated
health system were randomized to the TeenBP CDS or usual
care from April 15, 2014, to April 14, 2016. Differences in
primary care costs between study arms, defined by CPT-4
codes for new or existing patients seen in a clinic setting, were
compared in the 12 months pre- and post-study enrollment
using total paid insurance claim amounts. Continuous
insurance coverage, administered by an affiliated health
plan, was required over the comparison period for inclusion.
Three comparison groups were defined by patients meeting
the following criteria: 1) at least 2 visits within 1 year with
BP ≥ 120/80 mmHg or BP ≥ 90th and < 95th percentile (ie,
pre-HTN); 2) 1 visit with BP ≥ 95th percentile (ie, isolated
elevated BP); and 3) at least 3 visits within 1 year with BP ≥
95th percentile (ie, HTN). Generalized estimating equation
models, gamma-distributed with a log link, were used to
estimate differences between groups over time.
Results: Of the 4990, 3173, and 472 patients meeting criteria
for pre-HTN, isolated elevated BP, and HTN, respectively,
1520, 851, and 153 also met the continuous insurance
coverage requirement for inclusion in the analysis. Relative
to patients in usual care clinics, the pre-to-post difference
in primary care costs for patients in TeenBP CDS clinics
were lower: -$36 for pre-HTN (P=0.10), -$12 for isolated
elevated BP (P=0.65), and -$117 for HTN (P=0.13). None
of these differences were statistically significant at the 95%
confidence level.
Conclusion: This analysis indicates that embedding a
CDS tool to improve the recognition and management
of hypertension in youth did not lead to increases in
costs associated with primary care utilization. Further
investigation is needed to determine effects on other medical
costs, including laboratory services, specialty care, and
pharmacy.
Keywords: child and adolescent health, economic studies
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HealthPartners, Bloomington, MN; 2Children’s Hospitals
of Minnesota, Minneapolis, MN
1

Background: Appendicitis is a common surgical emergency
in children, yet the diagnosis can be challenging. An electronic
health record (EHR)-based clinical decision support system
(CDSS) designed to help guide management of pediatric
patients with acute abdominal pain was implemented as part
of a multisite pragmatic cluster-randomized controlled trial.
Methods: The CDSS was designed for rapid two-way
communication between the EHR and a web service that
contains clinical algorithms and a validated risk calculator.
The tool displays risk for appendicitis and management
suggestions. The CDSS was developed and implemented in
two phases. Phase 1 consisted of a best practice alert (BPA)
with a link to three questions to identify study eligibility for
the nurse or treating provider to complete. The provider also
has the option to choose an acknowledgment reason via the
BPA if appendicitis is not suspected. Phase 2 consisted of
another BPA directed toward the provider with a link to the
CDSS tool. The tool was designed for ease of use and to
accommodate differences in workflow. Weekly response rate
reports are circulated to all sites, and nurses who complete
the questions are entered into a drawing for a chance to win
a $50 gift card.
Results: Accommodating variations in workflow, staffing,
and competing priorities in a busy emergency setting has
been challenging. Minor edits to the tool were ongoing
during Phase 1 in response to user feedback. Adjustments
also occurred for a short period during Phase 2. Training and
outreach occurred throughout the project. Response rates
at the smaller sites consistently ranged from 77% to 93%.
Response rates at the larger urban sites were 61%–70%.
Conclusion: Implementation was challenging and uptake
of the tool has been highly dependent on local workflow
practices as well as urban versus rural setting. Addressing
variations in workflow and gaining trust of providers to
use the tool has been an ongoing challenge. In general,
smaller rural sites have had better uptake and less workflow
variation than larger urban sites. More qualitative feedback
from providers and nurses is needed to help identify and
mitigate barriers to use.
Keywords: child and adolescent health, acute inpatient care,
pragmatic trials, clinical decision-making, dissemination,
implementation, innovation
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DATA SCIENCE, INFORMATICS, DATA
MODELS
P6.01
Our Divided World: Can We Predict Division
Affiliation for the Unaffiliated?
Roy Pardee1
Kaiser Permanente Washington, Seattle, WA

1

Background: Kaiser Permanente Washington (KPWA)
members fall into one of two divisions — group practice
(GPD) or contracted network. Division controls the degree
to which their care is provided at KPWA clinics by members
of our physician group. The distinction has important
implications for capture of clinical (as opposed to just billing)
data and is a crucial component of our implementation of the
completeness-of-capture variables. A change in upstream
enrollment data significantly improved our ability to make
these distinctions, at the cost of a 12%–15% missing rate
(generally people without any utilization). That rate is
unacceptably high and so we set out to devise and evaluate
an imputation method for classifying these nonutilizers into
divisions.
Methods: Imputation was done using just two variables,
insurance product category and county of residence, which
are reliably populated for all. Crossing those two variables
yields about 420 different cells in a given month. For
each cell we calculate a probability that an unaffiliated
person will ultimately affiliate with the GPD by taking
the proportion of affiliated people in that cell that are
definitively GPD-affiliated. So if there are 120 people in a
cell, 100 of whom are affiliated one way or another and 80
of those are GPD-affiliated, we assign a probability of 0.8
to the 20 unknowns.
Results: To evaluate these imputations we isolated 107,775
instances in which a member went from an imputed value to
a definitive value and used the former as the sole predictor in
a logistic regression predicting the latter. Predictive power
was quite good, giving an overall area under curve of 0.88.
Inspection of sensitivity and specificity rates at different
cut-points revealed that 0.8 is a good criterion to use for
applications for which we need to divide members cleanly
into the two groups.
Conclusion: Using a simple imputation method, we were
able to triangulate from known data (proportion in group
affiliating with GPD) to unknown information (probable
future affiliation) in a highly accurate and useful manner.
We can safely use the imputed values to set enrollment flags
like incomplete_emr and incomplete_lab.
Keywords: managed care (features), virtual data warehouse,
health care organization
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The Vaccine Safety Datalink Pregnancy Episode
Algorithm:
Updates,
Enhancements,
and
Validation Work
Stephanie Irving,1 Don Bachman,1 Brad Crane,1
Kimberly Vesco,1 Stacy Harsh,1 Sanchita Sengupta,1
Elyse O. Kharbanda,2 Gabriela Vazquez-Benitez,2
Natalie McCarthy,3 Allison Naleway1
Kaiser Permanente Center for Health Research, Portland,
OR; 2HealthPartners Institute, Minneapolis, MN; 3Centers
for Disease Control and Prevention, Atlanta, GA
1

Background: The Vaccine Safety Datalink (VSD) is a
collaboration between the Centers for Disease Control and
Prevention and 7 integrated health care delivery systems.
Evaluating the safety of vaccination during pregnancy is an
important objective of the VSD, and accurate identification
of pregnancies, pregnancy start and end dates, and
pregnancy outcomes is vital to VSD research. The VSD
previously developed an algorithm to retrospectively
identify pregnancies using electronic medical record,
claims, and birth certificate data. Modifications to the
original VSD pregnancy episode algorithm (PEA) are
underway to update the algorithm with ICD-10 codes and
identify additional sources of gestational age data.
Methods: To update the PEA to accommodate the shift
from ICD-9 to ICD-10 codes, we reviewed and modified
the diagnosis and procedure code lists used to identify
potential pregnancies. In partnership with the Kaiser
Permanente Center for Safety and Effectiveness Research
pregnancy working group, we identified and incorporated
several new gestational age-specific ICD-10 codes. To
validate these modifications to the PEA, manual review of
pregnancy dates and outcome types will take place at all
VSD sites.
Results: ICD-10 codes were added to the PEA diagnosis
and procedure lists in early 2017. The PEA’s SAS program
was then modified to utilize ICD-10 codes and incorporate
the information from gestational age-specific ICD-10
codes into the estimate of pregnancy onset. The modified
PEA was pilot tested in May 2017 with data from all VSD
sites; 153,080 pregnancies were identified in 2015. Live
births and spontaneous abortions accounted for 66%–79%
and 13%–15% of all pregnancy outcomes, respectively, by
VSD site. Preliminary data indicate that the proportions of
live births were similar when restricted to ICD-9 or ICD-10
coding eras and that the updates to the algorithm may have
reduced misclassification of spontaneous abortions. The
modified PEA will be run on updated VSD data to identify
pregnancies through 2016; validation of these pregnancies
will begin in November 2017.
Conclusion: The VSD PEA is an important tool for studies
of vaccine safety during pregnancy. Recent modifications
have accommodated the transition to ICD-10 coding and
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refined capture of gestational age. Future work will focus on
real-time identification of pregnancies and preconception
care in the VSD population.
Keywords: observational study, technology assessment,
epidemiology
P6.03
Development of a Research Network for
Biosimilars: Creation and Operation of the BBCIC
Pamala A. Pawloski,1 Kevin Haynes,2 Daniel Kent,3
Cheryl McMahill-Walraven,4 Catherine Panozzo,5
Vanita Pindolia,6 Jeffrey Brown,5 Charles Barr,7
Bernadette Eichelberger8
HealthPartners Institute, Bloomington, MN; 2Anthem
HealthCore, Wilmington, DE; 3Kaiser Permanente
Washington, Seattle, WA; 4Aetna, Blue Bell, PA; 5Harvard
Pilgrim Health Care Institute, Boston, MA; 6Henry Ford
Health System, Detroit, MI; 7Academy of Managed Care
Pharmacy, Alexandria, VA; 8Biologics and Biosimilars
Collective Intelligence Consortium, Alexandria, VA
1

Background: The Biologics and Biosimilars Collective
Intelligence Consortium (BBCIC) initiated research in
third quarter of 2016 to generate postmarket evidence
in anticipation of the entrance of biosimilars to the U.S.
market. The BBCIC’s scientific approach was conducted to
answer patient and physician concerns about biosimilars and
to potentially facilitate greater acceptance and adoption of
biosimilars.
Methods: The BBCIC network leverages a Sentinel
distributed research network (DRN). The BBCIC
collaboration consists of 18 member organizations, including
managed care, integrated delivery networks, pharmacy
benefit managers, industry, and researchers. In preparation
for the introduction of biosimilars in the marketplace, four
descriptive analysis protocols were conducted to characterize
BBCIC DRN data — including the identification of
demographic and clinical patterns that determine differences
in utilization and outcomes. The descriptive analysis
projects and their primary outcome measures: 1) first-cycle
granulocyte colony-stimulating factor (G-CSF) prophylaxis
for breast and lung cancer (outcome: hospitalizations for
febrile neutropenia); 2) erythropoietin-stimulating agent
(ESA) use in hemodialysis; 3) long-acting insulin use in
types 1 and 2 diabetes (outcomes: major adverse cardiac
events and hypoglycemia; and 4) anti-inflammatory agent
use for rheumatoid arthritis and psoriatic and gastrointestinal
conditions (outcome: hospitalizations for serious infections).
Results: Preliminary descriptive analysis results
demonstrated: 1) We can identify G-CSF prophylaxis vs
treatment use, full vs partial treatment duration, and rare
safety events; 2) For upcoming comparative effectiveness
research (CER), the BBCIC will use Medicare’s end-stage
renal disease data set as its ESA data are more granular
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than BBCIC DRN data; 3) For long-acting insulin, primary
outcomes are comparable to other observational trials; and
4) For anti-inflammatory agents, serious infection outcomes
are comparable to other observational trials.
Conclusion: The BBCIC demonstrated outcomes comparable
to those in the published literature. Following accumulation
of sufficient biosimilar exposures, CER will be initiated to
assess the safety and effectiveness of individual biosimilars
compared with innovator compounds. In preparation,
work groups have been convened to define best practices
for the conduct of switching pattern and CER studies; for
transitioning from International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CD) to ICD10-CM mapping; and for monitoring data partner capture
of National Drug Code and Healthcare Common Procedure
Coding System codes for biosimilar injectables.
Keywords: pharmacy, observational study, epidemiology,
pharmaceutical prescribing/use
P6.04
Mining Time-Stamped Electronic Health Record
Data to Understand Physician Work Patterns
Dorothy Hung,1 Qianyun Zhang,1 Quan Truong,1 SuYing Liang,1 Harold S. Luft1
Palo Alto Medical Foundation Research Institute,
Mountain View, CA
1

Background: As primary care continues to face high patient
demand and provider burnout, interventions to improve
efficiency first require understanding physician work patterns.
We leveraged time-stamped electronic health record (EHR)
data to reconstruct daily physician time working. This
was achieved by processing a sample of 15 million daily
transactions among 303 physicians over 4 years.
Methods: EHR access logs were used to quantify daily
physician work activities. We focused on activities occurring
before, during, and after patient visits and noted work
locations (examination room, physician’s desk, remotely).
We addressed challenges in accurately identifying start/
end of patient care due to patients arriving early or late
or physicians running ahead or behind schedule. Another
complication was EHR capture of exam room “batching,”
which is when a physician is charting in an empty exam
room, creating false indications of a patient visit.
Results: We addressed these challenges using iterative
data mining and validation techniques. “Start of Patient
Care” time-points were identified by selecting the first EHR
transaction in an exam room with a patient, following that
patient’s check-in time. “End of Patient Care” was identified
by the last EHR exam room transaction for the last arriving
patient within 2 hours of the check-in time. This strategy
identified end points for 88.2% of physician workdays. For
the remaining 11.8%, we selected the last transaction in an
exam room occurring < 2 hours of a patient’s check-in time,
Supplement

or alternatively, < 2 hours of the appointment time (if the
patient checked in early). Using these approaches, we found
that physicians spent an average of 36 minutes working
before the start of patient care each day, and 1 hour and 16
minutes after the last visit of the day. Among physicians
who accessed the EHR remotely, approximately 1 hour and
7 minutes were spent working from home daily. Overall,
physicians spent about 8 hours and 53 minutes working
per day, including activities at the desk, during patient
appointments, and outside the office.
Conclusion: This study augments traditional, time-motion
research by using time-stamped EHR data to reconstruct
physician workdays over several years. Our approach to
describing physician work time may inform approaches
used by other health systems seeking to improve efficiency.
Keywords: information technology, primary care
P6.05
Tumor Registry Information Extraction Tool
(TRInE-T): A Supplemental Abstraction Tool for
Tumor Registrars
Celeena Jefferson, Aung Oakkar, Alphonse Derus,
Jackie Blank,1 Monica Ter-Minassian1
1

1

1

Mid-Atlantic Permanente Research Institute, Kaiser
Permanente Mid-Atlantic States, Rockville, MD
1

Background: Tumor registrars at Kaiser Permanente MidAtlantic States (KPMAS) are responsible for identifying
all incidences of cancer among members and abstracting
malignancy details into CNExT (tumor registry software).
Abstraction for tumor registry compliance is a time-consuming
task that requires searching multiple modules within the
electronic medical record (EMR). At KPMAS, the tumor
registry team developed the Tumor Registry Information
Extraction Tool (TRInE-T) to supplement the abstraction
process and minimize the time required to complete an abstract.
Methods: To develop TRInE-T, we created SAS programs
to extract structured data elements weekly from federated
sources, including the EMR. Tumor-related encounters were
identified using CPT and ICD (9th/10th revision) codes, and
the Cancer Research Network chemotherapy lookup tables
were utilized to capture additional disease and treatment
information. We followed the Facility Oncology Registry
Data Standards guidelines and used CNExT’s tumor abstract
template as a model for content, layout, and workflow. The
resulting data sets for TRInE-T consisted of encounter
information (including dates for diagnoses, procedures, and
cancer treatment), social history, demographics (current and
historic), and pathology reports. A SAS stored process was
created to provide users access to the data on the SAS Portal
website. When users log on to the site, they are prompted to
enter a medical record number. If cancer encounters exist
for the patient, TRInE-T returns HTML output of the data
onto one page and in the order of the CNExT tumor abstract
Supplement

template; if no cancer encounters exist, no data is displayed.
To ensure data security, access provision for TRInE-T is
strictly limited and all medical record number searches are
stored in an audit log.
Results: During user-acceptance testing, tumor registrars
reported quicker identification of patient information,
especially treatment dates. Immediate access to this
information reduced the time required to search the EMR
while abstracting.
Conclusion: TRInE-T is a data organizational tool that
provides a quick overview of structured patient information,
supplementing tumor registry abstraction and limiting the
need to search the EMR extensively. With increased use of
the tool, audit logs can serve as the foundation for application
metrics. This tool could be adapted for other tumor registries
within the Health Care Systems Research Network.
Keywords: cancer, information technology
P6.06
Precision and Census Block Group Estimates
Christopher Mack1
Kaiser Permanente Washington Health Research Institute,
Seattle, WA
1

Background: Researchers want the most specific data
from the most granular geographies to estimate the social
and economic characteristics of the neighborhoods of their
populations. The American Community Survey (ACS)
releases 5-year combined estimates at the block group level
for the majority of block groups in the United States. This
data would seem to be the most specific and most granular.
But how reliable are those estimates?
Methods: The variation of block group estimates within
census tracts can be broken into three components: observed
variation across point estimates, margins of error calculated
by the ACS, and true error. The last cannot be measured,
but using U.S. Census data we can distinguish between the
amount of variance driven by observed differences is point
estimates and the amount of variance driven by sampling
error.
Results: In preliminary analysis, we found 30%–50% of
variation in block group estimates to be driven by sampling
error, rather than by the observed differences in point
estimates.
Conclusion: If the variance from sampling error approaches
or exceeds that of the observed differences, we would have a
hard time believing that the available point estimates reflect
actual differences. For this reason, we would guide users to
resist the temptation to use the misleadingly attractive block
group data and instead use the more reliable data available at
the census tract level, despite the lack of granularity.
Keywords: geographic information systems, spatial factors,
demographics, virtual data warehouse, social determinants
of health
www.aurora.org/jpcrr
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Common Entities Among Common Data Models
John Weeks1
Kaiser Permanente Washington Health Research Institute,
Seattle, WA
1

Background: The value of having a health care common
data model for collaborative research has been gaining
recognition since the virtual data warehouse (VDW) emerged
in 2003. In the last 15 years many different common data
models have been introduced for different purposes. This
poster presents a visual interpretation of the history and
shared entities across many different popular models.
Methods: Helping people to understand the history of
common data models can help to bring awareness of the
shared work between these efforts. It also can help researchers
understand which models might best fit the needs of their
study. As we continue to build bridges between researchers
using shared data, an understanding of the history of the
VDW and the models that followed it is essential.
Results: The different technologies that are used to inform
the technology and some of the advantages and disadvantages
will be touched on as a part of this poster. Having a basic
understanding of some of the computer science concepts that
inform different technological decisions also can help researchers
in understanding the model that they are working with.
Conclusion: Finally, the necessity of testing and its value
to the research community will be addressed by comparing
the two most common approaches to testing. The poster will
show different models’ approaches to quality assurance and
the advantage of data curation to research and operational
concerns in a learning health care setting.
Keywords: information technology, virtual data warehouse,
research administration, contracting, operations
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Holly Groom,1 Bradley Crane,1 Stephanie Irving,1
Natalie McCarthy,2 Matthew Daley,3 James Donahue,4
Sungching Glenn,5 Kristin Goddard,6 Michael
Jackson,7 Erika Kiniry,7 Ned Lewis,6 Marlene Lugg,5
Lawrence Madziwa,7 Erica Scotty,4 Lina Sy,5 Kris
Wain,3 Allison Naleway1

P6.09
Building the eMERGE Observational Medical
Outcomes Partnership Common Data Model Using
the Virtual Data Warehouse

Kaiser Permanente Northwest, Portland, OR; 2Centers
for Disease Control and Prevention, Atlanta, GA; 3Kaiser
Permanente Colorado, Denver, CO; 4Marshfield Clinic,
Marshfield, WI; 5Kaiser Permanente Southern California,
Pasadena, CA; 6Kaiser Permanente Northern California,
Oakland, CA; 7Kaiser Permanente Washington, Seattle, WA

1

1

98

Background: Using data from 7 integrated health care
systems (sites), the Vaccine Safety Datalink (VSD)
evaluates vaccine safety across the lifespan. All VSD sites
use electronic health record (EHR) data to determine the
vaccination status of their members; 5 sites complement the
EHR with data from their state immunization information
systems (IIS). IIS are confidential, population-based
databases administered by state health departments that
contain a consolidated record of vaccine doses administered
within a defined geographic area. Our goal was to assess
the contribution of IIS data to the vaccination records of
members at each VSD site and to determine whether that
contribution differs by member demographics (ie, age,
enrollment duration) or by vaccine type.
Methods: We used administrative health care databases at 4
participating VSD sites to quantify the respective contribution
of IIS and EHR data to their members’ vaccination records
from 2000 through 2015. The assessments included: 1)
total doses administered, by age at assessment (5, 12, and
45 years) and enrollment duration; and 2) vaccine coverage
estimates for diphtheria-tetanus-acellular pertussis (DTaP)
and human papillomavirus (HPV) vaccines, with and
without inclusion of IIS data.
Results: Shorter duration of health care system enrollment
was associated with higher contributions from IIS data among
all age groups. Depending on age of assessment (5, 12, or 45
years), IIS contributed 5%–40% of total doses administered for
members with ≤ 3 years of continuous enrollment. Including
IIS data increased DTaP coverage estimates by 20%–35%
among children who had ≤ 2 years of continuous enrollment
for 3 of the 4 sites; the fourth site observed no added benefit
from IIS data for its pediatric population. Including IIS data
increased HPV coverage estimates for 15–26-year-olds by
4%–10%. This was evident across the 4 sites for members
with ≤ 7 years of continuous enrollment.
Conclusion: IIS appear to contribute a measurable amount of
vaccine data that would not otherwise be available to the health
care system. Enrollment duration and vaccine type impact
the proportionate contribution of IIS data. Including IIS data
improves completeness for studies pertaining to vaccination.
Keywords: virtual data warehouse, epidemiology
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John Weeks,1 David Carrell1
Kaiser Permanente Washington Health Research Institute,
Seattle, WA
Background: The Electronic Medical Records and
Genomics Network (eMERGE) was formed “to develop,
disseminate, and apply approaches to research that combine
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biorepositories with electronic medical record (EMR)
systems for genomic discovery and genomic medicine
implementation research” (https://emerge.mc.vanderbilt.
edu/about-emerge/). As part of this mission, eMERGE has
decided to implement Observational Health Data Sciences and
Informatics’ Observational Medical Outcomes Partnership
(OMOP) common data model (CDM) to simplify sharing of
phenotype definitions (eg, operational definitions of patients
with/without particular diseases) across sites.
Methods: To expedite this process, we have decided to
leverage our virtual data warehouse implementation to
populate eMERGE’s OMOP CDM. The high-level process of
mapping between the two models will be illustrated. We also
will add details of some of the challenges in bridging the two
models. Core entities used to provide phenotype data also will
be illustrated.
Results: We will share the results of the project and
share some of the challenges discovered as part of the
implementation.
Conclusion: As genetic information continues to be of
interest for research, finding ways to share this information
will continue to be an important subject area for common
data models to consider in their implementation.
Keywords: genetics, genomics, information technology,
virtual data warehouse
P6.10
Cervical Pathology Data Capture in a Mixed-Model
Health Care Delivery System
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Madziwa Lawrence,1 Vina Graham1
Kaiser Permanente Washington Health Research Institute,
Seattle, WA
1

Background: Evaluating cervical cancer screening for
population health management requires outcomes data
which, in most health care settings, must be extracted from
pathology reports containing unstructured text. In a mixedmodel health care delivery system that contracts pathology
services, capture of these data may pose additional challenges.
We describe a cervical pathology data capture strategy for
a cohort of 18–89-year-old women enrolled during 2010–
2014 at Kaiser Permanente Washington (KPWA), a health
care system with both internal and contracted pathology
services.
Methods: KPWA pathology reports are available in a
database, and those from contracted providers may be
available as transcriptions or scanned reports in the electronic
health record (EHR). We identified all KPWA reports and
external transcriptions for the cohort, loaded only records
containing cervix-specific terms into an ACCESS database,
and abstracted them for cervical precancers and cancers. We
identified all claims for cervical diagnostic and treatment
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procedures on the cohort and linked them to abstracted
pathology records. As gynecological surgery can have
multiple indications, we identified surgical procedures with
diagnosis codes indicating cervical intraepithelial neoplasia
grade 3 or worse to capture those that were performed for
cervical treatment. Unlinked abstracted pathology records
were set aside, and unlinked claims records that were not
procedures without pathologic specimens (ie, ablations
[n=171] and colposcopies without biopsies [n=1941]) or
surgeries with noncervical indications were assumed to
represent scanned pathology reports. We reviewed the EHR
to locate these reports and abstract outcomes.
Results: We identified 14,858 cervical pathology records
for our cohort; 7734 (52.0%) KPWA reports and 460 (3.1%)
transcriptions linked to cervical procedures from claims.
We abstracted 620 (4.2%) scanned reports, but 976 (6.6%)
external pathology reports from cervical procedures were
missing in the EHR. Remaining pathology records (n=5070
[34.1%]) represented gynecologic surgeries for noncervical
indications, noncervical procedures with cervical sampling
(eg, endometrial biopsy with endocervical curettage), or
coding errors in claims data.
Conclusion: Although data may not be complete, efficient
capture of cervical pathology outcomes in a mixed-model
health care setting can be achieved by aggregating all
available data sources and first addressing electronically
available text records to identify and minimize resourceintensive EHR review of scanned reports.
Keywords: cancer, quality improvement
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Background: Delayed treatment intensification is a main
contributor to suboptimal glycemic control in patients with
type 2 diabetes (T2D). An understanding of factors that
contribute to treatment intensification is required to design
novel health care interventions to mitigate clinical inertia
and improve patient outcomes. We sought to synthesize
the extant literature on factors that contribute to treatment
intensification with second-line therapy among patients with
T2D in real-word clinical practice in the United States.
Methods: We systematically searched PubMed, Embase,
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and Web of Science between January 1, 2000, and August 30,
2017, for research articles on treatment intensification in T2D.
We included peer-reviewed observational studies in English,
conducted on U.S. adults. We included studies of treatment
intensification determinants using quantitative, qualitative, or
mixed-method analyses. We excluded randomized controlled
trials and studies conducted in inpatient settings.
Results: We identified 20,493 unique citations. In a
preliminary analysis, we found 8 health care system
electronic health record (EHR)-based studies that examined
quantifiable patient-level factors as contributing to treatment
intensification with second-line T2D therapy. Six of the 8
studies were conducted in managed-care health care systems.
Consistently, younger age, higher hemoglobin A1c levels,
and better adherence to first-line therapy were associated
with having treatment intensified, which was confirmed by
at least 3 qualitative studies. Two health care system EHRbased studies examined quantifiable health care providerlevel factors in treatment intensification. One study,
conducted in a multipayer system, found that younger health
care providers and specialty vs primary care providers were
more likely to intensify treatment. Another study from a
managed care organization found that provides’ age, gender,
panel size, and type were not associated with intensification.
No studies included in this review examined health care
system-level factors. An updated analysis will be presented.
Conclusion: In real-world clinical practice, our preliminary
findings suggest that treatment intensification is influenced
by patients’ age, glycemic levels, and past medication
adherence. Information on the role of health care providerand system-level factors is scarce. More studies are needed
to understand the factors that contribute to treatment
intensification, particularly at the provider and system
level as well as in multipayer settings, in order to design
appropriate T2D health care interventions.
Keywords: systematic review, meta-analysis, ambulatory/
outpatient care, diabetes, chronic disease
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The Prevalence of Overweight and Obesity in
Communities Engaging in Interventions Aimed at
Preventing Childhood Obesity
Gabriela Vazquez-Benitez,1 Marna Canterbury,2
Julia Johnson,2 Andrea Chinchilla Elizondo,3 Juliana
Tillema,3 Thomas Kottke,1 Elsa Keeler4
HealthPartners Institute, Minneapolis, MN; 2Lakeview
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Background: Through PowerUp and BearPower,
HealthPartners supports community-level interventions
to make better eating and physical activity “easy, fun and
popular” for school-aged children and their families in the
St. Croix River Valley area. The interventions focus on
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community engagement to create multilevel community
change. Goals include changes in the food and physical
activity environment, community partnerships and outreach,
and programming in school and clinical settings. We present
preliminary child overweight and obesity data in intervention
communities and surrounding reference communities.
Methods: We collected data on weight and height for
children age 6 to 11 years from the HealthPartners clinical
warehouse. We selected measurements from well-child
visits when available, otherwise we used data from the most
recent clinic visit. We defined obesity as a body mass index
(BMI) ≥ 95th percentile of the Centers for Disease Control
and Prevention’s sex-specific BMI-for-age growth charts.
We defined overweight as BMI ≥ 85th and < 95th percentile.
We classified children as living in school districts where the
intervention took place (Valley and White Bear Lake areas) or
not (other). Initiation of the intervention was staggered from
2013 to 2015. We collected data on age, gender, race/ethnicity,
payer, and care group. We compared trends in the unadjusted
prevalence of overweight or obesity from 2011–2012 to
2015–2016 between intervention and reference communities.
Results: A total of 8710 children had a home address in
the intervention communities versus 18,268 in reference
communities. Intervention area children were predominantly
white (90%) and were less likely to have a governmental
payer (27.9%), whereas reference community children
were more diverse (57% white) and had more frequently
a governmental payer (55.64%). We observed lower
overweight and obesity prevalence for intervention area
children (29.7% in 2011–2012 and 26.6% in 2015–2016)
compared to reference community children (33.4% in 2011–
2012 and 33.6% in 2015–2016). Reference community
children more closely resembled national data.
Conclusion: Preliminary results suggest that children in the
PowerUp and BearPower intervention communities have
healthier overall BMI’s than reference community children.
Since PowerUp and BearPower were recently rolled out
(2013–2015), data are not yet adequate to determine the
impact of the intervention.
Keywords: child and adolescent health, demographics,
health promotion, prevention, screening, evaluation
research, racial/ethnic differences, health care organization
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Program for Diabetes Prevention in Clinical
Practice
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Background: The Group Lifestyle Balance™ (GLB)
program is an adaption of the landmark Diabetes Prevention
Program for community settings that has been approved by
Supplement

the Centers for Disease Control and Prevention as a model
curriculum for type 2 diabetes prevention. The long-term
impact of GLB is unknown when integrated into routine
care within a health care system. The implementation
of GLB across 4 largely autonomous and highly diverse
Sutter Health regional affiliates in 2010 provides a unique
opportunity to evaluate the program in a large multispecialty
health care organization as a natural experiment. Herein, we
report preliminary findings for the implementation of GLB
across regional affiliates and clinic sites.
Methods: We used snowball sampling to identify GLB
leaders and clinic facilitators within each region. We then
conducted pilot interviews with these populations to inform
future in-depth semi-structured interviews. Pilot interview
questions focused on the GLB curriculum structure,
participant costs, clinics resources, and workflows.
Results: We interviewed 4 GLB regional leaders and 8
clinic facilitators (each from a different site). Interviews
revealed that the GLB program was implemented at 19
clinic sites within the 4 regions. At 8 sites included in
this preliminary analysis, GLB is facilitated by a certified
diabetes educator. The program is not restricted only to those
with prediabetes, but most sites require individuals to have
high cardiometabolic risk (n=6). Participants are referred to
the program by a physician or dietitian. Main differences
in program implementation across clinics are related to
the curriculum used (original University of Pittsburgh
curriculum [n=5], newer Prevent T2 curriculum [n=2], or a
hybrid curriculum [n=1]), the length (range: 3–12 months)
and total number of sessions per program (range: 9–25), the
number of times the program was offered per year (range:
2–7), and the annual enrollment costs to participants (range:
$0–$688). An updated analysis, including the remaining 11
sites, will be presented.
Conclusion: This preliminary analysis suggests that
although the GLB program was implemented in a single
health system, there are important differences across and
within regions. Such differences offer a natural experiment
to understand how variation in the implementation of GLB
impacts program effectiveness and participant outcomes.
Keywords: health promotion, prevention, screening,
evaluation research, diabetes, health care organization,
qualitative research
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Background: There is substantial evidence that key
components of chronic kidney disease (CKD) care slow
progression of renal disease and substantially reduce the
occurrence of major adverse cardiovascular (CV) events.
We sought to determine if there are gaps in major CKD
quality care components in a large Minnesota care system.
Methods: Electronic health record data was evaluated
for adults age 18–79 years seen for office visits in one of
17 primary care clinics in 2015–2016. Patients who had
at least one glomerular filtration rate (GFR) test that met
criteria for stage 3–4 CKD (GFR: 15–59) were assessed
for a) identification of a CKD diagnosis (through ICD-10
visit or problem list code), b) blood pressure (BP) control
to < 140/90 mmHg or < 130/80 mmHg, c) angiotensinconverting enzyme inhibitor (ACEI) or angiotensin receptor
blocker (ARB) use if concomitant hypertension or increased
albuminuria was identified, d) A1c control, and e) frequency
of observed nephrology visits in the last 2 years for patients
with more advanced stage 4 CKD or stage 3b CKD with
increased albumin-to-creatinine ratio (>30 mg/g).
Results: Of 5766 adults meeting GFR criteria for stage 3–4
CKD, 88.2% had a hypertension diagnosis and only 49.2%
had a CKD diagnosis; 67.2% had a BP < 140/90 mmHg and
37.3% a BP < 130/80 mmHg; and 57.8% were currently on
ACEI/ARB. Of 35.8% with diabetes, 76.7% had A1c < 8%
and 50.3% had A1c < 7%. Of 636 patients with a nephrology
referral indication, 45.6% had seen a nephrologist. CKD was
more likely to be diagnosed in patients with more advanced
CKD (72% of stage 3b CKD and 87% of stage 4), but rates
of BP control, ACEI/ARB use, and glycemic control were
not significantly higher for this population.
Conclusion: Quality improvement strategies are needed to
overcome the sizeable gaps in quality of CKD care observed
in this well-organized primary care setting. The use of
clinical decision support tools that can identify patients
with CKD and provide timely suggestions for treatment of
key care components and referrals to nephrology has the
potential to improve CKD patient outcomes.
Keywords: cardiovascular disease, primary care,
ambulatory/outpatient care, clinical decision-making,
chronic disease, clinical practice patterns/guidelines, quality
improvement
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Background: In 2015, 34% of U.S. adults (age 18+ years)
were estimated to have prediabetes. Prediabetes is a state
of intermediate hyperglycemia, not quite high enough
to result in a diagnosis of type 2 diabetes. Diabetes is a
progressive disease and the categorization “prediabetes” is
used to identify a high-risk state for transitioning to diabetes.
Better understanding of who progresses from prediabetes
and when will enable development of targeted policies and
interventions to potentially mitigate the public health impact
of diabetes now and for generations.
Methods: Using multivariate regression we modeled the
transition from prediabetes to diabetes over the 10-year period
beginning January 1, 2007, through December 31, 2016, using
data from DaVita HealthCare Partners. American Diabetes
Association hemoglobin A1c cut-points were used to group
patients by glycemic level: diabetes (≥6.5%), prediabetes
(5.7%–6.4%) or normal (<5.7%). We studied the association
of age, gender, and other known risk factors for diabetes, such
as race and ethnicity, body mass index, hypertension, low
high-density lipoprotein cholesterol and high triglycerides.
Results: Our preliminary analysis began with a baseline
population of 48,119 in 2007 that had at least one hemoglobin
A1c test result; 41% of this total had hemoglobin A1c values
in the prediabetes range during 2007 (21% were below
5.7%, normal glycemic level, and 38% were above 6.4%,
diabetes level). Of those patients with a prediabetes A1c
level in 2007, 39% (7505) were ≤ 65 years and 61% (11,516)
were ≥ 65 years. The analysis then tracked this prediabetes
population over time and found that 3 years later almost onethird of this population had transitioned to diabetes levels,
and by the end of the period the transition rate reached
38%. Initial results indicated higher transition rates occur
among individuals living in lower-income Hispanic areas
with limited English proficiency and that increasing age
and female gender are significant predictors of the transition
from prediabetes to diabetes within 10 years.
Conclusion: These findings are potentially important
because they are based on a unique 10-year database
of a very large population of commercially insured and
Medicare-covered members who live in the ethnically and
socioeconomically diverse greater Los Angeles area.
Keywords: observational study, chronic disease,
epidemiology

in Youth study have provided estimates of the populationbased prevalence of type 1 (T1D) and type 2 (T2D) diabetes
among U.S. youth. This population of youth is at high risk for
increased mortality and morbidity due to future atherosclerotic
cardiovascular disease; as such, guidelines recommend lipid
screening in children ≥ 10 years of age soon after the diagnosis
and recommend considering pharmacological treatment in
those who continue to have low-density lipoprotein (LDL)
cholesterol > 160 mg/dL or LDL cholesterol > 130 mg/dL
despite medical nutrition therapy and lifestyle changes.
Methods: This is a retrospective, observational study
assessing year-to-year trends using medical and pharmacy
claims of enrolled youth age 2–20 years from 2001 through
2013. Proportions based on sample size and a positive
diagnosis for diabetes were used to determine prevalence.
Chi-squared tests for categorical data were used to compare
changes in prevalence.
Results: A total of 172,407 members age 2–20 years were
identified from 2001 to 2013. Overall prevalence of diabetes
of any type increased significantly. In terms of age group,
members 12–17 years and 18–20 years showed a significant
increase in prevalence of diabetes of any type. In terms of race/
ethnicity, prevalence of diabetes of any type for white and
Hispanic members increased significantly. While there was
not a significant increase in females, there was a significant
increase in prevalence of diabetes of any type. Highest change
in prevalence of statin treatment in youth with diabetes occurred
from 2006 to 2007, with the highest occurring in 2008.
Conclusion: Our data show that from 2001 to 2013, overall
prevalence of diabetes increased. As expected, prevalence
for T1D was greater than T2D; however, both are steadily
increasing. We observed minimal changes of the total
number of youth with any type of diabetes year to year,
likely as the result of kids aging out of the study, which
could have underestimated our results. Prevalences for some
races that are known to have high diabetes risk were unable
to be determined due to our low enrollment of Asians/Pacific
Islanders, Native Americans, and members of multiple races.
Keywords: child and adolescent health, pharmacy,
observational study, demographics, virtual data warehouse,
diabetes, chronic disease, clinical practice patterns/
guidelines, epidemiology
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Background: Data from the National Health and Nutrition
Examination Survey (NHANES) and SEARCH for Diabetes
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Background: Although there is some variation in leading
guideline-issuing organizations’ evidence-based breast
cancer screening and prevention recommendations, a
consensus has emerged supporting a paradigm shift from
a one-size-fits-all to an individualized risk assessmentbased approach. This shift is reflected in the recent
growth in programs commonly referred to as high-risk
breast clinics (HRBCs). While intended to optimize
patient outcomes, there is no formalized care model or
research-based information describing or evaluating
these programs, which are characterized by substantial
variation. The objective of this research is to conduct
a national environmental scan of HRBC programs to
describe the current state and to use the results to formally
define a new “Breast Risk Assessment using Cancer
Evidence” (BRACE) care model to facilitate and evaluate
implementation of risk assessment-based care.
Methods: A national environmental scan based on a
survey of HRBC programs is being completed using
systematic methods. Programs were identified primarily
through web- and literature-based searches of publicly
available information. A data collection instrument in the
form of an emailed online and/or phone survey is used to
obtain information on program characteristics based on
attribute domains identified for a preliminary conceptual
BRACE care model. Analysis of completed responses
will encompass key program attributes within domains,
such as target population, services offered, professional
staff composition and roles, and program structure.
Descriptive statistics will be calculated to report the
variability in attributes and chi-squared tests will be used
to test significance in attribute differences between HRBC
program categories.
Results: More than 100 HRBC programs have been
identified for survey dissemination. The environmental scan
results will be a synthesis of publicly available information
and analysis of survey responses to characterize the current
national landscape of risk assessment-based breast cancer
screening and prevention programs, identify distinct
program categories based on differences in key attributes,
and develop an initial conceptual BRACE care model for
dissemination.
Conclusion: The environmental scan findings are essential
to understanding the implementation, variation, feasibility,
barriers, and facilitators associated with recommended risk
assessment-based breast cancer screening and prevention
care, and to inform development of a scientific program
evaluation framework to assess and improve implementation.
Keywords: cancer, genetics, genomics, health promotion,
prevention, screening, quality improvement
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Background: The prevalence of precision medicine (PM)
–– using genomic information to guide treatment of
disease –– is rising, and with it, the need for patient
engagement. Patients engaged in their own care are
equipped with the skills to help manage their own
condition, are enabled to make decisions about their
own care, and are empowered to ask relevant questions.
For that to happen, patients must first understand PM,
difficult even for providers. The complexity and quickly
developing nature of PM creates unique challenges in
educating patients to a level of understanding that allows
for patient-centered care. To create effective tools for
patient education, we must identify what information
should be included, ensure that tools are tailored
to health literacy level, reading level, and language
of patients, and design them in a way that makes the
information easy to access. We aimed to address the first
of these questions, identifying the information patients
require to be engaged in PM.
Methods: We created a survey that asked users to rate
their understanding of PM concepts, their confidence
in their ability to use that knowledge to make informed
decisions about care, and the usefulness of tools
currently used in MedStar Health cancer centers. To
survey a wide population of people, we employed
Amazon’s Mechanical Turk, an online tool that allows
for fast recruitment and payment to a global user base.
We limited our survey to English-language users in the
United States who have cancer or an immediate family
member with cancer.
Results: Results of 200 respondents will be aggregated
to identify themes of understanding or misunderstanding
of the genetic concepts on which PM is based. We also
identified themes regarding the perceived usefulness and
accessibility of current tools. We will use results to identify
strengths and weaknesses of current tools in their ability to
address informational needs.
Conclusion: The complexities of PM and genetic
mutations need to be clarified so that participation in PM
is not hindered by misunderstanding. Future work will
identify and evaluate existing tools and their ability to
meet informational needs.
Keywords: cancer, quality of care, patient-provider
communication
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Jane Grafton,1 James Ralston,1 Aaron Scrol,1 David
Carrell1
Kaiser Permanente Washington Health Research Institute,
Seattle, WA
1

Background: A primary aim of the Electronic Medical
Records and Genomics Network (eMERGE) is to integrate
genomic information into clinical care through the electronic
medical record (EMR) –– including sequencing results for
the 59 medically actionable genes per the American College
of Medical Genetics and Genomics, which include colorectal
cancer (CRC) genes –– enabling providers to take clinical
action, including genomic counseling. When recruiting
biobank participants to participate in eMERGE, we identified
patient samples identified as having a history of CRC. We
initially required strong evidence of CRC for inclusion
(SEER tumor registry) but progressively relaxed evidence
requirements to achieve planned sample size for sequencing.
While returning results to 289 consented patients identified
as likely having CRC history, we uncovered two possibly
misclassified as having CRC. We chart-reviewed these cases
in the EMR (Epic). We investigated possible misclassification
among other eMERGE enrollees consented for return of
results whom were identified as likely having CRC.
Methods: Of 2400 sequenced eMERGE III participants, 533
were identified with CRC history. Criteria were CRC through
tumor registry, or 1+ diagnoses of CRC with associated
procedure. Of 533 participants, 289 consented to return
of results. To identify possible misclassification, the 289
participants were placed into four mutually exclusive groups.
Three chart review groups had reasonable possibility of CRC
misclassification: 1) n=34 patients with only 1 CRC diagnosis
and no CRC mention on problem list; 2) n=43 patients with
2+ CRC diagnoses and no CRC mention on problem list;
and 3) n=1 patient with CRC on problem list and no CRC
diagnosis. We did not review charts of patients in group
4 (n=211 patients with CRC on problem list and 2+ CRC
diagnoses), as misclassification seemed unlikely.
Results: EMR chart review outcome (CRC status) groups were
based on evidence in chart for determining presence/absence of
CRC: 1) CRC confirmed (34 of 78); 2) insufficient data in EHR
(10 of 78); 3) colorectal neuroendocrine tumor on pathology
report (6 of 78); 4) alternative diagnosis per pathology report
(26 of 78); and 5) alternative diagnosis by chart review (2 of 78).
Conclusion: Level of certainty for returning clinical
results is higher than needed for inclusion/exclusion from
the phenotype algorithm. We explore options to revise the
process of return of results to patients, including removal of
indication of CRC on the lab report returned to providers,
and omitting CRC indication from documents likely to
become part of the patient chart.
Keywords: genetics, genomics, patient-provider communication
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Background: Remarkable advances in DNA sequencing
technologies are enabling rapid analysis of a patient’s DNA
in clinical laboratories. However, despite the technological
breakthroughs in clinical sequencing, the adoption of
genomic knowledge in patient management for disease
prevention, diagnosis, and treatment decision-making is
lagging. Realizing advances requires a health care system
that responds and works in collaboration with research to
translate new knowledge into better outcomes. Nationwide,
research programs such as Electronic Medical Records
and Genomics Network (eMERGE), Clinical Sequencing
Evidence-Generating Research (CSER), All of Us, and
Geisinger Health’s MyCode are sequencing healthy
individuals to return certain genetic findings to research
participants. Direct-to-consumer genetic testing companies
also are delivering predisposition risks to consumers.
Increasingly, physicians encounter patients’ genetic testing
results from outside the health care delivery system. To
better understand the current clinical environment, physician
knowledge and attitudes toward genetics, and the return of
incidental findings both from genetic tests and research
participation, we worked with Kaiser Permanente (KP)
leadership, physicians, and experts to develop an online
survey for KP physicians.
Methods: The survey team outlined five domains of interest
and conducted a literature review to identify prior physician
surveys. In addition to external experts, we engaged KP
clinical experts in the Interregional Genetics Working
Group, the Interregional Genetic Counselors Working
Group, KP Research Bank, Permanente Medical Group, and
Laboratory and Clinical Pharmacy. KP Washington survey
consultants conducted two rounds of cognitive testing
with physicians, which focused on clarity and relevance of
content. Physicians also submitted feedback via email. We
conducted two rounds of user acceptability testing to check
online functionality on computer, phone, and tablet.
Results: Specific KP physicians (internal medicine,
oncology, cardiology, obstetrics/gynecology, pediatrics)
located nationwide will receive an invitation to complete the
online survey. Results will inform strategies to develop new
care pathways and infrastructure to ensure KP physicians are
well prepared for use of genomic information in precision
medicine.
Supplement

Conclusion: Including physicians and health system
stakeholders throughout the survey development and testing
process ensures the research insights will be relevant for
precision medicine planning.
Keywords: genetics, genomics, survey research and
methods
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the survey. In combination with the results of a parallel
physician survey, the results of the member survey will help
to develop KPRB’s policies on the return of genetic results
and inform an overall precision medicine strategy for KP.
Conclusion: Including patient advisors and other health
system stakeholders throughout the survey development
process ensured that the interests of those who may be most
impacted by the survey results are represented.
Keywords: genetics, genomics, survey research and
methods, engagement of stakeholders
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Background: The Kaiser Permanente Research Bank
(KPRB) currently has approximately 287,000 members
enrolled, with a goal to enroll 500,000 members total.
Members who enroll in KPRB have consented to having
their biospecimens and linked electronic health record used
for genomic research as well as other bioassays. To better
understand Kaiser Permanente (KP) member perspectives on
return of genetic research results, KP investigators worked
with a patient advisory panel (PAP) and other stakeholders
to develop an online survey for KP members.
Methods: We outlined 12 domains of interest and conducted
a literature review of published surveys and, when available,
standard instruments for these domains. Simultaneously, we
assembled a PAP of 6 advisors from the Colorado Patient
Partners in Research (CoPPiR) network. Four in-person
PAP meetings were held covering 1) project overview,
2) domain prioritization, 3) instrument selection, and 4)
feedback on first draft of the survey. After incorporating
PAP feedback, a second draft was circulated to scientific
leaders on the KPRB leadership team, members of KPRB’s
community advisory and bioethics advisory boards, the
KP Interregional Genetics Workgroup, and operational and
clinical KP leaders. Then, a third draft was circulated to the
PAP, reviewers from KP Office of Diversity, Equity, and
Inclusion, the KP Washington Survey Research Program,
and KP Mid-Atlantic States literacy specialists to simplify
the survey reading level. Finally, the survey was converted
into an online version, and the team conducted two rounds
of user acceptability testing for clarity and usability of the
online survey.
Results: From 7 KP regions, 10,000 KPRB participants and
100,000 KP members who are not participating in the KPRB
will receive the survey invitation via email. A $5 Amazon
gift code will be provided to participants who complete
Supplement
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Background: It has been said “your zip code matters more
than your genetic code” when discussing the impact of a
person’s neighborhood on life expectancy in the U.S. This
finding is embedded in the social determinants of health
–– factors like education, income, and race, which impact
where people live and their health outcomes. There is limited
evidence of the importance of social determinants of health
to the risk for developing type 2 diabetes. Methodological
limitations and varying endpoints make it difficult to
generalize or reach clear conclusions regarding the relative
importance of different factors. We utilize a large and
diverse sample of patients from an integrated care system in
the greater Los Angeles area (DaVita HealthCare Partners)
to investigate the impact of several social determinants of
health on the likelihood of transitioning from prediabetes
to diabetes. Prediabetes, in which blood glucose levels are
elevated above normal levels but not quite high enough to
be considered diabetes, is a high-risk state for developing
diabetes. It was recently estimated that one-third of younger
adult Californians, those age 18–39 years, have prediabetes.
Methods: Using Census zip code-level data from the
American Community Survey, we identified 10 social
determinants of health that have been found to be associated
with type 2 diabetes. These zip code-level variables were
included in a multivariate regression model of the transition
from prediabetes to diabetes, controlling for several
individual-level risk factors.
Results: For 2007, 19,021 patients were identified with a
prediabetes hemoglobin A1c level (5.7% to 6.4%); for 2018,
www.aurora.org/jpcrr
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an additional 12,673 were identified. Descriptive analysis
of zip codes suggested that higher rates of transition over
the 10-year study period occurred in less affluent, Hispanic
neighborhoods. After controlling for multiple individuallevel risk factors, our preliminary analysis indicated small
but statistically significant associations between transitioning
from prediabetes to diabetes with neighborhood educational
attainment, household income level, and home value.
Conclusion: Further investigation into the social
determinants of health and their role in the development and
progression of diabetes may provide opportunities for the
health care system to cost-effectively target resources.
Keywords: geographic/spatial factors, social determinants
of health, diabetes, small-area analysis

Conclusion: Conclusions from this study will identify gaps
in equitable care and inform efforts to improve culturally
competent practice in diabetes care.
Keywords: cardiovascular disease, observational study,
primary care, patient-provider communication, engagement
of stakeholders, racial/ethnic differences, social determinants
of health, diabetes, qualitative research, chronic disease,
patient experience/satisfaction
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Background: The Kaiser Permanente Northwest (KPNW)
region has reported a 12.6% gap in rates of glycemic control
between Hispanic and non-Hispanic white patients, with a
lower proportion of Hispanic patients showing adequate levels
of glycemic control (A1c > 8%). While recognizing that the
term “Hispanic” is used to describe a highly heterogeneous
population of diverse sociocultural backgrounds, it is critical
to identify nuanced and contextualized factors that contribute
to this gap in health outcomes, particularly in the context
of a comprehensive medical care organization. Relying on
qualitative data collection, this study explores sociocultural
factors that might help explain suboptimal levels of diabetes
control in this population. The goal is to identify actionable
elements to improve care and support for patient self-care.
Methods: The study team has partnered with a KPNW
primary care provider (PCP) panel serving Hispanic patients
diagnosed with type 2 diabetes to conduct a qualitative pilot
study. From the PCP’s Hispanic patient panel, individuals
with A1c > 8% will be invited to participate, which involves
direct observation of medical encounters between PCPs and
patients as well as individual in-depth telephone interviews
with both patients and PCPs. Observations and interviews
will center on identification of factors that may help optimize
patient-provider communication and patient adherence to
diabetes self-care recommendations.
Results: This is an ongoing study. By the expected
completion date (December 31, 2017), we hope to provide
thematic summaries regarding Hispanic patients’ experience
in receiving diabetes care at KPNW, barriers and facilitators
of optimal patient-provider communication, patient diabetes
self-care, and adherence to treatment recommendations.
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P9.03
Use of Interpreter Flag in Determining Eligibility
for Studies Conducted at Kaiser Permanente
Washington Health Research Institute: Mining
Information From the Survey Research Program

Kaiser Permanente Washington Health Research Institute,
Seattle, WA
1

Background: As a shared resource for Kaiser Permanente
Washington Health Research Institute, the Survey Research
Program (SRP) contacts thousands of participants annually
via phone, mail, and web-based surveys. Inevitably, there
are participants unable to participate either because they
are non-English speaking or hearing impaired. Since 2014,
only one of more than 50 fielded phone room studies
used Spanish-bilingual interviewers. Teletypewriter and/
or video relay services are available to participants with a
hearing impairment, but the participant must initiate use of
the technology. The electronic health record (EHR) has an
“Interpreter flag” field that identifies members requiring an
interpreter, including American Sign Language. Some studies
utilize the Interpreter flag as an exclusion criterion. Together,
this tells us that non-English speaking and hearing-impaired
individuals may not be invited to participate in studies or,
if invited, not able to participate. Using data in the SRP
database, augmented by information from the virtual data
warehouse (VDW), we will investigate how the Interpreter
flag is currently used and how to better utilize it in the future.
Methods: We identified approximately 50,000 unique
participant records from 24 studies in which the SRP
attempted telephone contact from 2014 to present. We
used the VDW to obtain the Interpreter flag status for
our sample. We used process and outcome variables (call
disposition, study type, final status), basic demographic
variables (date of birth, gender, ethnicity, race), and
Interpreter flag (checked vs unchecked) to determine: Is the
interpreter flag a predictor of final outcome? (complete vs
“ineligible: language,” “ineligible: hearing impaired,” and
“refused, unable to reach”). Seven of the 24 studies used the
Interpreter flag as one of their exclusion criteria. How did
response rates differ between those studies and studies that
did not use that exclusion? What is the age, race/ethnicity,
and gender distribution of those with an Interpreter flag?
Supplement

How often did SRP initiate contact with individuals
who could not participate due to language barriers or
hearing impairments? Could those individuals have been
preidentified by the Interpreter flag? Could study materials
or procedures be tailored to allow for individuals with these
barriers to participate?
Results: Across all 24 studies, only 2.1% of the participants
were determined to be ineligible for study participation
compared to 21.8% for those with an Interpreter flag. Of
the 1067 who were determined to be ineligible, 328 (30.7%)
were due to hearing and language barriers. Nearly all of
those with an Interpreter flag were screened out due to
language. Completed interviews or successful recruitment
were achieved for 40.6% of those having an Interpreter flag
as compared to 44.8% of participants without. A smaller
percentage of respondents with the flag refused or were
unable to be reached, suggesting that, if enabled, they might
be more likely to participate than those without a flag.
Conclusion: Participants with an Interpreter flag were
much more likely to be determined ineligible for study
participation, and almost all of those identified as ineligible
were so due to a language barrier. While 25.3% of all
participants were ineligible due to language barriers, this
was 98% of those with the Interpreter flag.
Keywords: survey research and methods, demographics,
access to services
P9.04
Depression Screening and Education: Options to
Reduce Barriers to Treatment (DESEO): Primary
Outcomes From a Culturally Adapted Education
Intervention to Increase Treatment Engagement
Among Hispanics in Primary Care
Katherine Sanchez1
Baylor Scott & White Health, Dallas, TX

1

Background: In 2014, the Centers for Medicare & Medicaid
Services’ Hispanic Health Services Research Grant Program
funded the Depression Screening and Education: Options
to Reduce Barriers to Treatment (DESEO) project to
implement an education intervention designed to increase
disease literacy and dispel myths about depression and its
treatment among Hispanic patients, thus reducing stigma
and increasing treatment engagement.
Methods: Universal depression screening was implemented
for all adult patients during visits with their primary care
providers using the 9-item Patient Health Questionnaire
(PHQ-9). Depressed patients (PHQ-9 score > 10) then
completed the 7-item Generalized Anxiety Disorder
assessment (GAD-7) and were invited to participate in
the study. DESEO utilized a one-group pretest-posttest
design to assess a culturally adapted depression education
intervention (a comic book-style fotonovela) within a
sample of 350 depressed Hispanic patients. The Depression
Supplement

Knowledge Measure (DKM) was used to evaluate the effect
of the education. Three stigma measures were used to assess
stigma associated with depression. Statistical tests of the
demographics were completed and differences examined.
Various bivariate statistical tests, including t-tests, chisquared (𝜒2), and Fisher’s exact, were used for changes in
participant-reported scores over time as well as repeatedmeasures analysis of variance. Multinomial logistic
regression was used to test the association between the selfreport measures from follow-up and the likelihood of the
treatment-engagement categories.
Results: Overall, participants reported significantly lower
scores for self-reported depression, anxiety, and mental
health stigma measures at second session and at 30-day
follow-up compared to baseline. These changes included
average PHQ-9 scores decreasing from 17.53 at baseline
to 9.47 at follow-up (P<0.001), GAD-7 scores decreasing
from 12.97 to 7.62 (P<0.001), and Stigma Concerns About
Mental Health Care decreasing from 0.43 to 0.10 (P<0.001).
Additionally, participants reported increased knowledge in
depression but also greater concern and negative perceptions
about antidepressant medication. Finally, a majority of
participants reported entering some form of treatment at
follow-up (273 of 305, 89.5%).
Conclusion: DESEO addressed the need for early
identification of depression, and the culturally adapted
education intervention increased knowledge of the disorder,
reduced stigma, and led to significant engagement in
treatment, which has implications for reducing the morbidity
of related medical illnesses.
Keywords: primary care, behavioral and mental health,
racial/ethnic differences, social determinants of health,
social work
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A Prospective, Randomized Study of Fixed Versus
Variable Dosing of 4-Factor Prothrombin Complex
Concentrate for Emergent Warfarin Reversal at a
Large Tertiary Care Medical Center
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Terwilliger,1 David Dries1
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Background: 4-factor prothrombin complex concentrate
(4FPCC), a U.S. Food and Drug Administration (FDA)approved medication for warfarin reversal, contains all the
vitamin K-dependent clotting factors inhibited by warfarin,
making it desirable for emergencies. Optimal dosing of
4FPCC is currently unknown despite multiple studies. The
www.aurora.org/jpcrr
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FDA-approved dosing is 25 to 50 IU factor IX per kilogram of
body weight, dependent on international normalized ratio (INR).
Regions Hospital recorded 67 4FPCC administrations from
January 2015 to May 2016. Mean dose administered was 3021
IU (range: 1000–7000 IU), with an average cost of $7,236.17
(range: $2,530–$17,710) per dose. If clinically effective, a lower,
fixed dose may cost less and allow for more rapid administration
compared to the FDA-approved variable dosing.
Methods: A prospective randomized trial is being conducted
to determine if fixed-dose 4FPCC is noninferior to variable
dosing for emergent warfarin reversal. Eligible patients are
randomized 1:1 to receive either a fixed or variable dose of
4FPCC. This study utilizes a permuted block randomization
schedule to allow for equal allocation of subjects. All enrolled
subjects were evaluated for thromboembolic events at day 7.
Results: Fisher’s exact test was performed to assess the
primary endpoint (INR reduced to ≤1.5 after initial dose)
using a noninferiority approach and a 95% confidence
interval. A total of 23 patients have been randomized ––
12 to fixed and 11 to the weight-based dose. A total of 5
patients did not achieve an INR ≤ 1.5; 4 of these patients
were in the fixed-dose group, while 1 was in the variabledose group. No statistically significant difference was seen
between the groups (P=0.1854). A Wilcoxon rank-sum test
was performed to compare cost between the two treatment
groups. Median medication cost of the fixed-dose was
lower ($2,529.27; interquartile range [IQR]: 63.59) than
the median cost of the weight-based dose ($3,372.36; IQR:
1614) (P<0.0001).
Conclusion: It is important to note that of the 5 subjects who
did not meet the primary endpoint, only 1 did not achieve an
INR of ≤ 1.7. No subjects were considered treatment failures,
requiring additional 4FPCC. A fixed-dosing strategy could
benefit patients in need of emergent anticoagulant reversal
if proven to be noninferior to the variable-dosing strategy.
Keywords: clinical decision-making, research findings,
clinical practice patterns/guidelines
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Community Paramedic Partnership: Shifting Health
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Municipal Fire/Emergency Medical Services and
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Background: A partnership between a Level I trauma center
and an urban municipal fire/emergency medical services (EMS)
department for patients with congestive heart failure (CHF)
was launched in 2014. The program aimed to improve health
care utilization and reduce readmissions through a unique
community paramedic (CP) partnership. We hypothesized that
patients who receive CP visits for 30 days postdischarge have
reduced rate of readmission and increased use of clinic visits.
Methods: Inpatients with admission diagnoses of CHF, chronic
obstructive pulmonary disease, or acute myocardial infarction
were offered visits by a CP for up to 30 days postdischarge.
Patients with homecare services upon discharge were excluded.
Patients were required to sign a written informed consent form
prior to participation. The CP visited the patient in the home
1–2 times per week for 4 weeks following discharge. At each
visit, the CP conducted medication reconciliation, a physical
examination, home safety evaluation, coordination of followup care, and referral to community or health care resources
as needed. Pre/post comparisons were analyzed descriptively
using means and standard deviations. Scores were assessed
with Wilcoxon signed-rank tests.
Results: Between February 2015 and July 2017, 64 patients
were enrolled; 32 patients completed the program with
complete data. A comparison of 90-day health care utilization
pre- and postadmission showed that patients who were provided
CP services had a significant decrease in hospital admissions
(68%, P<0.0001) and emergency department (ED) visits (62%,
P<0.0001), and had a 14% increase in clinic visits (ns, P=0.45).
A group of patients who met inclusion criteria but declined
consent to participate was compared to the patient group that
participated in the CP program. Patients who completed the
program had a significantly higher decrease in admissions
(P=0.0145) and ED visits (P=0.0009) pre- to posthospitalization
than those who did not enroll (n=20). There was no significant
difference in change in clinic utilization.
Conclusion: Partnership between fire-based EMS and hospitals
for community paramedic programs can be successful. CPs
providing postdischarge care results in a shift of health care
utilization toward reduced admissions/ED visits and increased
clinic visits. Further research with a larger cohort is needed to
determine if utilization patterns would be sustained past 90 days.
Keywords: program evaluation, primary care, quality of
care, patient-provider communication, complex disease
management, multiple chronic conditions, health care costs,
resource use, hospital, access to services, incentives
P11.02
Impact of Dental Provider Recommendations on
Adolescent Vaccination Rates
Allison Naleway,1 Michelle Henninger,1 Lisa Waiwaiole,1
Michael Leo,1 David Mosen,1 Daniel Pihlstrom2
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Dental Associates, Portland, OR
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Background: Dental visits provide an opportunity for
recommending adolescent vaccines and improving coverage,
but dental providers have not traditionally played a role in
recommending vaccinations.
Methods: We conducted a cluster-randomized trial to
evaluate whether dental provider recommendations would
improve adolescent vaccination rates. We randomized 16
Kaiser Permanente Northwest dental clinics to intervention
or usual care. Intervention clinic staff received training
about adolescent vaccinations and were asked to hand out a
brochure and verbally recommend vaccination. Dental staff
in the usual care clinics provided only a written reminder
of vaccinations that were due. To assess the impact of the
intervention, we compared pre/postintervention changes
in adolescent vaccination rates between intervention and
control clinics and accounted for the clustering of patients
within clinics using a mixed-effects logistic regression
model. The preintervention period was October 2014–
September 2015, and the postintervention period was
October 2015–September 2016.
Results: In the preintervention period, 11,613 adolescents
11–17 years of age had a dental visit and were included
the analysis; the postintervention period included 12,031
adolescents. During the intervention period, adolescent
vaccination rates increased at both intervention and control
clinics. No significant differences in the rate changes were
observed between the intervention and control clinics for
tetanus-diphtheria-acellular pertussis (Tdap) vaccination
(odds ratio [OR]: 1.10, 95% CI: 0.91–1.33), meningococcal
conjugate vaccination (OR: 1.12, 95% CI: 0.97–1.30),
human papillomavirus (HPV) initiation (OR: 1.03, 95% CI:
0.92–1.17), second-dose HPV vaccination (OR: 1.00, 95%
CI: 0.89–1.11), or third-dose HPV vaccination (OR: 0.99,
95% CI: 0.89–1.09).
Conclusion: Although vaccination rates improved overall
among adolescents, the observed changes in vaccination
rates did not differ in intervention and control clinics
after dental providers were encouraged to make vaccine
recommendations to their adolescent patients.
Keywords: child and adolescent health, health promotion,
prevention, screening, dental care
P11.03
Engaging With the “Other:” Lessons
Research to Inform Operations and
Operations to Inform Research

From
From

feedback informing their research. This study illustrates
lessons learned from the embedded researcher and the
operation team partnership.
Methods: Using longitudinal administrative and electronic
health record (EHR) data of a large ambulatory group
practice, the research team conducted a series of analyses
examining the association between physician practice
patterns and resource use, outcomes, and patient experience.
The study population included 242 primary care physicians
(PCPs) (726 PCP-years) from 2011 to 2013. Phase 1
identified PCPs who dealt with multiple problems during
acute visits (“max-packers”). Findings suggested that maxpacking is associated with better clinical quality, better
patient-reported experience, and lower annual per-patient
costs (all risk-adjusted), but more physician time using the
EHR system. Phase 2 explored factors associated with PCPs
who were max-packers, including practice processes (eg,
scheduled appointment blocks), physician characteristics,
patient-panel characteristics, and fixed effects (to account
for the organization’s 4 historically distinct regions), with
standard errors adjusted for correlation over time for the
same PCP. Presentation of early findings to operational leads
led to additional variables to consider.
Results: Female PCPs and appointment blocks allowing
more time for a visit were strong predictors of being a maxpacker. Other physician characteristics (years of practice,
specialty), physician clinical FTE, and patient-panel
comorbidity were not significant. PCPs in Region 4 were
substantially more likely to be max-packers (odds ratio:
4.68, 95% CI: 2.15–10.18). The operation team suggested
that access issues in Region 4 could lead PCPs to avoid
return visits. The model was revised to incorporate an access
metric, attenuating the Region 4 effect (odds ratio: 2.99, 95%
CI: 1.33–6.74). The operational team now plans to conduct
interviews with max-packers to learn their “secret sauce,”
after the research team revised the institutional review board
protocol to allow the identification of max-packers.
Conclusion: Collaborations between research and operations
may uncover organizational “insights” to improve research,
and vice versa
Keywords: quality of care, health care organization, costs,
resource use
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Implementing Smoking Cessation Counseling for
Lung Cancer Screening-Eligible Patients
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Background: Researchers embedded within health care
delivery systems can conduct studies using a wealth of
routinely collected data from the system, share findings with
the operations team for quality improvement, and receive

Background: Smoking cessation counseling has long been
recommended for heavy smokers, but uptake has been very
low. The new recommendation and coverage of lung cancer
screening with low-dose computed tomography (LCS-
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LDCT), which requires smoking cessation in parallel, has the
potential to increase the use of smoking cessation counseling.
Our aim was to assess the utilization of smoking cessation
counseling among LCS-LDCT-eligible patients following the
policy changes.
Methods: We analyzed the electronic health records data
from a large health care system in Northern California
during 2010–2016. Patients age 55–80 years who made at
least one visit to a primary care provider each year and had
no history of lung cancer at the time of visit (557,409 patientyears over 7 years) were included in the analysis. Trends
in documentation of smoking history, number of eligible
patients, and orders of smoking cessation counseling were
assessed. Patient-level and provider-level factors associated
with smoking cessation counseling orders during 2014–2016
were explored using hierarchical generalized linear models.
Results: Documentation of smoking history has increased
over time, from 61.5% in 2010 to 79.2% in 2016. Smoking
cessation counseling orders among current smokers who
were eligible for LCS-LDCT have increased from 5.3% in
2010 to 7.7% in 2016. Implementation of smoking cessation
counseling varied considerably across primary care providers.
Current smokers 75–80 years old (odds ratio [OR]: 0.5, 95%
CI: 0.4–0.8) were significantly less likely to receive smoking
cessation counseling orders compared to those 55–64 years
old. Heavier smokers with 50–59 pack-years history of
smoking were more likely to receive an order than lighter
smokers with 30–39 pack-years (OR: 1.7, 95% CI: 1.2–2.4).
Current smokers seeing their regular primary care provider
also were significantly more likely to receive a smoking
cessation counseling order (OR: 2.0, 95% CI: 1.3–3.1).
Conclusion: Future interventions to improve smoking
cessation
counseling
among
LCS-LDCT-eligible
patients may be more effective if they focus on accurate
documentation of smoking history and target lighter smokers
who are not visiting their usual PCP. Barriers and facilitators
of implementing smoking cessation counseling at patient,
provider, and systems levels need to be better understood to
inform targeted interventions.
Keywords: cancer, primary care, health promotion,
prevention, screening, hierarchical modeling, clinical
practice patterns/guidelines

of experience and cost have been developed for health
plans, a measure of population health with the same three
attributes has not. Therefore, we developed a method by
which disability-adjusted life years (DALYs) attributable
to a population and classes of conditions (musculoskeletal,
psychosocial, neurological, etc) can be calculated using
insurance claims and death records.
Methods: The Johns Hopkins ACG® System groups insurance
claims into expanded diagnostic clusters (EDCs) and further
groups EDCs into major EDCs (MEDCs). The conditions
listed above are examples of MEDCs. We matched a Global
Burden of Disease (GBD) project condition score to weight the
health impact of each EDC and rolled the EDC-level DALYs
up to the MEDC level to calculate the morbidity DALYs
attributable to each MEDC for our 2011, 2012, and 2013
commercial members. We ranked MEDCs by DALYs, levels
of function and levels of health reported by the members on
a health assessment, and cost to the health plan attributable to
each MEDC. We calculated correlation coefficients as below.
We also calculated correlation coefficients for the number of
MEDCs for which the member had claims with their function
and health.
Results: Measures for years 2011/2012/2013, respectively:
72,693/58,434/61,723 number of members; -0.24/-0.24/0.23 coefficient for GBD-weighted MEDC self-reported
function and -0.20/-0.19/-0.19 for self-reported health;
-0.14/-0.19/-0.19 coefficient for cost attributable to MEDC
self-reported function and -0.13/-0.15/-0.15 for self-reported
health; -0.21/-0.21/-0.21 coefficient for MEDCs per member
self-reported function and -0.20/-0.20/-0.20 for self-reported
health. *All coefficients are statistically significant.
Conclusion: The correlations between DALYs and selfreported function and self-reported health indicate that the
measure is valid. Assessing population health with DALYs
also is superior to assessing population health by analyzing
the costs attributable to an MEDC. The fact that the
performance of the DALYs is similar to the performance of
the measure based on MEDCs per member also supports its
validity. The year-over-year consistency of the correlation
coefficients indicates that the measure is reliable.
Keywords: quality of care, managed care (features), health
care organization, quality improvement

P11.05
Creating a Valid, Reliable, and Actionable Measure of
Current Population Health for Use by Health Plans

P11.06
Transgender Response and Quality of Care Study
at Kaiser Permanente Mid-Atlantic States: Data
Quality Metrics

Thomas Kottke,1 Jason Gallagher,1 Marcia Lowry,1
Sachin Rauri,1 Juliana Tillema,1 Jeanette Y. Ziegenfuss,1
Nico Pronk,1 Susan Knudson1
HealthPartners, Minneapolis, MN

110

Suma Vupputuri,1 Alphonse Derus,1 Christine Truong,1
Ayanna Wells,1 E.W. Emanuel1
Kaiser Permanente Mid-Atlantic States, Rockville, MD

1

1

Background: In 2008, Berwick, Nolan, and Whittington
proposed the Triple Aim as a measure of health care system
performance. While reliable, valid, and actionable measures

Background: It has been suggested that transgender (TG)
patients have poorer health than cisgender patients; however,
the quality of TG health care is unknown. The purpose of this
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study is to describe the transgender patient population at Kaiser
Permanente Mid-Atlantic States (KPMAS) and develop quality
health metrics to initiate the process of assessing quality of care.
Methods: We included patients who were reported by the
KPMAS HealthConnect® TG registry, which identifies active
patients using TG-related ICD codes, TG procedures, and
surgical history. We describe here the TG population at KPMAS
with respect to demographics, how they were identified as TG,
whether they had a TG procedure/surgery, and medications.
Preliminary TG quality health metric domains include health
care utilization, use of preferred providers, health system
engagement, and medication fills. Additional metrics to be
presented will include utilization of video and telephone visits,
canceled appointments, number of hormone orders vs fills, and
health maintenance and preventive screenings.
Results: We examined 282 current patients identified by the
KPMAS TG registry on October 16, 2017. The mean age
of this patient cohort was 33 years. There were 49% nonHispanic white, 22% non-Hispanic black, 8% Hispanic, and
2% Asian/Pacific Islander. Approximately equal numbers
of patients had procedures indicating a female-to-male
versus male-to-female TG status. (Natal sex, recorded from
administrative data, showed 57% female). Among the cohort,
77% patients were identified by at least 2 TG diagnoses, and
71% were identified by 1 diagnosis from either a behavioral
health or endocrinology encounter. Health care utilization
during a 2-year period included a median of 14 outpatient
encounters (interquartile range [IQR]: 8–22); 16 email or
telephone encounters (IQR: 7–28); and negligible inpatient
and emergency room encounters. TG-preferred providers
were seen by 70% of patients. In terms of patient engagement,
the median number days that patients signed on to KP.org was
38 (IQR: 17–63). (Additional metrics are in process.)
Conclusion: It is important to establish baseline descriptors
and quality indicators of the TG population at KPMAS to
help clinical administrators identify and resolve potential
care gaps. At KPMAS, the TG population seems to be a
young, highly engaged patient population, with average
health care utilization patterns.
Keywords: quality of care, gender/sex differences, health,
health care, quality improvement
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Health Care for Adolescents
Kimberly Erlich,1 Daniel Becker,1 Ellis Dillon,2 Martina
Li,2 Jinnan Li,2 Amy Heneghan3
Mills-Peninsula Health Services, San Mateo, CA; 2Palo
Alto Medical Foundation Research Institute, Mountain
View, CA; 3Palo Alto Medical Foundation, Palo Alto, CA
1

Background: Mental health is a key determinant of overall
well-being; 20% of adolescents have a behavioral disorder
Supplement

that impacts physical health, social relationships, and
societal engagement. Unfortunately, up to 50% of those with
behavioral disorders do not receive care. Reasons for this
include poor access to behavioral health providers (BHPs),
as well as primary care providers (PCPs) lacking training,
comfort, and competence with providing behavioral health
(BH) care. Integrating BH services into primary care (PC)
may alleviate roadblocks to care, improve patient satisfaction
and clinical outcomes, and increase PCP satisfaction. We
developed and implemented an embedded BH service for
adolescents as a model of PC-BH collaboration.
Methods: A BHP was embedded in two PC sites for 18
months, providing the following services collaboratively
with PCPs: evaluation, treatment planning, medication
management, and a cognitive behavioral therapy intervention
(COPE). Electronic health records data were examined for
service utilization. PCP surveys solicited opinions on service
utilization and experience.
Results: A total of 178 eligible patients were referred to
the embedded BHP in a 17-month period by 28 out of 32
eligible PCPs (87.5%), and 61.2% (109) had at least 1 office
visit. Of patients referred, 73.0% were female; mean age
was 15 years. The most frequent reasons for referral were
depression (44.4%), anxiety (44.0%), and stress (26.1%). Of
16 PCPs surveyed, 87.5% agreed that the program enhanced
clinical care and 93.8% agreed that it enhanced patients’
experience with care. PCPs rated the program favorably
on referral process (93.8%), communication with BHP
(100.0%), and overall experience with the service (93.8%).
Of PCPs surveyed, 81.3% stated they hoped the program
would continue. Some PCPs requested clarification about
guidelines for appropriate referrals.
Conclusion: Embedded BHPs is an efficient collaborative care
model to improve access to BH services for adolescents. This
model improves communication between BHPs and PCPs,
enhancing both clinical care and patients’ experience with care.
Keywords: child and adolescent health, primary care,
program evaluation, behavioral and mental health, access to
services, ambulatory/outpatient care, quality improvement
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Background: Cancer is a leading cause of death in the
United States. Reducing the incidence of common cancers
through more consistent primary and secondary prevention
in primary care is needed to achieve Healthy People 2020
goals. This paper focuses on preimplementation adaptations
made to a National Institutes of Health-funded study that will
integrate primary (tobacco cessation, obesity management,
human papillomavirus vaccination) and secondary (breast,
cervical, colorectal, lung) cancer prevention and shared
decision-making tools (SDMTs) with an existing electronic
medical record-linked and web-based cardiovascular
clinical decision support system (CDSS) currently being
tested in a large, rural integrated health care system based
in the Midwest. To facilitate implementation and maximize
utilization of the cancer prevention CDSS, the research
team made several adjustments to the original study design
in order to better adapt the intervention to fit the goals and
culture of the integrated health care system. Our paper helps
fill a gap in the literature, as few studies report on adaptations
made to interventions based on feedback from intervention
sites, particularly those that alter and enhance current CDSS.
Methods: Guided by the Consolidated Framework for
Intervention Research (CFIR), we analyzed data from
preimplementation study documents and meeting minutes
with health system providers and leaders and team meetings,
along with leadership and provider key stakeholder interviews
(n=28), focusing on preimplementation adaptations made to the
study design and to the cancer prevention CDSS. We present
those adaptations here, categorized by relevant CFIR domain.
Results: Based on feedback received from health care system
providers and leaders, we made adaptations related to CFIR
domains intervention characteristics, inner setting, outer setting,
and process. In brief, we modified one intervention arm to focus
on SDMTs rather than expanding the role of clinic medical
assistants and adapted some content in the cancer prevention
CDSS, our study design, and SDMTs to meet the needs of the
delivery system in which the study is being conducted.
Conclusion: The strategies we used to better adapt the cancer
prevention CDSS to the evolving needs of the integrated
health care system may provide useful guidance and reference
for other researchers implementing similar systems, including
those that expand and enhance current CDSS.
Keywords: cancer, primary care, qualitative research,
engagement of stakeholders, clinical decision-making,
dissemination, implementation, innovation, clinical trials
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Hepatitis C Cascade of Care at Kaiser Permanente
Mid-Atlantic States: The Laboratory Perspective
Cabell Jonas1
Mid-Atlantic Permanente Research Institute, Rockville, MD

1

Background: Chronic hepatitis C virus (HCV) affects the
large Baby Boomer-age population and those at risk due to
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blood exposure (such as those who use intravenous drugs).
A chronic HCV infection is detected through a positive
HCV antibody (Ab) test, followed by a positive HCV RNA
(viral load) laboratory test. Of patients who test positive for
HCV Ab, the literature shows that up to half are never tested
for HCV RNA, meaning a chronic HCV diagnosis cannot
be established. The gap between HCV Ab and HCV RNA
testing persists in part due to patient failure to return for a
second blood draw after the initial positive HCV Ab result or
incomplete ordering of HCV tests by providers.
Methods: In 2014, Kaiser Permanente Mid-Atlantic States
implemented a new HCV screening pathway specifically
designed to streamline laboratory testing for patients and
ensure a complete set of diagnostic tests are easily ordered
for the patient. Scalable resources, including laboratory
workflow tools and training guides, have been outlined
to promote adoption of this pathway by other Kaiser
Permanente regions. The new HCV Pathway simplifies
physician workflows and closes known care gaps through
the use of technology, laboratory reflex testing, and a HCV
care coordinator. Within the HCV Pathway, laboratory reflex
testing ensures that all patients receive HCV Ab, HCV RNA,
hepatitis B surface antigen, and human immunodeficiency
virus (HIV)-1/2 testing from the blood samples collected
from a single patient visit. If diagnosed as having chronic
HCV (Ab- and RNA-positive), the patient returns for
one more blood draw and a FibroScan® (hepatic transient
elastography) test to obtain a complete diagnosis and
assessment of liver function.
Results: Since the HCV Pathway was implemented
regionwide in early 2015, total HCV Ab screening has
nearly doubled. HCV Pathway patients are more likely to
receive HCV RNA testing (75% in usual care, >99% in HCV
Pathway) and HIV coinfection testing (68% in usual care,
>99% in HCV Pathway).
Conclusion: Specific clinical laboratory and regional
laboratory protocols support success in screening more than
84,000 patients through the new HCV Pathway.
Keywords: health promotion, prevention, screening,
chronic disease, ambulatory/outpatient care, dissemination,
implementation, innovation
P12.03
Comparing the Effectiveness of Automated and
Live Reminders for a Direct-Mail Fecal Testing
Program
Jennifer Rivelli,1 Gloria Coronado,1 Morgan Fuoco,1
Victoria Gawlik,2 Amanda Petrik,1 Ricardo Jimenez2
Kaiser Permanente Center for Health Research, Portland,
OR; 2Sea Mar Community Health Centers, Seattle, WA
1

Background: Patient reminders can improve rates of
colorectal cancer screening. As part of the Strategies and
Opportunities to STOP Colon Cancer in Priority Populations
Supplement

(STOP CRC) study, we partnered with Sea Mar Community
Health Centers to conduct two pilot studies on patient
reminders. Our first pilot compared the effectiveness of
reminder letters, automated phone calls, live phone calls, and
text messages in reminding patients to complete a fecal test
as part of a mailed fecal test program. Findings showed that,
for Spanish-speaking patients, the combined automated/live
call (61%) approach (up to 4 reminders) resulted in a higher
fecal test return rate than automated calls (30%) alone (which
delivered 2 reminders). It is unknown whether the return rate
difference is attributable to the relatively high number of
phone calls or to the personal communication in the live call
scenario. The second pilot compared the effectiveness of
automated phones calls only (n=6) vs combined automated
(n=3) and live (n=3) calls, making the total number of call
attempts the same for both groups.
Methods: Pilot 2 involved two clinics of Sea Mar, a
community-based organization in Washington state.
Adults age 50–75 years who had a primary care visit in
the previous year and were not up-to-date with colorectal
cancer screening received an informational letter and fecal
immunochemical test (FIT) kit by mail. Patients who did
not return their FIT kits within 3 weeks were randomized to
receive 1) 6 automated phone calls, or 2) 3 automated and 3
live phone calls. We recorded rates of screening completion
and rates of patients reached by reminder.
Results: Overall, a total of 271 patients were randomized
(72% who preferred English and 20% who preferred
Spanish). Among the randomized sample, 80% were
enrolled in Medicaid or Medicare, and 56% reported an
annual household income of less than $20,000. Analysis
is still underway to determine reach. Final results will be
presented in the poster.
Conclusion: To date, in the community health center
setting, automated and live phone call reminders to a directmail fecal testing program substantially increase colorectal
cancer screening rates.
Keywords: cancer, health promotion, prevention, screening,
dissemination, implementation, innovation
P12.04
Developing Implementation Strategies With
Stakeholders to Promote Firearm Safety as a
Suicide Prevention Strategy in Pediatric Primary
Care
Rinad Beidas,1 Courtney Benjamin Wolk,1 Shari JagerHyman,1 Brian K. Ahmedani,2 John Zeber,3 Joel Fein,4
Greg Brown,1 Courtney Gregor,1 Adina Lieberman,1
Steven Marcus1
University of Pennsylvania, Philadelphia, PA; 2Henry
Ford Health System, Detroit, MI; 3Baylor Scott & White
Health, Temple, TX; 4Children’s Hospital of Philadelphia,
Philadelphia, PA
1
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Background: The number of youth suicides by firearm has
steadily increased in the last decade, representing a public
health crisis. Promoting safe firearm storage as a universal
suicide prevention strategy in pediatric primary care is one
way to address this crisis. Safety Check is an evidence-based
practice for improving parental firearm safety behavior in
pediatric primary care. This study, Adolescent Suicide
Prevention In Routine clinical Encounters (ASPIRE), aims
to engender a better understanding of how to implement
components of Safety Check as a suicide prevention strategy
in pediatric primary care from a system-level perspective.
Methods: We are collaboratively developing implementation
strategies in partnership with stakeholders from 2 sites in the
National Institute of Mental Health-funded Mental Health
Research Network. We surveyed providers and leadership
of 82 pediatric primary care practices to understand
acceptability and use of the 3 firearm components of
Safety Check (ie, screening, brief counseling on firearm
safety, provision of firearm locks). In collaboration with
stakeholders, we are using intervention mapping and the
Consolidated Framework for Implementation Research to
systematically develop and evaluate a multilevel menu of
implementation strategies for promoting firearm safety as a
suicide prevention strategy in pediatric primary care.
Results: Results from the survey suggest that primary care
physicians (N=103) and clinical leaders (N=40) endorse
the acceptability of 2 intervention components, screening
and counseling, but reported only sometimes using these
strategies. Results indicate neutral acceptability for
provision of firearm locks, and physicians report they rarely
distribute such devices in pediatric primary care. Qualitative
interviews with 9 stakeholder groups are ongoing, as is
development of implementation strategies.
Conclusion: This study provides important insights into
acceptability and current use of evidence-based practices
for safe firearm practices in pediatric primary care for
suicide prevention. We also will outline our approach to
collaboratively developing implementation strategies with
stakeholders across 2 large systems using a systematic and
mixed-methods approach.
Keywords: child and adolescent health, patient-provider
communication, behavioral and mental health, engagement
of stakeholders, clinical decision-making, dissemination,
implementation, innovation
P12.05
Spreading CM-SHARE to Multiple Settings:
Strategies, Learnings, and Future Applications
Hannah Husby,1 Lily (Shuting) Liang,1 Jacob DelatorreReimer,1 Cory Mosser,1 Xiaowei Yan,1 J.B. Jones1
Sutter Health, Walnut Creek, CA

1

Background: Spreading technology applications to new
settings requires a thorough understanding of the new
www.aurora.org/jpcrr
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users, contexts, and spread strategies adapted to the new
audiences. It also is important to keep track of variations
in implementation that may affect and help explain
differences in adoption and use. CM-SHARE is a web-based
application that was designed to help manage patients with
cardiometabolic conditions at the point of care. In the pilot
phase, CM-SHARE was developed with 6 primary care
physicians (PCPs) at 2 sites and evaluated using quantitative
(application usage) and qualitative (user feedback) measures
to accelerate learning and iterative improvement of the
application. Herein, we share findings and learnings from
efforts to spread CM-SHARE to new users naïve to the
product development cycle and in various new settings.
Methods: Eight pharmacists, nurse case managers,
and social workers from a case management and care
coordination program, 13 certified diabetes educators,
and an additional 20 PCPs were given CM-SHARE in a
health system in Northern California. Prior to giving the
application to the new users, the study team tested different
strategies and ways of introducing the tool to new users,
creating training packages and setting up individual or teambased meetings to demo the application and understand new
settings, workflows, and challenges. Users were asked to
help determine the appropriate level of engagement. Once
users had the application, application usage was tracked and
user feedback was collected.
Results: Of the 20 PCPs who were given the application,
5 used it multiple times during initial roll-out and gave
feedback to help understand why CM-SHARE was used and
how. Providers outside of primary care gave insight on which
features were valuable to them and how the application
could be spread to their colleagues. The new settings varied
in leadership structure, priorities, and workflows.
Conclusion: Being both deliberate in what data is collected
and open with the feedback process helps promote buyin from users and elicits meaningful information that can
lead to a better understanding of the utility of application in
multiple contexts, improve and identify features with shared
value, and help message that value to others.
Keywords: information technology adoption and diffusion,
primary care, evaluation research, health care organization,
dissemination, implementation, innovation

understanding of factors and replicable approaches leading to
successful integration is needed. This presentation aims to fill
this gap by presenting the “secret sauce” that led to successful
integration of CM-SHARE into primary care. CM-SHARE is a
web-based application that helps providers and patients manage
cardiometabolic conditions such as diabetes, hypertension,
and dyslipidemia. CM-SHARE has been integrated into two
primary care clinics in Northern California and is used by 25+
physicians, case managers, and diabetes educators.
Methods: A user-centered design and development process
was employed. Observation of physician’s electronic health
records (EHR) use and physician-patient interactions during an
office visit were conducted to understand the workflows and
needs. One-on-one interviews and group design sessions with
physicians and patients were also done to design the solution.
We built a technology platform that allows CM-SHARE to be
seamlessly integrated with the EHR and synthesize data from
outside of the EHR. During pilots, web log data were used to
track the “who, what, where, when” of each user interaction
with the application. Additional interviews were conducted
periodically with pilot users to further enhance the application.
Results: The user-centered design process yielded a display
that gives clinicians a comprehensive picture of the patient’s
critical health information without any clicks. A live demo of
CM-SHARE and the technology that supports its integration
with the EHR will be presented. To date, CM-SHARE has
been used by 25 users for 7900 encounters with 3712 patients.
The most used features include medication adherence,
cardiometabolic graphs, and risk calculators, which allow
providers to discuss with patients their 10-year risks for heart
diseases, kidney failure, vision loss, and amputation.
Conclusion: Intimate involvement of users in the design
and development process will help make the technology
more relevant and useful, and therefore overcome the
adoption gap. Rapid learning and feedback to product
development and operating within real-world constraints are
key to adoption and sustained use of technology solutions in
primary care delivery.
Keywords: information technology adoption and diffusion,
primary care, ambulatory/outpatient care, diabetes, chronic
disease, dissemination, implementation, innovation, quality
improvement, patient experience/satisfaction
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Secret Sauce to Integrating Technology Innovations
Into Care Delivery: An Illustration From CM-SHARE

MATERNAL AND PERINATAL CARE

Jacob Delatorre-Reimer,1 Lily (Shuting) Liang,1 Hannah
Husby,1 Cory Mosser,1 J.B. Jones1

P13.01
Initial Results From a New Algorithm to Identify
Pregnancy Outcome Episodes Across Kaiser
Permanente Regions

Sutter Health, Walnut Creek, CA

1

Background: Integrating new technology innovations into
routine care delivery is challenging; many applications fail
to get meaningful user uptake or sustained usage. With the
rising demand for new technologies in health care, a thorough
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Sharon Fuller,1 Don Bachman,2 Sanchita Sengupta2
Kaiser Permanente Washington Health Research Institute,
Seattle, WA; 2Kaiser Permanente Center for Health
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Background: The Kaiser Permanente (KP) Center for
Effectiveness and Safety Research (CESR) is a national research
collaborative comprising KP’s research centers in Colorado,
Georgia, Hawaii, Mid-Atlantic States, Northern California,
Northwest, Southern California and Washington. The CESR
Data Coordinating Center (DCC) has built and distributed an
algorithm to create a virtual data warehouse (VDW) pregnancy
outcome episodes table, containing one record for each
identified pregnancy for which an outcome exists.
Methods: The DCC convened a workgroup of stakeholders
from all KP regions, including researchers, clinicians,
and programmers. The DCC drew on workgroup clinical
expertise and case review and from existing pregnancy
project and specific CESR site algorithms. The final product
is a sophisticated algorithm to identify pregnancy outcomes
using a broad range of data sources, extensive diagnosis
and procedure code lookup tables, and detailed decision
rules. Data sources include health records of pregnancy
history, episodes, and deliveries; diagnoses, procedures, and
medications from the existing VDW; and mom-baby link
tables. Variables include pregnancy outcome type (live birth,
spontaneous abortion, therapeutic abortion, stillbirth, ectopic
pregnancy, molar pregnancy, and uncertain outcome);
outcome procedure (vaginal delivery, cesarean, etc);
outcome date; onset date (imputed if not known), estimated
date of delivery, last menstrual period, and gestational age;
maternal age and gravida/para status; flags for enrollment
and utilization during pregnancy; and flags for weak or
conflicting evidence and overlapping episodes. Additional
maternal information can be obtained from existing VDW
demographic and enrollment tables.
Results: Using the multisite program that implements the
algorithm, the 8 KP regions have identified a total of more than
3 million pregnancy episodes, with records for most regions
dating back to the early 1990s. This poster presents descriptive
data, illustrating volumes and trends in outcome types over time
and by region. Data were obtained from a regularly scheduled
quality assurance program run by each region.
Conclusion: With its large number of records, broad time
range, and national reach, we expect the CESR pregnancy
outcome episodes table to greatly facilitate single- and
multisite research on pregnancy, reproductive health, and
preconception health.
Keywords: virtual data warehouse
P13.02
Mother-Infant Linkage Data for Research Purposes
Jingyi Zhu, Avalow Olsen, Terese A. DeFor, Amy L.
Butani,1 Gabriela Vazquez-Benitez1
1

1

1

HealthPartners Institute, Bloomington, MN

1

Background: HealthPartners Institute has participated in
several research networks and studies requiring motherinfant linkages. Importance for this linkage in research
Supplement

includes pregnancy safety and effectiveness studies as well
as for infant studies. Study teams have developed their own
algorithm or shared-network algorithms targeted to their
population of interest. We present an overall view of targeted
populations, methods, and preliminary data to guide a wide
institutional approach to developing a mother-infant linkage
that can be incorporated into the virtual data warehouse.
Methods: Data sources for mother-infant linkage include
demographics, utilization, contract numbers, and state
birth records. Algorithms selected correspond to the target
population. Linkage of mothers with live birth delivery
data and health plan membership only may be linked by
contract number; mothers and infants receiving care in our
institution may be linked using the electronic health record
(Epic) table. Mothers and infant may be linked through
state birth records. Validity of each method may need to
be evaluated and a common hierarchy applied. Preliminary
data are available from current efforts: Medication Exposure
in Pregnancy Risk Evaluation Program (MEPREP), Vaccine
Safety Datalink (VSD), Patient Outcomes Research To
Advance Learning (PORTAL), and Birth Defect Study to
Evaluate Pregnancy exposureS (BD-STEPS).
Results: Of 115,450 MEPREP women, 152,800 deliveries
were identified through procedure and diagnoses codes. An
81% mother-infant match was reached using Epic table,
contract data, and other demographic data combined with
hospital admit, discharge, and birth dates. Of 122,184
member-patient infants in the VSD files, 60% (n=72,961)
were linked to member-patient women using state birth
data, contract data, and Epic table. Of 108,869 deliveries,
64% (n=69,375) had a mother-infant match. Using similar
methods as MEPREP, the PORTAL and BD-STEPS studies
found a 75% and 60% mother-infant match, respectively.
Conclusion: Differences in matching rates may be
associated with different inclusion criteria. Understanding
these differences will inform investigators how to select
their population. Through numerous study-specific efforts,
we have expanded our methods for linking mothers to
infants and are easily able to participate in multisite studies
that require these data.
Keywords: virtual data warehouse, research findings
P13.03
Building, Validating, and Using the Pregnancy
Outcome Episodes Table Available at All Kaiser
Permanente Regions
Don Bachman,1 Sanchita Sengupta,1 Jackie Blank,2
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Washington Health Research Institute, Kaiser Permanente
Washington, Seattle, WA; 4Kaiser Permanente Northern
California Division of Research, Oakland, CA; 5Kaiser
Permanente Institute for Health Research, Kaiser
Permanente Colorado, Denver, CO
Background: The Kaiser Permanente (KP) Center for
Effectiveness and Safety Research (CESR) is a national
research collaborative comprising the research centers from
the 8 KP regions. The CESR Data Coordinating Center
(DCC) devised a comprehensive algorithm synthesizing
data from multiple sources to create a virtual data warehouse
(VDW) pregnancy outcome episodes table at each KP
region.
Methods: The DCC convened a workgroup consisting of
investigators, obstetrics/gynecology providers, pregnancy
data experts, and programmers, with representatives from
each region, and created criteria for a VDW table containing
all pregnancy outcome episodes, available for any research
project, and synthesized the best available source data from the
electronic medical record (including the Epic Stork module),
VDW, CESR, and local data sources. This workgroup
evaluated 11 existing algorithms. As none completely met
the criteria, the workgroup designed specifications and the
DCC created a new algorithm informed by the best methods
learned during the evaluation. The table contains outcome
type (live birth, stillbirth, spontaneous abortion [SAB],
therapeutic abortion [TAB], ectopic, molar, etc); pregnancy
outcome and onset dates (imputed if not known); estimated
delivery date, last menstrual period, and gestational age;
delivery type (vaginal delivery, cesarean, etc); maternal
age; gravidity and parity; and variables identifying imputed
values, weak data, conflicting evidence, or overlapping
episodes. More than 500 episodes were reviewed at the
DCC site during the development of the algorithm. More
than 200 episodes also were reviewed at 3 other KP regions.
Furthermore, the table was validated against pregnancy data
from other projects (ie, Vaccine Safety Datalink, Maternal
Morbidity, Kaiser Permanente Mid-Atlantic States finance
delivery table). The CESR algorithm was continually
improved based on these evaluations.
Results: The combined table documents more than 3 million
pregnancy episodes (including 2.2 million live births,
12,000 stillbirths, 365,000 SABs, and 300,000 TABs). An
independent validation chart review will be reported.
Conclusion: This algorithm produces a comprehensive
pregnancy outcome episodes table in the VDW that can
facilitate single- and multisite pregnancy and reproductive
health research. The algorithm also could be used at other
sites with Epic and VDW data. The table has quality flags,
source data indicators, and value descriptions so projects
can choose all episodes of interest or limit their selection to
those with the strongest evidence.
Keywords: virtual data warehouse
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MENTAL HEALTH, ALCOHOL AND
SUBSTANCE USE/ABUSE
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Grapheme-Color Synesthesia Is Associated With
Posttraumatic Stress Disorder: A Confirmation of
Previous Findings and Research Implications
Stuart N. Hoffman,1 Thomas G. Urosevich,1 H. Lester
Kirchner,1 Joseph J. Boscarino,2 Richard E. Adams,3
Charles R. Figley,4 Carrie A. Withey,1 Ryan J. Dugan,1
Joseph A. Boscarino1
Geisinger Clinic, Danville, PA; 2William James College,
Newton, MA; 3Kent State University, Kent, OH; 4Tulane
University, New Orleans, LA
1

Background: Previously, we reported an association between
posttraumatic stress disorder (PTSD) and synesthesia among
deployed U.S. veterans (Psychosom Med. 2012;74:912915). Grapheme-color synesthesia is a perception in which
a particular letter or number elicits a concurrent image or
perception of a specific color. PTSD has been associated
with specific neuropsychological processes, including
memory function, intelligence level, cognitive processing,
and mixed handedness, among other phenomena.
Methods: Since our earlier study reported an association
between PTSD and synesthesia, our current objectives were
to validate this association using a new study and to explore
reasons for this association. To assess this, we randomly
surveyed 1730 veterans who were outpatients at Geisinger
Health, the largest multihospital system located in central
and northeastern Pennsylvania. As in our previous study, all
veterans had served in 1 or more warzone deployments.
Results: In our sample, the mean age of veterans was 59.6
years and the prevalence of PTSD was 7.6% (95% CI:
6.5–9.0). Altogether, 3.4% of veterans (95% CI: 2.7–4.4)
screened positive for grapheme-color synesthesia. Bivariate
analyses suggested that synesthesia was associated with
current PTSD (odds ratio: 4.1, P<0.001). Multivariable
regression results, adjusting for age, gender, marital
status, education level, psychotropic medication use, and
concussion history, confirmed this association (odds ratio:
3.0, P=0.006). Synesthesia also was significantly associated
with higher anxiety, neuroticism, and attention deficit
disorder symptoms (P<0.001 for each).
Conclusion: Our study confirms that synesthesia is associated
with PTSD among a second cohort of U.S. veterans.
Additional research is recommended to expand these findings
and to determine if synesthesia is also a risk factor for PTSD
among nonveterans. (Study funding: support for this study
was provided in part by U.S. Department of Defense [Contract
No. W81XWH-15-1-0506] to Joseph A. Boscarino.)
Keywords: survey research and methods, VA health system,
behavioral and mental health, research findings
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Male-Female Differences in Diagnosed Mental
Health Conditions and Risk of Suicide Mortality
Hsueh-Han Yeh,1 Joslyn Westphal,1 Yong Hu,1 Edward
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Cathrine Frank,1 Kirsti Autio,1 Farah Elsiss,1 Gregory
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Washington, Seattle, WA; 3Kaiser Permanente Colorado,
Denver, CO; 4Kaiser Permanente Northwest, Portland,
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School and Harvard Pilgrim Health Care Institute, Boston,
MA; 7Georgia State University / Kaiser Permanente Georgia,
Atlanta, GA; 8Kaiser Permanente Hawaii, Honolulu, HI
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Background: Suicide is a major public health issue in the
United States. Although mental health conditions are widely
considered to be risk factors for suicide, there is limited data
available within the general U.S. population. This study
aims to fill this gap as well as assess whether risk differs
by sex, given that there are wide variations in both rates of
suicide death and health care service utilization between
men and women.
Methods: The study sample was obtained from 8 health care
systems in the Mental Health Research Network. This study
used a case-control study design. Cases were identified as
those who died by suicide between 2000 and 2013. Each
case was matched with 100 controls from the same health
care system and enrolled during the same time period. A total
of 2674 individuals who died by suicide as well as 267,400
matched controls were identified. Mental health diagnoses
in the year before suicide were extracted from the virtual
data warehouse. Conditional logistic regression was used to
investigate 5 mental health diagnoses and suicide mortality.
Results: Nearly half of cases had at least one mental health
diagnosis in the year before death, compared to 13% for
controls. Cases had an average of 5.2 health care visits that
included a mental health diagnosis in a year prior to their
death, compared to 0.6 visits for controls. Risk of suicide
mortality risk was highest among individuals who had a
diagnosis of schizophrenia spectrum disorder (adjusted odds
ratio [aOR]: 15), followed by bipolar disorders (aOR: 13.2),
depressive disorders (aOR: 7.2), anxiety disorders (aOR:
5.8), and attention deficit hyperactivity disorder (aOR: 2.4).
After stratification by sex, the risk of suicide among women
with a bipolar disorder diagnosis (aOR: 22.9, 95% CI: 17.8–
29.4) was significantly higher than in men (aOR: 12.6, 95%
CI: 10.1–15.8).
Conclusion: Nearly all of the mental health diagnoses were
associated with increased risk of suicide. The findings will
help health care professionals to identify at-risk individuals
for suicide and implement effective prevention strategies for
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both male and female. However, nearly half of individuals
who died by suicide did not have mental health diagnoses
in the year before death. Therefore, suicide prevention
efforts may need to reach beyond those with mental health
diagnoses.
Keywords: behavioral and mental health, gender/sex
differences, health care, epidemiology
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Background: Health care settings have been identified as
strategic environments for implementing suicide prevention
approaches. Although health care utilization is common
among individuals in the year prior to suicide, there is limited
research on how visit patterns differ from those who do not
die. This study examined the type and timing of health care
visits utilized prior to index date for individuals who died by
suicide and matched controls in a U.S. general health care
population sample.
Methods: Health care utilization data were collected from
8 health care systems within the Mental Health Research
Network using a virtual data warehouse. A total of 2674
individuals who died by suicide between 2000 and 2013 were
matched with 267,400 controls by year and location. Visit
types, stratified by mental health and chemical dependency
diagnoses, within 1 year and within 4 weeks prior to index
date were identified. Index date was defined as the date of
death for those who died by suicide and the same date for
controls.
Results: Most individuals received health services in the
year prior to index date (92% of cases vs 86% of controls);
however, in the 4 weeks prior to index date, 57% of cases
received services compared to 29% of controls. When
compared with controls, individuals who died by suicide
were more likely to have had a medical visit for a mental
health condition (54% vs 15% within 1 year; 28% vs 3%
within 4 weeks) or a visit for chemical dependency (28%
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vs 5% within 1 year; 10% vs 1% within 4 weeks) before
the index date. A greater number of cases had inpatient and
emergency mental health and chemical dependency visits
than controls in both time periods (P<0.001). Emergency
room visits with a mental health diagnosis in the 4 weeks
prior to index date were associated with the greatest odds of
suicide (adjusted odds ratio: 64.36).
Conclusion: This study provides insight into how health
services sought by individuals who died by suicide up to
1 year before their death differed from individuals who did
not die by suicide. This may guide prevention efforts toward
targeted resource allocation.
Keywords: health promotion, prevention, screening,
behavioral and mental health, epidemiology
P14.04
Successful Implementation of a Multidisciplinary
Violence Risk Assessment Tool
Alexia Terwilliger,1 Gayle Godfrey,1 Laura Billstein,1
Sandi Wewerka1
Regions Hospital, Saint Paul, MN
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Background: Health care professionals are faced with many
challenges. One of these challenges is maintaining personal
safety at work. In December 2014, Regions Hospital
formed a Workplace Violence Committee responsible for
the research and development of a violence risk assessment
tool currently used throughout the hospital. The primary
objective of this study was to determine if the use of the
MIAHTAPS violence risk assessment and appropriate
interventions reduced the frequency of injuries at Regions
Hospital after implementation. MIAHTAPS was designed
from two well-known evidence-based tools that have proved
to be valid and reliable in different hospital settings.
Methods: A retrospective chart review was completed
on all admitted patients to Regions Hospital during the
time nursing units were piloting the MIAHTAPS violence
risk assessment. A second chart review was completed
on the same nursing units after staff were trained and the
MIAHTAPS violence risk assessment became mandatory
hospitalwide. Security reports were analyzed during both
time periods to determine if the implementation of the
MIAHTAPS violence risk assessment decreased the number
of reported violent incidences and injuries.
Results: The primary aim of this study was to determine if
implementation of the MIAHTAPS violence risk assessment
tool and appropriate interventions reduce the frequency of
violent behavior in 5 specific units at Regions Hospital
after implementation. In the pilot time period, there were
69 incidences of reported aggressive behavior and 48
incidences resulting in injury to staff. In the hospitalwide
time period, there were 58 reported incidences of aggressive
behavior and 28 reported injuries to staff. A Fisher’s exact
test was performed to test for statistical significance. There
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was no statistical difference in the number of physical
aggressive incidents by time period (P=0.15). There was a
statistically significant decrease in the amount of reported
physical injuries to staff (P<0.04).
Conclusion: Before the implementation of MIAHTAPS,
there was no standard of care, such as suggested
interventions, for deescalating potentially violent patient
behaviors. This study ultimately showed that the incidences
of violent behavior did not decrease between the two time
periods, but the injuries to staff decreased significantly.
Keywords: human subjects research, aging, elderly,
geriatrics, health care organization, workforce, nursing,
acute inpatient care, behavioral and mental health, clinical
decision-making, hospital, dissemination, implementation,
innovation, quality improvement
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Risk of Suicide in Patients With Traumatic Brain
Injury
Rebecca Rossom,1 Edward Peterson,2 Mansi
Sethi Chawa,2 Cynthia DiGiandomenico,3 Deepak
Prabhakar,2 Yong Hu,2 Ashli Owen-Smith,4 Gregory E.
Simon,5 L. Keoki Williams,2 Samuel Hubley,6 Frances
Lynch,7 Arne Beck,8 Beth Waitzfelder,9 Christine Lu,10
Brian K. Ahmedani2
HealthPartners Institute, Minneapolis, MN; 2Henry Ford
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Northwest, Portland, OR; 8Kaiser Permanente Colorado,
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Harvard Medical School and Harvard Pilgrim Health
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Background: Traumatic brain injury (TBI) increases the
risk of suicide by nearly 9-fold, greater than other comorbid
illnesses. Our objective was to determine what further
increases suicide risk in people with TBI to better guide
future potential interventions
Methods: Design: This was a case-control study. Setting:
8 Mental Health Research Network-affiliated health
care systems that serve over 5 million patients across the
United States were included. Electronic health record,
insurance claim, and other administrative data as well as
state mortality records were organized into a virtual data
warehouse (VDW). Participants: 61 cases with TBI who died
by suicide and their 75 matched controls with TBI who did
not die by suicide between January 1, 2000, and December
31, 2013, were included. Main outcome measures: Suicide
deaths were identified via the VDW using ICD-10 codes
of X60–X84 and Y87.0. Analysis: Descriptive statistics
characterized the sample stratified by cases and controls,
while conditional logistic regression models estimated the
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adjusted odds (aOR) of suicide.
Results: Men (aOR: 5.00, 95% CI: 1.33–1.67, P=0.016) and
people with psychiatric diagnoses in general (aOR: 5.96,
95% CI: 1.35–26.26, P=0.02) or depression specifically
(aOR: 4.86, 95% CI: 1.20–19.64, P=0.03) were at greatly
increased risk of suicide beyond the already high baseline
rate for people with TBI. Risk for suicide in people with TBI
generally increased with age (aOR: 1.04 per year, 95% CI:
1.00–1.08, P=0.047). There were no significant associations
with anxiety, alcohol, or tobacco use disorders.
Conclusion: Our findings provide clinicians with important
predictors of suicide for people with TBI, a population that
should be carefully screened for suicide risk.
Keywords: behavioral and mental health
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Innovative Methods to Build and Assess Virtual
Data Warehouse Mom-Baby Linkage Across All
Kaiser Regions
Sanchita Sengupta,1 Don Bachman,1 Jackie Blank,1
Carmen Wong,1 Mark Gray,1 Catherine Cleveland1
Kaiser Permanente, Portland, OR
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Background: The Kaiser Permanente Center for
Effectiveness and Safety Research (CESR) is a national
research collaborative comprising KP’s research centers in
8 regions: Colorado, Georgia, Hawaii, Mid-Atlantic States,
Northern California, Northwest, Southern California, and
Washington. The Data Coordinating Center (DCC) of CESR
built an extract, transform, load (ETL) package that creates
a virtual data warehouse (VDW) pregnancy database based
on a common data model at each of the 8 regions. One of the
tables in the database is the preg_mom_baby_link, consisting
of 6 variables including mother identification number, baby
identification number, baby’s date of birth, baby’s sex,
and primary data source. We sought to evaluate the best
method to link records while accounting for differences in
regions. Identifying linked records was challenging due to
the differences among the delivery settings (hospital vs nonKaiser hospital regions) and deliveries occurring outside
hospitals, like birth centers, or when the mother was not
enrolled in the system. We designed an algorithm that uses
the best available data sources from each site.
Methods: We distributed an algorithm-based ETL that
runs against the Stork module of Epic/HealthConnect®,
Health Care Systems Research Network, CESR VDW
tables, and prior data from region-specific projects. We
used two additional approaches and validated the records
against mothers with live-births: 1) identifying mom-child
relationship using insurance benefit subscriber group;
and 2) identifying family units using location coordinates
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and subsequently identifying mother-child relationship
within the family unit using demographics information.
The resulting pregnancy database will be periodically
assessed using CESR DCC quality assessment processes.
We will provide an analysis of confidence scores based on
comparison against known links, maternal enrollment status,
and source of data.
Results: The algorithm was validated by regions with
existing mom-baby linkage. About 2.5 million mom-baby
links were recorded at Kaiser regions, with about 89% having
data on delivery, gestational age, and other key variables.
Almost 100% of the linked records for two nonhospital
sites came from the benefits-subscriber group and location
coordinates method.
Conclusion: By using all available data sources, this
algorithm improved identification of mom-baby links for all
Kaiser sites, collectively resulting in the largest database of
linked records of mother-child.
Keywords: virtual data warehouse
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Comparison of Two Methods to Obtain Consent for
Patient-Reported Outcomes in a Pragmatic Trial:
Maximizing Data Completeness and Participant
Autonomy
Jeanette Y. Ziegenfuss,1 Kayla Dean,1 Anna Bergdall,1
Mary Sue Beran,1 Beverly Green,2 Alison Helm,1 Chris
Norton,3 Patrick J. O’Connor,1 Leif I. Solberg,1 Patty
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Background: In pragmatic trials, researchers often rely on
electronic health record (EHR) data. A waiver of consent may
be granted if the research could not be practicably carried
out otherwise. However, when EHR data are supplemented
with patient-reported outcomes (PROs), obtaining consent
is feasible and appropriate. If participants decline consent to
use their EHR data, this could reduce data completeness and
statistical power. In a cluster-randomized trial to optimize
treatment for high blood pressure, the primary outcome
is blood pressure obtained from EHR data and secondary
outcomes are PROs obtained by survey. The study team,
including patient partners, designed a pilot experiment to
understand how to maximize both survey and EHR data
completeness, while protecting participant autonomy.
Methods: Eligible participants, enrolled in the study under a
waiver of consent, were mailed a survey and cover letter that
included consent language. We randomized 213 participants
to two methods of obtaining consent to use EHR data to
compare the effect on survey and EHR data completeness.
In the first method, the respondents were asked in the survey
for permission to use their EHR data for research. Primary
outcome data from the EHR would be unavailable for
www.aurora.org/jpcrr
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those that responded “no.” The second method included a
statement in the cover letter that the use of EHR data for
research is part of the study and participants consent to this
with survey completion. We hypothesized that the second
method would reduce survey response rate but that all
respondents would have usable EHR data.
Results: Overall response rate was 45% (n=96) and did not
differ between the two consent methods. When respondents
were asked for permission to use EHR data, 11% declined,
resulting in a 5% reduction in the sample available for the
blood pressure primary outcome.
Conclusion: The second method of obtaining consent
did not reduce survey response rates and maximized the
completeness of the EHR outcomes data. The full study
will survey 2000 individuals and will include language
in the cover letter indicating that by returning the survey,
participants consent to using their health records for
research. Other changes to improve survey response rates
are being tested.
Keywords: human subjects research, program evaluation,
survey research and methods, confidentiality/HIPAA
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Enhancing Death Data for Multisite Studies With a
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Morgan Fuoco,1 Phillip Crawford,1 Dea PapajorgjiTaylor,1 Reesa Laws,1 Mary Ann McBurnie,1 Kristina
Hansen,2 Lisa Weatherby3
Kaiser Permanente Center for Health Research, Portland,
OR; 2Kaiser Permanente Washington Health Research
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Background: The occurrence of death is an important
outcome in many research endeavors. The National Death
Index (NDI) is an often-used data source that can be used
to identify or confirm death and cause of death. Ensuring
that death outcome data are complete, accurate, and
standardized is particularly important in a multisite study;
however, coordinating the preparation of standardized
NDI data requests across sites is challenging. The Data
Coordinating Center (DCC) for a large multicenter study of
opioid overdose incidence and risk factors among patients
using long-term opioid treatment for chronic pain has
developed a NDI application approach to support a multisite
study examining, among other outcomes, death and cause
of death relating to opioid use. This approach allows sites
to create data files that are formatted to NDI specifications,
are standardized across sites, and maintain participating
institutions’ protections for personal health information.
Methods: Each of the four participating sites maintains a
Sentinel Common Data Model. As part of the application
process, sites will provide a list of their data sources, a
summary of the project activities at the site level, applicable
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documentation verifying institutional review board
approval, and signed confidentiality agreements to abide by
the terms and conditions related to disclosure of individual
information. The DCC will distribute code to sites that will
identify patients according to criteria developed by study
investigators and will create, according to NDI specifications,
standardized files containing records of patients for whom
death information is needed. Sites will customize a portion
of the code to extract patient Social Security number and
name, two data elements required by NDI. Each site will
submit its own data request in order to maintain local patient
confidentiality requirements. The DCC will submit the
overall application.
Results: The application process developed by the DCC
resulted in an efficient standardized approach for submitting
a single NDI application across multiple sites.
Conclusion: Employing a standardized bundled NDI
application approach using distributed code and centralized
administrative resources will reduce the effort required by
the sites and will minimize errors and inconsistencies in
NDI data request files across sites.
Keywords: substance abuse and addiction, research
administration, contracting, operations, quality improvement
P15.04
Validation of Spontaneous Abortion Following
Inadvertent Quadrivalent Human Papillomavirus
Vaccination During Pregnancy in the Vaccine
Safety Datalink
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Background: The Vaccine Safety Datalink maintains a
pregnancy episode table to evaluate the safety of maternal
vaccination. It uses a pregnancy episode algorithm (PEA) to
retrospectively identify pregnancies from electronic health
and birth data. Spontaneous abortions (SAB) are identified
through diagnosis and procedure codes and assigned a
default gestational age (GA) of 10 weeks. Since outcome
misclassification could cause bias, our objective was to
validate SAB and GA within a cohort study of inadvertent
human papillomavirus vaccine (4vHPV) administration
during pregnancy.
Methods: The cohort was comprised of women 12–27
years potentially exposed to 4vHPV during three exposure
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windows: distal (16–22 weeks prior to last menstrual period
[LMP]), peripregnancy (the 42 days prior to LMP), and
during pregnancy (up to 19 completed weeks gestation).
Seven sites conducted structured chart reviews for SAB,
identified exclusions, and initial LMP dating. Test-retest
validity was assessed on 10%. Case adjudication was
performed by two obstetricians for eligible pregnancies.
Adjudicators recorded the range of fetal demise dates and
GA at which fetal demise could have occurred. Validation
was performed for SAB outcomes, dating of fetal demise,
and GA at fetal demise.
Results: From a cohort of 3695 pregnancies, 843 (23%)
potential SAB were identified by the PEA. Kappa was above
70% for SAB outcome, GA documentation, and ultrasound
documentation. A total of 308 SAB (37%) were adjudicated.
In total, 66% of episodes were confirmed as a SAB occurring
at ≥ 6 weeks gestation, 7% did not have records to confirm
the pregnancy outcome, and 21% had other etiologies such as
ectopic or molar pregnancy, pregnancy loss before 6 weeks,
or other study exclusions. Based on LMP dating, 29% were
not exposed to 4vHPV; mean GA in weeks was 9 (SD: 3).
Among those adjudicated, mean recorded range of GA was
2.6 (SD: 2.2) weeks. Fetal death dating departed from PEASAB dating by an average of 0.7 (SD: 1.1) weeks, with a
mean recorded range of 1.3 (SD: 2.1) weeks.
Conclusion: In order to study vaccine-SAB associations,
chart abstraction and, frequently, adjudication are needed to
refine estimates. Uncertainty in dating can be incorporated
in sensitivity analyses.
Keywords: epidemiology
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Highly Motivated Population Provides Two
Successful Recruitment Methods to the TMD SelfCare Study and PACT Program
Elanadora Sour,1 Jeanette Y. Ziegenfuss,1 Gabriela
Vazquez-Benitez,1 Elizabeth Grossman,1 Robin
Whitebird,2 James Fricton1
HealthPartners Institute, Bloomington, MN; 2School of
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Background: Research study recruitment and committed
participation is an essential but challenging component of
clinical research. In a pilot study testing the feasibility of
recruiting and retaining patients into an online self-care
program for temporomandibular disorder (TMD) pain
management, we tested two recruitment methods.
Methods: Two methods were used to recruit participants.
Invitation letters were sent to affiliated patients or members
with a recent diagnosis of TMD. Others were recruited
through self-referral after exposure to the study by other
means, including a provider’s recommendation or brochure
displayed in a dental clinic. Both methods offered initial
telephone screening and referral to an online screening
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questionnaire. If eligible, patients were randomized to the
online Personalized Activated Care and Training (PACT)
program or traditional self-care. Participant feedback was
obtained from program evaluations at 8 and 16 weeks,
unsolicited comments, and qualitative phone interviews
from a subset of PACT participants.
Results: Among the 81 randomized participants, 60% were
recruited by letters sent and 40% by self-referral. Of 150
letters sent, 49 individuals were recruited into the study, and
61% of these recruits initiated phone or email contact prior
to an outbound recruitment call. Of the 47 self-referrals, 68%
of these were successfully recruited into the study. Survey
completion rates were 93% and 91% at the 8- and 16-week
follow-up evaluations, respectively. Pain was a common
explanation of participant’s initial interest and study
compliance. Participants expressed, “I’ve tried everything. I
hope this helps [my pain]!” One highly engaged participant
reported, “I found it to be a good alternative to avoid having
to take pain medication for my jaw.”
Conclusion: The TMD Self-Care pilot study demonstrated
two successful recruitment approaches that yielded high
recruitment and retention rates as exhibited by follow-up
survey response rates. Participant feedback suggests that this
highly motivated population is seeking alternative methods
to control chronic pain. Understanding these successful
recruitment rates and the incentive of controlled chronic
pain bodes well for a planned larger trial.
Keywords: clinical trials
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Iterative Design and Embedding Research Into an
Operational Survey of Health and Well-Being
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Background: To create a summary measure of health and
well-being for our organization, we needed a subjective
measure of well-being necessarily dependent on self-report.
In July 2015, we launched a member survey for this purpose.
While there is a secular trend of falling response rates,
we have introduced a number of survey implementation
changes that have increased response rates to nearly 50%,
approximately doubling our initial response rates. In this
presentation, we describe the implementation and impact
of iterative design changes to the survey in the context of
a learning health system, including the observed impact on
response rate and potential impact on nonresponse bias.
Methods: In July 2015, we began a monthly survey of a
random cross-section of 1448 members. The initial survey
process included a mailing of a 7-page survey, followed by a
second mailing and phone follow-up to nonresponders. Our
www.aurora.org/jpcrr
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current process includes an initial email survey to the 40% of
members who have an email address on file, a single mailing
of a 3-page survey with a $2 incentive and subsequent
phone follow-up to nonresponders. Most changes have been
introduced experimentally, allowing us to understand the
impact of each independently.
Results: To date we have collected 14,267 surveys. We have
improved our response rate from 26% to a high of 50%. We
have learned the positive impact of a $2 incentive compared
to no incentive, a shorter or mid-length survey compared to
a longer survey, and the null impact of including a picture
with an email request to complete a web-based survey. We
also will report on the overall impact of introducing an
additional mode for survey completion.
Conclusion: In the context of a robust data collection
effort to meet organizational needs, we have embedded
iterative experiments to improve survey response rates and
representativeness of the resultant data.
Keywords: survey research and methods
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Methods and Guidelines for Integrity of Multivariable
Analysis of Real-World (Observational) Data
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Background: The credibility of observational data analysis
(ODA) for scientific evidence is a prevalent concern.
Numerous threats militate against validity, reproducibility,
integrity of inference, and the self-correcting mechanism
of the scientific method. Sampling error is only one
component in a long sequence of distortive forces in the
scientific process that informs the clinical knowledge base,
and often not the most important. Many methodological
and systematic pitfalls introduce loss and distortion of the
“signal” representing causal relationships in nature, much
as noise compromises transmission in a communication
channel. Existing practices (including analysis methods,
standards, and guidelines) for multivariable ODA borrow
substantially from those for randomized trials and do not
specifically address many idiosyncrasies of ODA that must
be taken into account if reproducible and scientifically
meaningful results are to be obtained. Updated approaches
to addressing ODA quality (ie, veridicality) are needed.
Methods: We deconstruct the process of generating
scientific evidence about health effects and outcomes with
ODA and identify prevalent, but often overlooked, sources
of potential distortion of information and inference. Our
perspective connects multiple-bias modeling, causal graph
theory, modeling strategies, reproducible research methods,
and Bayesian epistemology to define a coherent approach to
ODA that optimizes inferential integrity. On this basis, we
make recommendations for remediation at critical points.
Results: Major points of focus for revised practice standards
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include a) explicit specification of the underlying causal
and modeling assumptions; b) uncertainties due to model
specification, overfitting, and predictive optimism; c)
formal incorporation of reproducibility and expectation for
reproduction of research into ODA; and d) expression and
evaluation of results in terms of reduction of uncertainty and
alteration of prior belief.
Conclusion: The value of ODA for clinical decisionmaking is constrained by uncertainties above and beyond
those represented in estimated standard errors. This theory
of a system of practice suggests guidelines for ODA and
a standard for ODA evaluation. This model for ODA
encourages a coherent approach focused on support for the
self-correcting mechanism in science and optimization of
inferential integrity.
Keywords: observational study, risk adjustment, clinical
outcomes, biostatistics, research findings
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Background: As “apps” that work with electronic health
record (EHR) systems become increasingly common, an
important question is how to evaluate an app’s effectiveness,
particularly to answer the question of whether the app
can overcome the inertia of habit by improving physician
efficiency. We describe an EHR app (CM-SHARE) for
cardiometabolic conditions that has been developed to
improve physician efficiency and close care gaps (improve
evidence-based care). Herein, we describe our approach to
measuring the impact on physician efficiency using EHR
audit log data and learnings from user feedback.
Methods: Population: CM-SHARE was implemented in 2
primary care clinics for 6 providers since April 2016. By
studying audit data, we can reconstruct major steps in the
clinic workflow as well as how the EHR is used during
each time interval. The workflow measures derived from
audit log file were validated by in-clinic observation of 100
encounters from 4 providers. We used pre-post case-control
cohort selection to determine comparable cases (ambulatory
visits in which CM-SHARE was used) and controls
(ambulatory visits in which CM-SHARE was not used) for
the preimplementation and postimplementation periods.
Physician EHR time and total number of EHR clicks in the
examination room are primary outcomes. We used a mixedeffect model to evaluate the intervention’s effect. Patient
characteristics (age, gender, level of service, primary reason
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for visit, comorbidities) also were controlled in the model to
remove a residual confounding effect.
Results: After patient-level matching, there were 1037
encounters from 290 intervention patients, 1008 encounters
from 290 postimplementation matched controls, and 2901
encounters from 870 preimplementation matched controls.
Comparing intervention to control patients, there was no
difference in overall encounter duration, regardless of
encounter characteristics (ie, level of service). CM-SHARE
significantly reduced providers EHR time in the exam
room by 25%–35% for diabetes- or hypertension-related
encounters. The impact of CM-SHARE also was presented
through a 21%–36% reduction of provider total number of
EHR clicks for diabetes- or hypertension-related encounters.
Providers’ overall EHR activities were not significantly
reduced.
Conclusion: EHR audit log is a helpful tool for evaluating
“apps” in improving physician efficiency.
Keywords: cardiovascular disease, information technology
adoption and diffusion, primary care, health care
organization, technology assessment
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An Emergency Department Intranet Site Is an
Effective Method of Making Time-Sensitive
Information Available to Frontline Staff
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Background: Regions Hospital is a Level 1 trauma center
and stroke center with an emergency department (ED)
serving 80,000 patients per year. More than 450 full- and
part-time staff members work in the ED and need to provide
care to a wide variety of patients at all hours of the day
with continuously evolving guidelines, practice patterns,
interdepartmental agreements, quality standards, and
regulatory requirements.
Methods: Our department developed a robust intranet site
(EDNET) based on the Microsoft Sharepoint™ platform in
2014 to create a repository for up-to-date information that is
readily accessible by ED frontline staff on a 24/7 basis.
Results: Since 2014, EDNET has become the largest
department intranet site in Regions Hospital, with 1183–
6900 hits per month in 2017. We’ve developed direct
links to EDNET from our electronic medical record. After
brief instruction from information technology services,
an emergency medicine physician was able to create the
site architecture, optimized for frontline staff. Department
leadership staff members with limited website expertise are
able to quickly upload pertinent operational information.
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EDNET stores text from emailed operational updates,
freeing staff from the need to access email during busy
shifts. A robust search function allows staff to quickly search
for pertinent information. Volume of search queries varies
from 145 to 401 unique queries per month in 2017. Most
common search terms are “dka,” “ortho grid,” “tia,” “tpa,”
and “detox.” We are able to quickly update information
on EDNET without having to tax limited information
technology availability. We also can highlight pertinent
policies and make them more readily available to staff.
Conclusion: Our ED has found benefit in the use of a
Sharepoint-based intranet site as a one-stop shop for the
information that our staff needs to safely and effective care
for our patients.
Keywords: health care workforce, information technology,
hospital, dissemination, implementation, innovation,
research findings
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Background: Patients have served as powerful health
advocates for prevention of various diseases including lung
and breast cancer. This study explores whether cervical
cancer patients may serve as health advocates to adolescents
and their parents in encouraging the uptake of the human
papillomavirus (HPV) vaccine. Despite recommendations
that adolescents age 11–12 years receive the vaccine, only
about half of females and less than half of males receive the
recommended vaccine dose. HPV is the cause of nearly all
cervical cancer.
Methods: The study targeted an opportunity sample of
women seen in the gynecologic oncology clinic for cervical
cancer. During interviews, patients were asked about
provider conversations regarding causes or prevention of
cervical cancer, what HPV was, what the HPV vaccine
was, what discussions they may have had with family or
friends about the causes or prevention of cervical cancer,
and whether they would be willing to talk with family or
friends about the HPV vaccine. A total of 23 interviews were
conducted in 2016–2017. Patients ranged from 28 to 85
years of age. Four team members developed a preliminary
coding list, refined the list into overarching themes, then
used these themes to code the interviews.
Results: Six primary themes resulted from analysis of the
transcripts –– 1) patients’ expressed fears about vaccines;
www.aurora.org/jpcrr
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2) low level of health literacy and understanding of the
causes of cervical cancer; 3) patients’ acquiring health
information from sources other than medical professionals
(eg, television, internet); 4) whether or not providers held
conversations with patients regarding HPV and the vaccine;
5) patient stigma or lack of stigma surrounding cervical
cancer; and 6) patients’ willingness or reluctance to serve as
a health care educator.
Conclusion: While cervical cancer patients overall
expressed a willingness to serve as health care educators,
barriers remain. Low health literacy expressed as vaccine
fear and a lack of understanding of the causes of cervical
cancer persist. Many patients described receiving their HPV
vaccine information from television advertising, as opposed
to coming from their health care provider. These issues will
need to be addressed in order for cervical cancer patients to
be effective health care advocates.
Keywords: human subjects research, cancer, health
promotion, prevention, screening, patient-provider
communication, qualitative research
P16.03
Improving Response Rates in Patient-Reported
Outcome Measurement Questionnaires in the
Orthopedic and Neurosurgery Patient Population

HealthPartners Institute, these units agreed on a common
system using email with internet links, as well as paper
surveys for those without computer access, combined with
in-clinic tablets for nonresponders. The system feeds results
into our EMR system and clinical workflows for patients
having a knee replacement, hip replacement, or spinal
discectomy/laminectomy or fusion.
Results: Over the past 5 months, since implementation,
we’ve collected 1033 more outcomes questionnaires from
our patients than we did in 2016. Our 1-year response
rate has improved from 29% to 74%. With the automated
identification of patients, staff no longer have to manually
identify and collect PROM data. Staff also are prompted in
the EMR when a patient is due for a follow-up questionnaire.
Conclusion: In large specialty care settings, capture of
outcomes data is challenging due to cost, workflow, and
patient challenges. By incorporating advanced multimodal
data capture into clinical workflows and EMR system,
response rates at baseline and postsurgery have achieved
levels that are credible for stakeholder needs and quality
improvement.
Keywords: information technology adoption and
diffusion, survey research and methods, patient-provider
communication, health care organization, patient-reported
outcomes/function
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Background: The effective and efficient collection of
patient-reported outcome data and integration of such data
directly into the electronic medical record (EMR) and
downstream databases has often been referred to as the
holy grail for determining the effectiveness of orthopedic
treatment. The manual process of collecting such data
has proven costly, ineffective, and disruptive to clinical
workflows. Poor baseline and post-surgical follow-up survey
response rates are difficult to overcome. This project focused
on automating data capture using existing tools to improve
response rates, unburden care teams, and promote use of
the data for shared decision-making as well as including the
data in existing registries.
Methods: The need for patient-reported outcome data
for public reporting and to meet payer and governmental
programs and internal quality improvement prompted
HealthPartners to pursue solutions for collecting patientreported outcome measures (PROM) through pilot within the
orthopedic and neurosurgery departments. In a collaborative
effort between TRIA Orthopaedic Center, Park Nicollet
and HealthPartners orthopedics and neurosurgery, and
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Background: Health care is being challenged to achieve the
Triple Aim as defined by the Institute of Medicine. Learning
health systems (LHS) represent a model with much potential
to achieve the Triple Aim when embedded in a culture of
learning and improvement. While LHS concepts have been
well described, the practical steps to create such a system are
not well defined. Dentistry faces challenges in establishing
the necessary infrastructure to become a learning health
system.
Methods: We examined the current LHS literature that
defines the framework for measuring progress in creating
the infrastructure of a LHS. This framework was utilized to
measure progress and consider future steps in creation of a
LHS in dentistry. We looked for entities in dentistry who
have publically declared their intention to create a LHS.
Results: The current literature provided a consistent
framework for a LHS. This literature comes from hospital,
health care, and educational settings but none from dental
settings. The National Institutes of Health/National Institute
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of Dental and Craniofacial Research-funded National
Dental Practice-Based Research Network has created an
infrastructure that links many dental practices in the United
States and creates a culture of learning and improvement but
lacks the knowledge grid and the feedback loops that allow
for learning and sharing of knowledge. We identified 3 large
dental groups within health care systems that have made
progress in building cultures of learning and improving and
in the creation of the knowledge grid, and that are working
to create a LHS.
Conclusion: Dentistry has made progress in establishing
a LHS, although these efforts have been limited to a few
organizations. The most progress has been achieved in
establishing network for sharing, and the case example
of HealthPartners Dental Group will be presented as an
organization that has been able to establish a culture of
learning and quality improvement. Challenges remain in
establishing the knowledge grid and the essential systemic
feedback loops. These findings establish important factors
that will shape the future agenda for creation of a LHS in
dentistry.
Keywords: dental care, quality improvement

more likely to be white (68%), have greater than a high
school education (89%), be hormone users (89%), and
have no history of TG surgical procedures (64%). The
most common themes coded in preliminary analyses were
confidence in providers’ care (“It’s insulting. I shouldn’t
know more about my care than my physician.”); issues
related to the TG case manager (“I don’t know whether [the
case manager] is experienced in this position … she dropped
the ball … she’s not proactive.”); navigating KPMAS for
TG care (“It’s already overwhelming navigating the system,
but [to have to] be the bridge for two [KP departments] … is
a little frustrating.”); and lack of information for TG patients
(“Very few people actually know what’s covered”).
Conclusion: Improvements in the quality of care for
TG patients requires targeted efforts on patient-focused
initiatives. Resources to further grow the KPMAS TG health
services program (such as hiring personnel, training staff/
providers, website support, and a dedicated TG advocate)
could result in considerable achievements in TG quality of
care at KPMAS.
Keywords: quality of care, qualitative research, quality
improvement, patient experience/satisfaction

P16.05
Transgender Response and Quality of Care Study
at Kaiser Permanente Mid-Atlantic States: Patient
Focus Groups

P16.06
Developing Patient-Informed Health Education
Materials in an Integrated Health System: The Case
of Safe Fish Consumption

Suma Vupputuri,1 Christine Truong,1 Ayanna Wells,1
Alphonse Derus,1 E.W. Emanuel1

Jennifer Renner,1 Abigail S. Katz,2 Thomas Kottke,2
Patricia McCannn,3 Lisa Harvey,1 Jeanne Mettner,1
Ruth Taswell,1 Jeanette Y. Ziegenfuss1

Kaiser Permanente Mid-Atlantic States, Rockville, MD
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Background: Transgender (TG) patients are a heterogeneous
group of health care consumers and the quality of their care
is unknown. The purpose of this study is to describe Kaiser
Permanente Mid-Atlantic States (KPMAS) TG care from
the patient perspective using qualitative analyses from focus
groups.
Methods: A comprehensive literature review was conducted
to inform the development of the focus group script. We
solicited feedback on experiences with KPMAS health care,
barriers/facilitators of care, expectations, and satisfaction.
Recruitment consisted of a brief message sent via KP.org
to patients in the TG registry. Of the total 254 patients
who were messaged, 54 responded by phone and/or email
to participate. We recruited 39 patients to participate in 1
of 4 focus groups, and a total of 28 patients attended the
2–3-hour group discussions. (Groups ranged from 6 to 8
patients). Atlas.ti software was used to code and organize
themes for the typological qualitative analysis.
Results: Of the 28 TG patients who participated in the focus
groups, 11 identified as female, 3 as male, 6 as transwomen,
1 as transman, 5 as nonbinary/gender queer, and 2 as not
sure/questioning or other. Focus group participants were
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Background: It is important that health materials for
patients be designed with their input, especially for a topic
as nuanced as safe fish consumption (the message: eat fish,
but be informed and intentional about which species you
choose to eat). As a large integrated health system, we have
numerous existing avenues –– our research and education
institute (Institute), care delivery system, and health plan ––
to collect this type of input.
Methods: In partnership with the Minnesota Department of
Health (MDH), we developed materials promoting safe fish
consumption for women who are or could become pregnant.
Initial research, not detailed here, involved focus groups of
women in the target population to inform alpha versions of
our materials. To further refine these materials, we tapped
into our organization’s feedback avenues, reaching out
to HealthPartners’ myVoice marketing panel (1200 plan
members and/or patients willing to share insights about
specific topics via online panel 1–2 times per month) and
Patient Council (15 plan members who meet in person
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10 times per year). Findings from these member/patient
feedback sources were used to refine the alpha materials with
expertise from the Institute’s patient education department.
Results: The myVoice panel reported trust in both
HealthPartners and the Institute but more familiarity with
the HealthPartners brand, which informed the logo used on
our materials. Patient Council confirmed an unfamiliarity
with the Institute and reported confusion about the title of
our brochure, which resulted in a new name, Choose Your
Fish, to clarify its contents.
Conclusion: The ability to make use of the numerous
established feedback pathways built into our integrated
system has been invaluable, and the partnership was
successful. Input from patients and members through
embedded feedback sources has resulted in fish consumption
materials designed for and informed by patients. With proper
formal partnerships, it is possible to simultaneously meet
MDH and HealthPartners goals using the extant resources
of our organization.
Keywords: health promotion, prevention, screening,
engagement of stakeholders, health care organization,
qualitative research
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The Patient Engagement in Research Scientific
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Leslie Wright,1 Ellis Dillon,2 Sarah Madrid,1 Gina
Napolitano,3 Leah Tuzzio,4 Mary Schramke5
Institute for Health Research, Kaiser Permanente Colorado,
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Health, Mountain View, CA
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Background: The Health Care Systems Research Network
(HCSRN) Patient Engagement in Research Scientific Interest
Group (PER SIG) aims to help researchers build infrastructure
for PER and to develop generalizable tools to enhance
engagement efforts. We are a network of researchers committed
to and experienced with patient engagement who want to
collaborate and build support and best practices for PER.
Methods: The PER SIG began in 2013 as the Member
Engagement in Research Work Group, following the inception
of a member engagement toolkit developed by research staff
at Kaiser Permanente Colorado. Attendees motivated to
further PER within HCSRN conducted a baseline assessment
of organizational readiness to conduct PER and created the
Patient Engagement Workbook, a set of standards for guiding
engagement practices. The workbook was presented at the
2014 meeting and generated interest in patient-engaged
126 JPCRR • Volume 5, Issue 1 • Winter 2018

research. This group became a formal SIG in spring 2014
and includes researchers and patient partners from within and
outside of HCSRN who contribute to discussions at monthly
webinars, offer consulting services, and co-lead PER SIG
workshops. PER SIG webinars are well attended and cover
novel methods for expanding patient engagement.
Results: The PER SIG currently has 122 members, with 50%
being very active. We’ve hosted numerous presentations and
consultations during our monthly webinars and presented at
the 2015–2017 HCSRN annual meetings. During the 2016
conference we hosted a half-day workshop on patientengagement fundamentals, sustaining engagement, and
gaps in assessing impact. This was followed by a 1.5-day
workshop focused entirely on developing methods for
assessing impact, funded by a Patient-Centered Outcomes
Research Institute (PCORI) Eugene Washington award.
These workshops have generated 2 publications and many
collaborations within HCSRN and with other organizations.
Patient partners have expressed that our collaboration across
research institutions communicates sincerity.
Conclusion: The PER SIG is a rich resource for fostering
patient engagement within HCSRN and is recognized by
PCORI and our local organizations as a leader in PER.
It has created a virtual community of practice that shares
tools, manuscripts, and questions through its listserv and
will ensure continued research support for PER despite
fluctuations in national funding for this work.
Keywords: research ethics, patient-provider communication,
patient experience/satisfaction, engagement of stakeholders,
patient-reported outcomes/function, clinical decisionmaking, dissemination, implementation, innovation
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Background: Patient recruitment studies use a variety
of methods; however, little is known about recruitment
strategies on response rates by race. The purpose of this
analysis is to describe patient response, by race, to different
Supplement

recruitment strategies employed at 3 study sites for a 6-month
pragmatic clinical trial assessing the effectiveness of values
affirmation on reducing racial disparities in antihypertensive
medication adherence.
Methods: HYVALUE is an ongoing patient-level
randomized controlled trial being conducted at Denver
Health (DH), Kaiser Permanente Colorado (KPCO) and
Kaiser Permanente Mid-Atlantic States (KPMAS). White
and black adult patients with uncontrolled blood pressure,
who have an upcoming appointment with their primary
care provider, are eligible for inclusion. All sites identify
potentially eligible patients from the electronic medical
record and perform recruitment telephone calls. The 3 sites
customize additional recruitment methods including use of
introductory mailed letters (KPMAS), voicemail messages
left for all eligible patients (KPCO), and dual enrollment of
patients engaged in a similar study (DH). We compared the
recruitment rate (number of patients completing screening
form / number of patients called) by race for each site.
Results: During the first 6 months of HYVALUE, 206 patients
were recruited out of 714 (28.9%) called. The proportion of
white and black patients at each site varies. The recruitment
rates by site were 32% at DH, 32% at KPCO, and 26% at
KPMAS. At DH, the recruitment rate by race was 27.8%
white and 34.4% black. At KPCO, the recruitment rate was
33.9% white and 27.9% black. At KPMAS, the recruitment
rate was 18.8% white and 26.7% black. Further, KPMAS had
an 8.5% patient response to the mailings alone (ie, patients
contacted the study by phone or mail), with the majority of
these responses from black patients. Of the 206 patients that
were recruited, 154 patients were enrolled (74.8%).
Conclusion: The initial recruitment experience of
HYVALUE demonstrates little difference in recruitment by
race at DH and KPCO, but higher recruitment rates of blacks
compared to whites at KPMAS. These results emphasize
the need for multimodal recruitment strategies based on the
underlying sampling population to optimize the recruitment
rates in multicenter trials.
Keywords: cardiovascular disease, human subjects research,
racial/ethnic differences, health care, clinical trials
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Cost-Effectiveness of Physician Incentives for
Resident Feedback
Jessie Nelson,1 Hilary Simon,2 Callie Schnitker,2 Sandi
Wewerka3
Emergency Medicine, Regions Hospital, Saint Paul,
MN; 2Regions Hospital Emergency Medicine Residency,
Saint Paul, MN; 3Critical Care Research Center, Regions
Hospital, Saint Paul, MN

Graduate Medical Education for graduation. Facultygenerated feedback has been shown to improve residents’
progression toward these ends. Unfortunately, feedback
quality has often been lacking in residency education.
Our EM residency introduced cards completed by faculty
at end-of-shift to highlight and hopefully improve direct
feedback given to residents, but initial use by faculty was
inconsistent. In response to resident-perceived deficiencies
in end-of shift feedback, small annual financial incentives
were offered for improved percentage of end-of-shift cards
completed (as a proxy for feedback quantity) as well as
resident-rated quality of each faculty physician’s end-ofshift feedback.
Methods: The aim of this study was to determine if
faculty-directed financial incentives improved shift card
completion percentage and resident-perceived quality of
faculty-to-resident feedback. In this institutional review
board-approved retrospective observational study, feedback
was compared pre- and postimplementation of a financial
bonus policy. Eligible faculty were employed throughout
a 1-year time period before and after implementation of
the incentive (n=24). Quantity of feedback was calculated
as the number of cards completed per shift worked with
at least one resident. Quality of feedback was determined
from annual surveys asking residents to rate the quality
of feedback received from each faculty member over the
previous year on a scale from 1 to 9. The average faculty
score before and after incentive implementation was
determined and compared.
Results: Mean percentage of shift cards completed was
significantly higher postincentive (mean: 129.51%, SD:
42.82) compared to preincentive (mean: 26.54%, SD:
41.69); P<0.01. Mean resident-perceived feedback quality
scores were similar preincentive (mean: 7.52, SD: 0.63)
and postincentive (mean: 7.71, SD: 0.57); P=0.66.
Conclusion: This financial incentive is associated with
significantly increased quantity of end-of-shift card
completion, but no difference in resident-perceived quality
of end-of-shift feedback.
Keywords: human subjects research, health care
workforce, hospital
P16.10
Assessing Researcher Experience and Attitudes
Toward Patient Engagement in Research
Michael Gionfriddo1
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Background: Emergency medicine (EM) residents in
the United States must attain predetermined educational
milestones set forth by the Accreditation Council for

Background: Patient engagement is becoming increasingly
recognized as not only an ethical approach to research but
also an important way to make research more applicable and
relevant to the ultimate end-user: the patient. The PatientCentered Outcomes Research Institute has mandated
that all proposals have an engagement plan defining how
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the proposed research will engage relevant stakeholders,
including patients, throughout the research, from topic
selection through dissemination activities. We conducted
a survey to better understand researchers’ experience with
and attitudes toward patient engagement in research at our
institution (Geisinger Health).
Methods: The survey was sent to all staff listed as primary
investigator, co-primary investigator, or co-investigator on
a research protocol approved by Geisinger’s institutional
review board.
Results: We had a 24% response rate (140 of 588). Of those
who responded, 81% conducted human subjects research.
While the majority responded that they involved patients
as participants in research, few engaged patients in other
ways, with the second most common way (18%) being
having patients help them identify topics and questions
for research. Researchers reported barriers to involving
patients in research, with the most common being that it
was logistically challenging (48%) and that it takes too
much time (34%). Of those who reported involving patients
in their research in some way, 53% reported substantial
benefits. Of all respondents, 46% were interested in
learning more about involving patients in research, with
most wanting to learn about resources for supporting and
facilitating patient involvement in research and effective
strategies for initiating and sustaining patient involvement
in research.
Conclusion: These data will be used to help us refine our
organization’s strategies for promoting and facilitating
patient engagement in research.
Keywords: engagement of stakeholders

Jessie Nelson,1 Alan Sazama,2 Kristi Grall,1 Sandi
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team by attending conference, attending conference on
time, and completing evaluations. The inaugural season of
the competition was from August 2016 to May 2017. This
planned preliminary analysis details the impact of the first
3 months of “competition” on emergency medicine faculty
attendance, resident tardiness, and conference evaluation
completion.
Methods: We retrospectively reviewed faculty attendance
data from August to October in 2014, 2015, and 2016.
Percentage of faculty attendance was calculated by
noting the number of faculty attending at least 1 hour
of conference and dividing it by the total number of
clinically active faculty. Number of tardies to conference
was compared within the time period of August 2016–
October 2016. Finally, we reviewed conference evaluation
completion rates from August to October in 2014 and 2015
and compared them to 2016 completion rates.
Results: Faculty conference attendance in August–
October of 2014 and 2015 (pre-Conference Cup) averaged
8.17 (SD: 2.88, 95% CI: 6.33–10.00) and 10.25 (SD: 3.44,
95% CI: 8.06–12.44), respectively. In August–October
2016, faculty conference attendance was 13.25 (SD: 3.82,
95% CI: 10.82–15.67). Average number of residents tardy
to conference trended downward in each month of the
Conference Cup (August: 7, September: 5.3, October: 4.6).
Conference evaluations completed for August–October
was 9.09 (95% CI: 2.48–15.70) in 2014; 10.73 in 2015
(95% CI: 4.96–16.50), and 23.3 in 2016 (95% CI: 17.90–
28.70).
Conclusion: The first months of Conference Cup
competition were associated with increased percentage
of emergency medicine faculty attendance at weekly
residency didactic conference compared to 2014 and
trending to significant improvement over 2015. Conference
evaluation completion rates similarly show a strong trend
toward a significant increase. Within the time period of the
Conference Cup, faculty and resident tardy arrivals are
trending downward.
Keywords: health care organization, workforce, hospital,
quality improvement

Emergency Medicine, Regions Hospital, Saint Paul,
MN; 2Regions Hospital Emergency Medicine Residency,
Saint Paul, MN; 3Critical Care Research Center, Regions
Hospital, Saint Paul, MN

P16.12
Colorado Patient Partners in Research: Engaging
at Multiple Intersections in Patient Health

P16.11
Preliminary Impact of a Novel Team-Based
Competition on Faculty Attendance to Weekly
Residency Didactics

1

Background: Our residency implemented a novel teambased competition called the Regions Conference Cup with
several goals for the academic year, including improved
faculty didactic conference attendance, improved ontime attendance, and improved conference evaluation
completion rates. Team captains were chosen from residency
leadership. Opportunities for scoring were determined by
residency leadership, a priori, based on preexisting goals.
Residents and faculty were then randomly assigned to
teams. Players (residents and faculty) score points for their
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Colorado Patient Partners in Research, Denver, CO

Background: Colorado Patient Partners in Research
(CoPPiR) is a Denver Health/Kaiser Permanente partnership
designed to raise patients’ voice, involvement, and
leadership in Colorado health research. Our work centers
on three approaches: a patient stakeholder council (CoPPiR
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Council); the CoPPiR Network connecting researchers
with patient partners; and social media promoting patientcentered research approaches and directing people to the
CoPPiR Network. The CoPPiR Council governs all three
aspects of our work.
Methods: The CoPPiR Council provides broad guidance to
Colorado-based research shops and individual researchers
on patient-centered approaches to research design,
implementation, data interpretation, and dissemination. To
ensure a safe and respectful place for all council members
to be heard, and for engagement to be beneficial, various
trust-building strategies have been implemented: a member
recruitment plan co-developed by community advisors and
community research liaisons; opening each meeting with
a Conocimiento question; and capacity-building trainings
emphasizing co-learning and exploring the intersection of
patient engagement and research partnership.
Results: In the span of 18 months the council has grown
to 9 very diverse, core members. They have completed 6
trainings specifically tailored to council goals, developed
the CoPPiR Council and Network governance document,
presented at 3 statewide conferences, attended 2 PatientCentered Outcomes Research Institute annual meetings,
and provided research consultation.
Conclusion: The CoPPiR Council and CoPPiR Network
form a model for patient-engaged research that can be
replicated throughout the health enterprise
Keywords:
research
ethics,
patient-provider
communication, engagement of stakeholders, health care
organization, clinical decision-making, patient-reported
outcomes/function,
dissemination,
implementation,
innovation, access to services, patient experience/
satisfaction

class of research interns, typically students in transition
between undergraduate and graduate programs, trained
these individuals in research practice, and contracted for
statistical and study design support from the Institute.
CCRC also provides research experience to trainees at the
University of Minnesota who do not otherwise have access
to this patient population. Local leadership comes from a
hospital-based physician advisory group.
Results: Over the last 5 years 176 projects have
been initiated, resulting in 115 research presentations
and generating $2.75 million of external funding,
complemented by $570,000 from internal grants. Internal
funding has allowed enhanced support for study design,
data analysis, and manuscript preparation, resulting in an
increased transition to external funding sources. CCRC
also has attracted funding from the Anderson Foundation
to further develop its infrastructure. In 2017, Regions
Hospital leadership sponsored a community survey to
evaluate community attitude and awareness of ongoing
hospital programs in our region. One point of emphasis
in the survey was respondent awareness of research and
clinical trials. When Regions Hospital was considered,
two-thirds of Twin Cities consumers had a more positive
impression of the hospital associated with the conduct of
research and clinical trials.
Conclusion: Driven by a multidisciplinary physician
commitment and organization support, this research center
model allows participation in multiple study types without
the need for extensive academic infrastructure.
Keywords: human subjects research, health care
organization, engagement of stakeholders, research
administration, contracting, operations, hospital

P16.13
Critical Care Research Center: A Research
Platform for the Community Hospital

POPULATION,
COMMUNITY,
WORKSITE HEALTH

David Dries,1 Sandi Wewerka,1 Paula Miller1
Critical Care Research Center, Regions Hospital, Saint
Paul, MN
1

Background: Regions Hospital, due in large part to
specialty care service lines including Level I trauma
and burn management along with critical care, is well
positioned to advance clinical practice through research.
However, the hospital lacks the academic infrastructure of
a university medical center.
Methods: In partnership with the HealthPartners Institute,
a group of physicians in areas including emergency
medicine, critical care, burn care, trauma, emergency
medical services, and hospital medicine created a research
center funded with grants from committed departments.
The Critical Care Research Center (CCRC) hired a
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Background: It is widely recognized that one of the keys
to successfully managing population health is improved
measurement of health status. Recognizing this issue,
DaVita HealthCare Partners implemented a program
to expand the number of Southern California members
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who receive a hemoglobin A1c test as a tool to diagnosis
prediabetes/diabetes and to improve glycemic control
in current diabetic patients. It was recently estimated
that nearly half of adult Californians (13 million) have
prediabetes or undiagnosed diabetes.
Methods: Laboratory results were searched for hemoglobin
A1c tests results (Logical Observation Identifiers Names
and Codes, or LOINC® codes, 4548-4, 4549-2, 59261-8,
62388-4, and 17856-6) during the period January 1, 2007,
through December 31, 2016. In the greater Los Angeles
area, DaVita HealthCare Partners serves over half a million
members.
Results: Of the more than 2.5 million hemoglobin A1c test
results found during the study period, nearly all (over 99%)
were due to LOINC code 4548-4, which is the standard in
the United States today. In 2009, an international expert
committee recommended the hemoglobin A1c test be
available (in addition to fasting plasma and oral glucose
tolerance tests) to help diagnose type 2 diabetes and
prediabetes. The total number of hemoglobin A1c tests
administered increased substantially over the 10-year
study period, from 81,864 in 2007 to a high of 509,067
tests in 2015 and 414,726 tests in 2016. The number of
new members tested in each year averaged 54,756 over the
10-year period. The number of tests per member averaged
1.81 per year with slight year-to-year variation.
Conclusion: DaVita HealthCare Partners successfully
expanded the coverage of hemoglobin A1c testing among
their Southern California population. The increase is
largely due to expanding the number of members tested
rather than an increase in the number of tests per member.
A multifaceted approach, involving both providers and
patients, appears effective at increasing hemoglobin A1c
testing among those previously not tested. The results
of ongoing interviews that describe the intervention to
increase testing, including key components, barriers,
and lessons learned, will be incorporated as part of this
research.
Keywords:
observational
study,
patient-provider
communication, engagement of stakeholders, diabetes,
qualitative research, chronic disease, clinical practice
patterns/guidelines
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Background: About half of physicians report burnout
nationally. Physician surveys revealed that 36% of
all physicians and 44% of primary care physicians (a
specialty already facing a workforce shortage) in this large
multispecialty health system reported symptoms of burnout.
It is an organizational priority to address physician burnout
by exploring factors contributing to burnout and potential
interventions to enhance well-being.
Methods: The study included a survey, the results of
which helped guide in-depth interviews. The survey, which
regarded burnout (using a nonproprietary single-item
measure) and factors affecting burnout, was delivered to
all providers at 5 multispecialty medical groups. Univariate
and bivariate analyses were conducted to study providers’
self-care practices, perceptions of work environment, and
their associations with well-being. The in-depth interviews
were conducted with frontline physicians and organizational
leaders and included discussion of factors identified as
associated with well-being/burnout via the surveys and what
changes might be made to improve well-being. Two coders
analyzed interviews using deductive and inductive coding
methods to identify themes and conceptual domains related
to well-being.
Results: Survey response rate was 47%; 40% reported
burnout symptoms (41% among physicians and 33%
among nonphysician health care providers). Average life
satisfaction was 80 (SD: 23) on a scale of 0–100; 82%
perceived having control over work schedule; 9% felt that
physicians are highly valued; 67% reported calm atmosphere
in work area. Lower burnout rates were found for providers
who perceived having good control over their work schedule
(32% vs 75%; P<0.001), who felt physicians were highly
valued by the organization (16% vs 43%; P=0.009), who
reported a calm atmosphere in their primary work area
(32% vs 57%; P<0.001), who slept ≥ 7 hours/night (27%
vs 45%; P=0.003), and who exercised ≥ 2 days/week (35%
vs 50%; P=0.017). Interviews were conducted with 17 key
informants. Interviewees prioritized organizational factors
over individual factors. Reducing physician workload and
electronic health record (Epic) in-basket work (described as
“a virtual hamster wheel”), increasing feeling valued by the
organization, and creating meaning in work were identified
as most salient for addressing well-being. A factor identified
as protective of well-being is a sense of community at
work. Suggestions included maximizing resources so that
physicians are working at the top their skill level, having
the right support staff available, and rethinking full-time
equivalence (FTE) definitions. Interviewees suggested that
addressing these topics would have a trickle-down effect on
workload, work-life balance, and autonomy.
Conclusion: Burnout symptoms varied by self-care
practices and perceived work experience. Addressing
in-basket burden, allocating sufficient support staff, and
maximizing resources may have a ripple effect and improve
other dimensions related to improving physician wellbeing. Changes at every level of the organization must be
coordinated to maximize physician well-being.
Supplement
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Background: Poor access to care leads many patients in
the United States to use the emergency department (ED) for
conditions that may be “avoided” by timely ambulatory care.
The NYU/Billings ED algorithm is one of several systems
for estimating these potentially-avoidable ED visits. Health
care systems use these tools to improve patient outcomes
and lower costs through actuarial risk stratification and
individual interventions. We used geographic information
systems (GIS) and spatial analysis to examine if geographic
clusters exist and overlap for potentially avoidable visits
and high institutional costs of care, suggesting potential
opportunities for Triple Aim interventions.
Methods: 74,644 ED visits to Regions Hospital were
analyzed using the NYU/Billings ED algorithm as applied
to up to 5 discharge diagnoses to determine the probability
that each condition needed ED care, selecting the condition
with the highest probability of being emergent. Trauma,
mental health, and drug/toxicology cases were excluded.
Internal cost-accounting figures for each ED visit were
then obtained, including associated inpatient costs when
applicable. For each ED visit, the potential visit avoidability,
the costs for the visit, and other visit characteristics (eg,
acuity, disposition) were then aggregated by block group for
cluster and hotspot analyses using ArcGIS.
Results: Spatial statistical analysis of average acuity,
avoidability, and cost per visit did not show significant
differences among neighborhoods. However, GIS analysis
demonstrates significant clustering and overlap of both
potentially avoidable ED visits and high total and marginal
costs in a small but significant number of block groups.
These neighborhoods have similar 2010 U.S. Census
characteristics as well as similar propensities for ED use
based on data from the Minnesota Department of Health.
Notably, they also have significantly fewer primary care
resources available.
Conclusion: Geospatial analysis of ED visits for potential
avoidability and cost can identify opportune neighborhoods
for educational, primary care, or alternative health care
interventions to improve care and lower costs through
improvements in public health. Our future analyses and
modeling will integrate patient-level factors in order to
specify which conditions, patients, and neighborhoods are
most likely to benefit from Triple Aim efforts to reduce
potentially avoidable ED visits and their costs by improving
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health care access.
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Background: The SuperShelf model of food shelf design
uses behavioral economic strategies to influence customers’
healthy food selection by making the healthy choice the
easy choice. But the critical question is whether it is costsustainable for food shelves to implement the model. We
are examining the feasibility of defining the relationship
between the amount of money the food shelf spends on
food, the quantity of food provided to customers, and the
nutritional quality of the food. If measurement is feasible,
we will test the cost-sustainability of the SuperShelf model.
Methods: We implemented the SuperShelf model in
two Minneapolis/Saint Paul metro area food shelves. We
analyzed food shelf invoices for January to July from the
two main food banks before (2016) and after (2017) we
implemented SuperShelf to control for seasonality effects
on cost and availability. We calculated cost per person per
month (“pppm”) and pounds of food pppm. Food shelf
invoices were scored for nutritional quality using the Food
Assortment Sorting Tool. We also analyzed food shelf
invoices for two control sites in the same way.
Results: Food shelf assessments showed that SuperShelf
was delivered with greater fidelity at intervention site A
compared to site B. Neither SuperShelf food shelf increased
pppm cost and both were able to provide customers with
more food pppm than before the intervention. Additionally,
intervention food shelves maintained food quality
postintervention. We observed a similar trend in control site
A, but an opposite trend in control site B.
Conclusion: We conclude that it is feasible to measure the
cost-effectiveness of the SuperShelf model. Preliminary
results indicate that food shelves that implement the
SuperShelf model can be cost-sustainable and can increase
the quantity and amount of healthier foods provided to
customers.
Keywords: financial analysis
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